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SUMMARY.
The aim of the work presented in this thesis was to investigate the status of the 
guanine nucleotide - binding protein, G0, in the neuroblastoma x glioma hybrid cell 
line, NG108 -15 and to assess any functional changes brought about by morphological 
differentiation of these cells.
The guanine nucleotide - binding proteins ( G - proteins) are a family of highly 
homologous proteins which function to couple a considerable range of cell surface 
receptors for hormones, neurotransmitters and growth factors, either to enzymes 
involved in the generation of intracellular second messengers or to specific ion 
channels. Each G - protein consists of three subunits termed a , (3 and y, although it is 
the diversity in the sequence of the a  subunit which defines the identity of each G - 
protein. Amongst this family is G0, originally the G - protein of unknown function, 
which is implicated in the regulation of voltage - sensitive Ca^+ channels.
The first part of this thesis describes the production and characterization of 
specific antisera directed against unique peptide stretches of the a  subunit of G0 
obtained from molecular cloning sequence analysis. Three antisera, each raised against 
different regions and specific for G0a  were produced using this strategy. These were 
characterized using
1. Immunoblot analysis with purified preparations of G0a.
2. Comparison of immunoblot analyses with various tissues known to contain G0a.
3. Mixing experiments with existing well characterized G0a  antisera and other G - 
protein antisera.
Morphological differentiation of the neuroblastoma x glioma hybrid cell line,
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NG108 -15, can be achieved with any of a number of pharmacological agents which 
exert their function by raising intracellular cAMP. When subjected to ADP - 
ribosylation by pertussis toxin, a marked increase in incorporation of radiolabel was 
observed in membranes from these treated cells when compared to controls. 
Subsequent quantitative immunoblot analysis with the specific G0a  antipeptide 
antiserum, IM1, revealed there to be a marked increase in G0a  immunoreactivity over 
control in the membranes prepared from each of the treated cells. The other G0a  
antisera produced similar results, confirming the original observations. However, the 
levels of the p subunit did not change appreciably with differentiation.
As well as increases in the levels of G0oc, differentiation of these cells with db 
cAMP (1 mM, 6 days) resulted in a marked decrease in the levels of Gj2oc as 
determined using two specific antisera. Stimulation of high - affinity GTPase activity in 
response to opioid peptides, which in this cell line interact with an opioid receptor of 
the 5 subclass, was much decreased in the db cAMP - differentiated cell membranes in 
comparison with membranes of untreated cells. Also, inhibition of adenylyl cyclase by 
these same opioid peptides was almost entirely attenuated in differentiated cell 
membranes although it was noted that opioid receptor number was also decreased in 
these membranes in comparison with the control cells.
Bovine brain has recently been shown to contain two forms of G0cc, namely 
G0a  and G0a*. Two - dimensional analysis consisting of an isoelectric focussing first 
dimension followed by SDS - PAGE and immunoblotting revealed two species of 
immunoreactive G0a, with isoelectric points of 5.5 and 5.8, in membranes from 
NG108 - 15 cells. Differentiation with all of the treatments resulted in an increase in the 
levels of only the more acidic isoform. The possibility that these isofoims differed by 
some form of covalent modification was considered. Both were shown to be substrates 
for ADP - ribosylation by pertussis toxin and incubation with alkaline phosphatase,
X X I I I
under conditions that dephosphorylate Gi2oc, had no effect on either of the G0a  
isoforms.
Separation of the two isoforms was achieved in one - dimension using SDS - 
urea PAGE analysis. The more slowly migrating band was the more acidic form and 
corresponded exactly in mobility with the major form of G0a  from both rat and mouse 
brain. However, there was no equivalent in brain of the more rapidly migrating form of 
G0a  in the cells suggesting that this protein was not identical to G0oc*.
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Chapter 1. 
INTRODUCTION.
Chapter 1.
INTRQPUCTiQK
1. I. Historical Perspective - The involvement of GTP in the hormonal
control of adenvlvl cvclase.
Many hormones, growth factors and neurotransmitters exert their actions on 
target cells through modulations in the levels of a number of intracellular second 
messengers. It is now apparent that many of these effects are elicited via a family of 
closely related guanine nucleotide - binding proteins [ G - proteins ] which act as 
transducing elements.
In a pivotal series of experiments performed in the late 1950’s and early 1960's 
Earl Sutherland and his colleagues discovered that cAMP was able to mediate the 
actions of adrenaline upon canine liver [Rail et al., 1957; Sutherland et al., 1962]. 
Sutherland suggested that the enzyme responsible for regulating cellular cAMP levels, 
adenylyl cyclase [ E.C. 4. 6 .1 .1 . ] , could be hormonally stimulated and that this 
activation was mediated through specific receptors on the cell surface. Once the receptor 
was filled by a hormone, a conformational change in the catalytic moeity of the enzyme 
resulted in a switching - on of the cAMP apparatus.
In the ensuing two decades much effort was expended into the investigation of 
hormonal regulation of cyclic nucleotide synthesis and in the identification of the 
various components involved in that regulation.
Rodbell and his co - workers first demonstrated that GTP was required for 
glucagon activation of adenylyl cyclase in plasma membrane fractions from rat
i
hepatocytes and that GTP enhanced the dissociation rate of radiolabelled glucagon in 
these membranes [Rodbell et a l, 1971a; Rodbell et al., 1971b; Harwood et al.,
1973]. Subsequent studies using radiolabelled p - adrenergic antagonists and purified 
erythrocyte plasma membranes gave essentially the same results as for glucagon thus 
confirming a central role for GTP in receptor - mediated activation of adenylyl cyclase 
[Rodbell, 1980].
Using non - hydrolysable analogues of GTP [ namely GTPyS and GppNHp ] 
Schramm & Rodbell noted that it was possible to irreversibly activate adenylyl cyclase, 
even in the absence of hormone [Schramm & Rodbell, 1975]. The effect of hormone 
on this process was to increase the rate of formation of the irreversibly activated 
enzyme [Cautrecasas et al., 1975] suggesting that the role of the hormone - receptor 
complex is to make it possible for activation of adenylyl cyclase by guanine 
nucleotides. A divalent metal ion was also needed for activation and indeed no 
irreversible activation was seen in its absence [Rodbell, 1980].
Hormonal stimulation of adenylyl cyclase results in the hydrolysis of GTP to 
GDP. The demonstration of this receptor - controlled event and its apparent 
involvement in termination of the hormonal response was first described by Cassel & 
Selinger. They showed that activation of p - adrenoreceptors in turkey erythrocytes 
simultaneously caused an increase in high affinity GTPase activity and resultant GTP - 
dependent stimulation of adenylyl cyclase [Cassel & Selinger, 1976]. Although GTP 
involvement was shown in hormone activation of adenylyl cyclase, its means of 
interaction with the components of the signalling pathway was still largely unknown.
Since these pioneering studies showing involvement of G - proteins in 
hormonal signalling, it has become increasingly apparent that a family o f : i ~ :
highly homologous G - proteins are the targets for guanine nucleotides in these 
processes and that these proteins act as the main transducing element between the
2
receptor and its effector [ Figure L I . ] .
Classical G - proteins involved in the control of hormone action are however a 
subset of a larger group of GTP - binding proteins. Members of this superfamily 
include the proteins that control protein synthesis of which Elongation Factor Tu ( EF - 
T u) is the most studied [for review see Allende, 1988] and a group of " small " G - 
proteins with molecular masses of 20 - 25 kDa. Included in this group are the ras proto 
- oncogene product [Barbacid, 1987], Gp, a protein isolated from placenta [Evans et 
al., 1986] and the products of the yeast YPT1 and SEC4 genes [Salminea & Novick,
1987]. However, this introduction will concentrate mainly on those proteins involved 
in hormonal signal transduction.
1. 2. G - Proteins - Characterization. Structure and Function.
1. 2. 1. Characterization of the G - Protein a  subunit.
All of the G - proteins so far characterized appear to exist as heterotrimers 
comprising 3 non - identical protein subunits termed a, P and yin order of decreasing 
mass. They are classified by the identity of their distinct a  subunit and it is believed, in 
the majority of instances, that it is the a  subunit which defines the nature of the 
interactions between that G - protein and both the receptor and the effector moieties 
with which it interacts.
To date nine genes that encode for the a  subunits have been identified [Kaziro, 
1990]. 12 polypeptides are known to be the the products of these genes [ Table 1.1. 
]. The a  subunits range in size from 39 - 46 kDa from primary sequence information as 
derived from corresponding cDNA clones. The twelve a  subunits characterized in this 
way are:
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Figure 1. 1.
Schematic diagram of a generic G - protein - coupled receptor and 
effector.
Activation of receptor ( R ) by the first messenger leads to interaction with and 
activation of the heterotrimeric G - protein ( G ) associated with the cytoplasmic surface 
of the membrane which in turn interacts with and regulates an effector ( E ) that 
generates an intracellular second messenger.
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Table 1. 1.
The structure and function of the » classical 11 G - proteins.
G - protein Sensitivity to Function 
ADP - ribosylation 
bv bacterial toxins
Distribution
Gs ( x 4 ) cholera toxin stimulation of adenylyl universal
cyclase,
activation of
dihydropyridine
- sensitive Ca^+ channels
Tdl cholera toxin 
pertussis toxin
activation of cGMP 
phosphodiesterase
rod outer 
segments
Td2 cholera toxin 
pertussis toxin
activation of cGMP 
phosphodiesterase
cone outer 
segments
Golf cholera toxin stimulation of adenylyl olfactory
cyclase sensory
neurones
Gz (Gx) none undefined, 
stimulation of 
phospholipase C ?
undefined, but 
restricted
Gil pertussis toxin undefined limited; high 
levels in brain
G{2 pertussis toxin inhibition of adenylyl 
cyclase, 
stimulation of 
phospholipase C
universal
G;3 pertussis toxin regulation of K+ 
channels
undefined; 
universal ?
G, pertussis toxin regulation of Ca^+ 
channels
limited
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Gsa  .Two forms of Gsa  corresponding to polypeptides of 46 and 44 kDa 
have been identified [Northup et al., 1980]. However, molecular cloning has revealed 
the existence of four forms of Gsa  cDNAs ( Gsa  1 - 4 ) which have been isolated and 
characterized from human brain. Gsa l  and Gsa3 are identical except that Gsa3 lacks a 
single stretch of 45 nucleotides. Gsoc2 and Gsa4 have three additional nucleotides to 
Gsa l  and Gsa3 at the 51 end of exon 4 [Bray et al., 1986]. Bovine adrenal gland has been 
shown to contain two Gsa  cDNAs that correspond to Gsa l  and Gsa4 which when 
expressed in COS - m6 cells generated the 52 and 45 kDa forms of the Gs protein 
[Robishaw et al., 1986a; Robishaw et al.> 1986b]. Translation of the four forms 
indicated that the two short forms of Gsa  consist of 380 and 381 amino acids and have 
Asp 71 - Glu 72 and Asp71 - S e r 7 2  at the splice junction respectively. The two long 
forms of Gsa  consist of 394 and 395 amino acids, having a 15 amino acid insert in 
place of the Asp71 residue.
The human Gsoc gene isolated by Kozasa et al., 1988 contained thirteen exons 
and twelve introns spanning approximately 20 kilobases of the genomic DNA.
Comparison of the four human Gsa  cDNAs with this human genomic sequence 
suggests that four types of Gsa  mRNAs may be generated from the single Gsa  gene. 
Analysis of the nucleotide sequence upstream of the initiation codon reveals a high G +
C region suggesting the possible binding site for the transcriptional factor Spl. No 
typical TATA box or CCAAT box was found in the promotor region of the Gsa  gene 
[Kozasa et al., 1988]«
Gs has been unequivocally established as the stimulatory regulatory element of 
adenylyl cyclase as demonstrated by its ability to reconstitute hormonal, fluoride and 
guanine nucleotide regulation and cholera toxin sensitivity to the Gsa  - negative 
adenylyl cyclase system of cyc~ S49 lymphoma cells [Northup et al., 1980; Codina 
et al., 1983]. Purified preparations of Gs have also been shown to stimulate the fully
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purified catalytic subunit of adenylyl cyclase [May et al., 1985]. Gs has also been 
implicated to have a role in the stimulation of dihydropyridine - sensitive Ca^+ 
channels. Yatani and coworkers were able to demonstrate that both GTPyS and a 
purified preparation of Gs were able to prolong the survival of, and indeed stimulate, 
this class of calcium channels in membrane patches excised from guinea pig cardiac 
myocytes and bovine cardiac sarcolemmal vesicles incorporated into planar lipid 
bilayers [Yatani et a l 1987]. These results were confirmed when analysis using 
skeletal muscle T - tubule calcium channels inserted into lipid bilayers were also, 
regulated by Gs. The advantage of these channels over cardiac channels is their «
stability, thus allowing assessment of the effects of Gs under steady state conditions 
[Yatani et al., 1988]. These findings seemed to challenge the hypothesis that although 
one G - protein can interact with several receptors, a given G - protein can only interact 
with one effector. However, since Gs may consist of up to four distinct polypeptides, it 
is conceivable that each variant may couple to a different effector species. To test this  ^
Mattera and coworkers looked at the ability of the splice variants of Gsa  to interact with 
both adenylyl cyclase and calcium channels. These workers utilised recent advances in 
recombinant DNA techniques to synthesize three of the four splice variants and were 
able to demonstrate that each of these polypeptides activated both adenylyl cyclase and 
the calcium channels to some extent [Mattera et al., 1989].
Tdltx, T d 2 a : The visual transduction cycle exists as a parallel to the 
hormonal transduction cycle. Both systems consist of receptor activation of a G- 
protein resulting in its interaction with effector and subsequent modulation in the 
production of second messengers. In the case of the rod photoreceptor cells, 
phototransduction occurs in the retinal rod outer segment. Activation of the 
photoreceptor, rhodopsin, by light results in its photoisomerization from the 11 - cis - 
retinal to the all - trans - retinal form enabling rhodopsin to interact with transducin (
Td), the G - protein of the phototransduction cascade. Transducin then undergoes 
exchange of GDP for GTP and subsequent dissociation from its heterotrimeric
conformation. This enables the activated a  subunit of transducin to stimulate a specific 
cGMP phosphodiesterase which rapidly hydrolyses cytosolic cGMP [for review see 
Stryer, 1986]. Activation of a single receptor molecule causes the hydrolysis of 10^ 
cGMP molecules in a fraction of a second. The transient decrease in the levels of cGMP 
causes the closure of the cGMP - sensitive cation channels on the plasma membrane of 
the cell resulting in the hyperpolarization of the cell. Deactivation of the activated 
transducin occurs upon hydrolysis of the bound GTP by the intrinsic GTPase activity 
of transducin and subsequent reassociation of the holomeric protein. A similar 
transduction system exists in cone photoreceptor cells, however this system uses a cone 
specific form of transducin ( termed Td2 as opposed to Tdl for rod transducin). Both 
forms of transducin have been cloned and the primary amino acid sequence homology 
between the two transducins is more than 85 % [Lochrie et al., 1985; Lerea et a l ,
1986].
Golf : As well as visual transduction, G - proteins appear to be involved in 
other sensory systems. Evidence has been presented to show that, at least for some 
odorants, olfactory signal transduction is mediated by an adenylyl cyclase cascade 
coupled through a G - protein [for review see Bruch & Gold, 1990]. Previously, Jones 
& Reed identified five distinct cDNAs encoding the a  subunits of Gs, G0, and Gjl-3 
from a rat olfactory cDNA library [Jones & Reed, 1987]. However, rescreening of this 
library using low stringency hybridization with a fully degenerate oligonucleotide probe 
directed towards a portion of the highly conserved GTP - binding domain and 
subsequent elimination of the known a  subunit cDNAs left a single class of clones that 
hybridized weakly with Gsa. These cDNAs encoded for a single olfactory 
neuroepithelium - specific Gsa  - like protein which the authors called G0jf [Jones & 
Reed, 1989] and was exclusive to olfactory tissue, particularly the olfactory neurons. 
The predicted primary structure of G0jf reveals a 44 kDa polypeptide consisting of some 
381 amino acids sharing 88 % identity with Gsa.
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Gx (Gz) : This a  subunit was cloned simultaneously from human brain 
[Matsuoka et al., 1988] and human retina [Fong et al., 1988] and hence the confusing 
nomenclature. It has 355 amino acids and is 41 -67 % identical in amino acid 
composition with those of other known a  subunits, being most similar to the GjOC 
family of proteins.
G jl, Gj2, Gj3 : Originally designated as the G - protein which mediated the 
inhibition of adenylyl cyclase, molecular cloning has revealed, to date, the presence of 
three highly similar a  subunits termed Gil, Gi2and Gf3 based on the order in which 
they were cloned. The term Gj is ambiguous, while it first defined the G - protein 
mediating inhibition of adenylyl cyclase, it is now used widely to define those G - 
proteins, other than Go, which have a  subunits that are substrates for pertussis toxin 
catalysed ADP - ribosylation. The distribution of these proteins is markedly different 
Whilst G{2 and G{3 appear to be present in all tissues so far examined, G^l is mainly 
expressed in brain tissue. Heterogeneity of these proteins has been confirmed both 
immunologically [Milligan,1988; Milligan^l990] and through their deduced primary 
amino acid sequences obtained by molecular cloning [ Jones & Reed, 1987; Itoh et al.,
1988].
There is evidence to suggest that, in some cell types, Gj2 is the G - protein that 
mediates hormonal inhibition of adenylyl cyclase [McKenzie & Milligan, 1990] and that 
Gj3 is involved in the ability of muscarinic receptors to stimulate a certain class of K+ 
channels in atrial and pituitary membrane patches [Yatani etal., 1987]. However, no 
such function has yet been ascribed to Gjl.
G0 : cDNA cloned from libraries made with mRNAs from a number of sources 
predict a polypeptide of 354 amino acids which has most homology to the G^a class of 
polypeptides. This protein is more fully discussed in section 1. 4.
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Cloning studies have revealed there to be a high degree of species homology 
between the members of the G - protein family. Figure 1. 2. shows the complete 
predicted amino acid sequences for several cloned a  subunits. The amino acid sequence 
of Gsa  is strongly conserved between human and rat, only 1 out of 394 amino acids is 
different and the sequence of bovine G ila  is identical to that found in human. Even a 
form of Gsa  found in Drosophila is 71 % identical with that from mammalian sources 
[Kaziro, 1990].
To date genomic clone analysis has been performed on a small number of the G 
- proteins. Screening of human genomic libraries with the corresponding rat cDNA's 
has led to the isolation of human genes coding for Gsa, G ila, Gi2a, Gi3a and G0a  
as well as the a  subunit of Gz ( Gx ).
1. 2. 2. Properties of the G - protein a  subunit.
G - protein a  subunits contain the guanine nucleotide - binding site and are able 
to bind GTP in the submicromolar range. The a  subunit also contains the intrinsic 
GTPase activity which is necessary for the role of the G - protein in signal 
transduction. Since the function of these G - proteins is to couple agonist - activated 
receptors to various effector systems which are able to alter the levels of a number of 
discrete second messengers, this regulation must be under strict control. Thus the 
activation of effectors must be of limited duration and the G - proteins involved in that 
particular coupling should undergo subsequent deactivation. In the absence of a 
hormone - receptor complex, the rate of dissociation of GDP, the product of the 
GTPase reaction, limits the rate of the GTPase, since the catalytic rate is roughly 10 - 
fold faster than the GDP dissociation rate [Freissmuth et al., 1989]. The a  subunit 
also contains at least one high - affinity binding site for divalent metal ions; Mg^+ is the 
physiological ligand required for the formation of the activated GTP - bound species. In 
addition, Mg^+ appears to interact with a low - affinity binding site within the GDP -
10
Figure 1. 2.
Primary sequences of the a  subunits of the currently identified pertussis 
toxin - sensitive G - proteins expressed in rat.
Areas of identity are shaded. In cases in which identity at particular residues 
does not extend across all the polypeptides, then the closest homolgy to the" Gj - like " 
subfamily is indicated. Where each of Gjl, G{2 and Gj3 is represented by a different 
amino acid at one position then no further homology to G0, Tdl or Td2 is noted. The 
sequences for G0, Gjl, G[2 and Gj3 are taken from Jones & Reed [1987], that for Tdl 
from Tanabe et al. [1985] and that for Td2 from Lochrie et al. [1985]. This figure is 
reproduced from Milligan [1988].
>_)>-• >< fu Gw f»
W 13 O U Q  U  IIFigure 1. 2
0  V J i4 * 4  z  s
e ea&r&g0 Q «< O << ><
Si cIcScl ^
MHM £,
►q ,w w  H» u> & &&& %
; iu . w
H  H  
« «  'g M
£8 ££
M >  iMcO i<8
«  V  ^  ^  H  H
O  O CTO O H  E-t•j u  ^ s MO  O  0 C 3 0  H Ho  o  c5 c!Tc5  e-T h
11
liganded a  subunit and the affinity of this site may be regulated by the agonist - bound 
receptor [Gilman, 1987].
Figure 1. 3. shows the classical G - protein cycle [Gilman,1984; Gilman,
1987]. In the resting state the holomeric G - protein exists with GDP bound to the 
guanine nucleotide - binding site of the a  subunit. Upon receptor activation the rate of 
release of GDP, which appears to be the rate limiting step in the G - protein activation / 
deactivation cycle, is enhanced and the the released GDP is replaced with GTP. The 
holomeric aPy complex is now able, in the presence of Mg^+, to dissociate into an 
activated a  subunit with GTP bound and free py. The active a  subunit is now able to 
interact with the catalytic moiety of its particular second messenger generating system 
e.g. adenylyl cyclase, phospholipase C, or a variety of ion channels to alter the rate of 
production of the second messenger. Hydrolysis of the terminal phosphate of the 
bound GTP by the intrinsic GTPase activity of the a  subunit results in its deactivation. 
The a  subunit, now with GDP bound, is able to reassociate with py to restore the G - 
protein to its resting state. Interruption of this cycle can occur when non - hydrolysable 
GTP analogues such as GTPyS or GppNHp are introduced. These have the effect of 
permanently activating the G - protein due to the complete blockade of the 1 turn o ff' 
GTPase activity [Gilman, 1987].
Another means of permanently activating the a  subunit artificially has been to 
use certain fluorometallic compounds which simulate the terminal phosphate of GTP. 
Stemweis and Gilman were able to show that the activating effect of millimolar 
concentrations of F" ions depended on the presence of micromolar amounts of 
aluminium and suggested that the real activating species could be the ion complex A1F^‘ 
[Stemweis & Gilman, 1982]. Bigay and coworkers then measured the stoichiometric 
binding of one aluminium per transducin and furthermore, the presence of GDP 
binding to transducin was essential to this activation. Noticing strong structural
12
Figure 1. 3.
The role of GTP binding and hydrolysis in the activation and 
deactivation of a schematic G - protein.
The function of the G - proteins is to couple agonist - activated receptors to their 
effector systems. This process appears to be cyclical and of limited duration. This 
figure is reproduced from Milligan [1988].
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analogies between AIF^- and a phosphate group they proposed that the metallofluoride 
complex bound in the nucleotide site and mimicked the presence of the terminal 
phosphate of GTP, hence conferring on the G - protein its active conformation [Bigay 
e ta l, 1985; Bigay etal., 1987].
G - protein a  subunits contain sites for covalent modification by various 
bacterial exotoxins which catalyse NAD+ - dependent ADP - ribosyltransferase 
reactions* One such toxin, cholera toxin from Vibrio Cholerae has been shown to ADP 
- ribosylate both Gs and transducin. The toxin catalyses the ADP - ribosylation of an 
arginine residue at position 201 in Gsa  [Van Dop et al., 1984]. Covalent modification 
of these polypeptides by the toxin stabilises the GTP - form of the a  subunit, inhibiting 
its intrinsic GTPase activity and resulting in the permanent activation of the a  subunit in 
much the same way as the non - hydrolysable GTP analogues [Milligan, 1988; Spiegel,
1988]. In the case of Gs, adenylyl cyclase is now maximally stimulated and no longer 
under hormonal control.
The primary structure around this substrate arginine is highly conserved in all of 
the G - proteins which have been so far identified and the arginine itself is invarient in 
the equivalent position in the other G proteins. Using amphipathic and secondary 
structure analysis of the primary sequences of Gs, Tdl, Td2, Gj and G0, Masters and 
her coworkers were able to predict the secondary structure of a composite a  subunit 
which they termed a ayg . This subunit was shown to contain four short regions of 
sequence homology to regions in the guanine nucleotide - binding domain of bacterial 
Ef - Tu. Similarities between the predicted secondary structure of cc^g and the known 
secondary structure of EF - Tu allowed for the construction of a 3 - D model of the 
guanine nucleotide - binding region of a avg [Masters et al., 1986]. Arg 201 was 
found to be close to the guanine nucleotide - binding domain in this model.
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Pertussis toxin, an exotoxin from the organism Bordetella Pertussis has been 
extremely useful in the identification of a subset of G - proteins which are themselves 
substrates for mono ADP - ribosylation by the toxin. The toxin itself consists of six 
subunits one of which, the SI subunit, displays an ADP - ribosyltranferase activity [for 
review see Gill, 1977]. Like cholera toxin, pertussis toxin was originally shown to 
produce sustained elevation in the receptor - mediated production of cAMP in pancreatic 
islets, hence the toxin originally being called Islet Activating Protein ( IAP) [Katada & 
Ui, 1979; Katada & Ui, 1981].
Amongst the substrates for this toxin are Tdl, Td2, G^l, Gj2, Gj3 and G0. 
Pertussis toxin appears to exert its effect on the G - protein cycle in a manner different 
from that of cholera toxin. Instead of inhibiting the intrinsic GTPase activity of the a  
subunit by converting GTP into a superactive nucleotide thus irreversibly activating the 
simulatory G - protein, pertussis toxin appears to prevent the receptor - mediated 
dissociation of the afty complex resulting in the inability of the G -protein to interact 
with its effector. The site of pertussis toxin - catalysed ADP - ribosylation in G - 
proteins that are substrates for this toxin is a conserved cysteine residue located four 
amino acids from the C - terminus [Masters et al., 1986]. Interestingly, in Gx (Gz) the 
Cys residue is replaced by lie indicating that this G - protein is refractory to 
modification by pertussis toxin [Matsuoka etal., 1988; Fong et al., 1988] and Gs, 
which is also resistant, contains a Tyr instead of Cys at this position [Itoh et al.,
1986].
1
1. 2. 3. Characterization of the G - Protein B subunit.
There is also diversity in the nature of the p subunit. Two forms have been 
isolated: a major form running at 36 kDa on SDS - PAGE ( p i ) and a minor one 
running at 35 kDa ( P2) [Winslow et al., 1986; Evans et al., 1987; Woolkalis & 
Manning, 1987]. Both forms are widely distributed [Hinsch et al., 1989] with the
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exception of retinal tissue which appears to contain only pi and placenta where P2 is 
the major form [Evans et al., 1987]. p i and P2 are immunologically distinct [Roofer 
al., 1985; Evans et al., 1987] but have a 90 % homology in primary amino acid 
sequence [Fong et al., 1987; Gao et al., 1987].
The two P subunits are not the result of alternate splicing of a single gene but 
are the products from two separate genes [Amatruda etal., 1988]. These genes have 
been located on separate chromosomes in human, pi on chromosome 1 and p2 on 
chromosome 7 [Lochrie & Simon, 1988]. A third p subunit ( termed P3 )has recently 
been sequenced from a cDNA from brain. This protein, with a Mr of 37 kDa, has close 
homology to the other P subunits. The amino acid sequence of P3 has 83 % identity to 
pi and 81 % identity to p2 although the 3* untranslated regions of the three cDNAs 
encoding for the proteins show no significant homology [Levine et al., 1990].
1. 2. 4. Characterization of the G - Protein y subunit.
The y subunits exist as a group of small (8 -1 0  kDa) distinct proteins which 
under all physiological conditions remain tightly bound to the P subunit in a complex 
generally refered to as the py complex. Although the total number of y subunits is not 
yet known, immunoblotting studies suggest the existence of at least four different y 
subunits with possible tissue - specific distribution. These are the and y^ subunits 
associated with brain Gs, Gj andG0 [Robishaw et al., 1989], y which is associated 
with retinal transducin [Hildebrandt et al., 1985] and a form found exclusively in 
placenta [Evans et al., 1987].
To date only the retinal y subunit [Hurley et al., 1984; Ovchinnikov et al.,
1985] and the brain y, subunit [Gautam et al., 1989; Robishaw et al., 1989] have o
been cloned and sequenced. The retinal y clone produced a cDNA which encoded a
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peptide consisting 74 amino acids with a calculated molecular weight of 8.4 kDa 
whereas the brain y^ clone encoded for a protein with three amino acids fewer. When 
aligned, comparison of these two predicted amino acid sequences revealed significant 
variability, with substitutions in no less than 41 of 71 of the aligned residues. The 
majority of these differences occured in the amino - terminal halves of the proteins and 
were mostly non - conservative substitutions, often resulting in the replacement of 
charged residues in the retinal y  subunit with uncharged residues in the brain y^ subunit 
[Robishaw etal., 1989].
Fung and coworkers have recently demonstrated, in brain py, that the y  subunit 
is methyl esterified on the a  - carboxyl group of a C - terminal cysteine residue and that 
this modification is likely to be associated with lipidation at the sulphydryl group 
of the same cysteine [Fung et al., 1990], thus explaining the tight membrane binding 
property of the py complex. This event has a precedent, in ras proteins, the C - 
terminal cysteine appears to be polyisoprenylated in the biosynthetic step prior to the 
attachment of a palmitoyl group on a nearby cysteine residue [Buss et al., 1987].
Fukada and coworkers recently reported that it was possible to separate the 
transducin py complex into two components, each of which appeared to differ only by 
the y subunit They found that one of the retinal py complexes, which they termed Tpy- 
2, enhanced the binding of GTP to the a  subunit of transducin in the presence Qf  
metarhodopsin n  by about 30 - fold when compared to the other Py complex( TPy-1) 
indicating that a specific y subunit1 is essential for the physiological function of 1 
transducin [Fukada et al., 1989]. In a more recent article the same authors reported that 
as well as being methyl esterified, a famesyl moiety is attached to the C- terminal 
cysteine residue of the y subunit in the Tpy-2 complex, which is the active form 
[Fukada et al., 1990]. Such modifications were missing from the other py complex 
suggesting that the attached famesyl group is indispensable for the GTP - binding
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activity of transducin. The possibility that such modifications occur in the y subunits of 
the other heterotrimeric G - proteins is unknown at this time.
The diversities in the number of both p and y subunits raises the possibility of 
the existence of numerous different holomeric isotypes of the holomeric G - proteins. 
For example three p subunits and four y subunits produce' twelve possible Py complex 
combinations. The ability of each separate py to interact with each of the known fourteen 
a  subunits would be able, in theory, to provide specifity for the signal transducing
pathways known to interact with G - protein - linked receptors.
/
1. 2. 5. The role of the By complex.
V - .
The role of the py complex has still to be conclusively determined. Although 
detergents are required to solubilize the hormone receptor - linked G - proteins from the 
plasma membrane, once solubilized the a  subunits behave as hydrophilic molecules 
suggesting that a possible function of the py complex could be to anchor the a  subunit 
to the plasma,membrane [Neer & Clapham, 1988]. Certainly the y subunit contains a 
site for possible membrane attachment, a cysteine residue which may undergo lipidation 
upon membrane insertion [Fung et al., 1990] and since the py complex does not 
dissociate under physiological conditions its potential role in anchorage of the a  subunit 
must be considered. Furthermore, removal of the 2 kDa amino terminal region of G jla  
and G0a  with trypsin, although not affecting their GTPase activities, prevents the 
association of these polypeptides with Py. Digestion of the carboxyl terminus of the a  
subunits with carboxypeptidase A did not interfere with the formation of the 
heterotrimer [Neer et al., 1988]. However a  subunit anchorage by py cannot be the 
whole story, since the GTP - induced dissociation of the apy heterotrimer does not 
result in the rapid release of G - protein a  subunits from the membrane. It has been 
noted, however, that analogues of GTP but not of GDP or ATP will cause a slow, time
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- dependent release of the a  but not the py subunit of pertussis toxin - sensitive G - 
proteins from membranes of both NG108 -15 and C6 BUlcells. This guanine 
nucleotide - dependent release does not require proteolytic cleavage of the G - proteins 
as the released forms are the same size in SDS - PAGE as the membrane attached 
forms. Further, antisera directed against both the extreme N - and C - terminal regions 
identified both the released and membrane bound forms [McArdle et al., 1988].
Certain of the G - protein a  subunits are able to undergo a number of different covalent
modifications. Immunoprecipitation of G0a, Gja and Gsa  from astrocytoma cells
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prelabelled with [^Hl myristic acid have demonstrated the presence of amide - linked 
myristate on Gj and G0 but not on Gs [Buss et al., 1987; Schultz et al., 1987], thus 
the observed release of the a  subunits may have more to do with the turnover of 
myristate in the membrane than with any function ascribed by their association with the 
Py complex.
In solution, activation of the G - proteins by non- hydrolysable analogues of 
GTP results in the dissociation of the heterotrimer into the activated a  - GTPyS and free ' 
py. By mass action, increasing the concentration of py should favour the reassociation 
of the subunits, thus deactivating the G - protein. Northup was able to show that 
increasing the py concentration reversed the the activation of adenylyl cyclase by 
GTPyS - liganded Gsa  [Northup, 1985], leading to the proposal that elevation of free 
py concentration could be a general mechanism for hormone receptor - mediated 
inhibition of adenylyl cyclase. Bokoch was able to reinforce this idea when he 
demonstrated that addition of exogenous, purified py was able to inhibit forskolin - 
activated adenylyl cyclase in a dose - dependent manner. Further this inhibition was 
reversed upon addition of proteins which were able to bind pye.g. G - protein a  
subunits [Bokoch, 1987]. A similar scheme has been proposed by Moriarty and 
coworkers as model for the regulation of phospholipase C. The xenopus oocyte has a 
muscarinic receptor - activated Cl- channel that is mediated by inositol [1,4,5] 
trisphosphate. Cells microinjected with human erythrocyte or bovine brain py complex
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showed a dose - dependent reduction of up to 95 % in the evoked Cl“ current [Moriarty 
et al., 1988].
However, if reversal of adenylyl cyclase activation of Gsa  by the release of a 
Py complex from a variety of activated G - proteins was the only mechanism of 
hormonal inhibition of the enzyme, then inhibition ought never to be observed in the 
absence of stimulation by Gsa. In fact, somatostatin is able to inhibit adenylyl cyclase 
in the mutant S49 lymphoma cell, cyc~, which is entirely lacking in Gsa  [Hildebrandt 
et al., 1982] thus inhibition must be occuring via some other method, possibly by 
direct inhibition of the enzyme by G^a.
The dissociation of the major retinal rod outer segment G - protein, transducin ( 
T d l), upon activation by light and the subsequent activation of cGMP 
phosphodiesterase has been the subject of much study [Stryer, 1986; Hingorani & Ho, 
1990]. It has been demonstrated that light also activates phospholipase A2  in dark - 
adapted rod outer segments of bovine retina via a transducin - dependent mechanism 
[Jelsema, 1987] and, more recently, that addition of purified P y - stimulated 
phospholipase A2  activity in dark - adapted, transducin - poor rod outer segments. 
Addition of the a  subunit of Tdl, which itself slightly stimulated phospholipase A2  
activity in this system, inhibited the py- induced increase in enzymic activity probably 
as a result of subunit reassociation since the GTPyS - liganded a  subunit ( which 
cannot associate with Py) was not able to inhibit the activation of phospholipase A2  
induced by py [Jelsema & Axelrod, 1987].
The initial observation that the muscarinic gated - K+ channel ( Ij^Ach) ^  
cardiac myocytes was dependent upon a pertussis toxin - sensitive G - protein 
[Pfaffinger et al., 1985; Breitweiser & Szabo, 1985] and that this channel can be 
studied in isolated patches of membranes has led to the development of sophisticated
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reconstitution assays that involve application of purified G - protein subunits onto the 
patches themselves. Using such a protocol, Logothetis and coworkers reported that 
nanomolar concentrations of purified brain py subunits activated lK.Ach ^  chick 
embryonic patches [Logothetis et al., 1987].
1. 3. Isolation of and G[.
Gill & Meren demonstrated that the A l subunit of cholera toxin, an exotoxin 
from the organism Vibrio Cholerae, was able to activate adenylyl cyclase in pigeon 
erythrocytes. This activation was shown to require GTP, was irreversible and as such 
resembled that produced by the non - hydrolysable analogues of GTP. Activation in 
pigeon erythrocytes could be correlated with the appearance a [ P] - labelled
O/)polypeptide of 42 kDa when the membranes were incubated with the toxin and [ P] 
NAD+ [Gill & Meren, 1978]. Cholera toxin contains an ADP - ribosyltransferase 
activity which allows for the transfer of the ADP - ribose moeity from the radiolabelled 
substrate onto a protein acceptor. From these studies it was first deduced that the GTP 
sensitivity in the hormone signalling pathway was transduced via a stimulatory GTP - 
binding protein or G - protein first named Ns [ stimulatory nucleotide - binding protein 
] but now called Gs [Rodbell, 1980].
As well as GTP and the toxin itself there is a third requirement for toxin - 
catalysed ADP - ribosylation of Gs. Gilman and his colleagues noted that the presence 
of an intrinsic membrane protein was also necessary for the toxin to have its effects 
[Schleifer et al., 1982]. This protein termed the ADP - Ribosylation Factor ( ARF) 
has been found in in every preparation of plasma membranes tested including those 
from cultured mouse lymphoma cells, and human and turkey erythrocytes [Kahn & 
Gilman, 1984]. ARF has been purified from from rabbit liver membranes as a 21 kDa 
polypeptide [Kahn & Gilman, 1984]. More recent studies have shown ARF to contain
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a high affinity guanine nucleotide - binding domain and can therefore be classed among 
the small molecular weight G - proteins. Binding of GTP or its analogues to ARF is 
necessary for the activity of the cofactor in cholera toxin action although no ARF 
GTPase activity could be detected [Kahn & Gilman, 1986].
Having identified a role for a G - protein in the hormonal stimulation of 
adenylyl cyclase resulting in an increase in intracellular cAMP, attempts were made to 
resolve the system further. Using affinity chromatography, Pfeuffer was able to 
dissociate G - protein from a pigeon erythrocyte adenylyl cyclase preparation with 
Lubrol PX solubilization. This resulted in a loss of guanine nucleotide and fluoride 
activation, both of which could be restored upon reconstitution reinforcing the 
proposed involvement of a GTP - sensitive element which was discrete from adenylyl 
cyclase [Pfeuffer, 1977]. Subsequently Pfeuffer & Cassel showed that the 42 kDa 
cholera toxin substrate was specifically bound and eluted from the GTP - binding 
column by the same proceedure and so contained a GTP - binding domain. They 
concluded that cholera toxin affected the adenylyl cyclase system by catalyzing an ADP 
- ribosylation of this 42 kDa polypeptide G - protein thus showing that this G - protein, 
Gg , was a separate molecular species from adenylyl cyclase [Cassel & Pfeuffer,
1978].
i
The resolution of Gs as a signal transducing element w a s  (u n eq u iv o ca lly  - 
obtained using genetic varients of the S49 murine lymphoma cell line. In this cell line^ 
cAMP is cytotoxic to the cell enabling Bourne and his coworkers to select for a clone 
which was unable to synthesize cAMP [Bourne et al., 1975]. This clone named cyc~ 
because it was originally thought to be deficient in adenylyl cyclase has proved to be a 
valuable tool in the elucidation of the various elements of transmembrane signalling.
Using detergent extracts from the wild type S49 cells in which the adenylyl 
cyclase activity was inactivated^Ross and Gilman were able to restore cyclase activity to
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membranes from eye  and that the reconstitution was sensitive to both fluoride and 
guanine nucleotides. They concluded that the eye  cells were actually deficient in Gs 
and not adenylyl cyclase, an observation which was confirmed when they were able to 
show the presence of the enzyme in these cells by direct stimulation of of its catalytic 
moeity [Ross & Gilman, 1977a; Ross & Gilman, 1977b; Ross et al., 1978].
Subsequent cholera toxin ADP - ribosylation of these membranes revealed that whereas 
the wild type S49 contained two cholera toxin substrates at 52 kDa and 45 kDa, the 
eye  membranes lacked any endogenous acceptors for the ADP - ribose transferred by 
the toxin [Northup, 1985]. The use of eye  and the ability to restore adenylyl cyclase 
activation in reconstitution provided an ideal assay to check further Gs purification 
protocols. Northup and his colleagues used such a reconstitution as an assay for Gs 
when it was eventually purified to homogeneity from rabbit liver [Northup et al.,
1980].
Purification of Gs brought with it a number of surprises. Analysis of the 
purified protein by denaturing SDS - PAGE revealed an oligomeric structure
with three distinct polypeptides. These comprised the a  subunit which consisted of two 
subtypes with molecular weights of 52 and 45 kDa and two smaller subunits, P and.y, 
which had molecular sizes of 35 and 10 kDa respectively.
The organization of the G - protein oligomer in the hormonal cycle and the 
means by which it was able to interact with it were unknown at this time. It could be 
shown that the G - protein appeared to exist in two distinct states, non - activated and 
activated. In its heterotrimeric formation Gs could be shown to be in the non - active 
basal state whilst its activated form was shown to be the GTP - bound free a  subunit 
[Northup, 1985]. Activation of the G - protein either directly by hormone or indirectly 
by fluoride or the GTP analogues resulted in the dissociation of the oligomer, releasing
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the activated a  subunit. Preparations of purified Py were shown to have no effect in 
activating adenylyl cyclase in eye and so the activation appeared to be solely 
dependent on the activated a  subunit. However whilst no stimulatory function was 
ascribed to it, py was shown to exert an inhibitory constraint on adenylyl cyclase 
activity and, with the availability of purified Py, it was shown that Py inhibited the 
activation of Gs [Northup et al., 1982; Northup et al., 1983]. Py appeared to interact 
with only one a  subunit, a conclusion based upon the ability of holomeric Gs, 
containing the apy complex, to inactivate fluoride - stimulated Gs. Incubation of Gs at
30 °C, and in the presence of divalent cations, resulted in the irreversible dissociation
<
of Gs into a  and py. Placement into the fluoride activation assay allows for the 
determination of the stoichiometry of the subunits. Detergent extracts of S49 cells 
assayed in this way revealed that the amount of py released upon incubation at 30 °C 
exceeded the calculated levels for Gs. This suggested that py was complexed with one 
or a number of G - proteins other than Gs. This hypothesis was supported by the 
finding that the levels of Py in the cyc~ cells were identical to those in the wild type 
S49 cells and that incubation at 30 °C in the presence of a divalent cation was required 
for eye  suggesting that py was indeed complexed to another G - protein. [Northup et 
al., 1983].
It was suggested that as well as hormone stimulation of adenylyl cyclase via 
Gs, the enzyme could be inhibited through a ligand coupled to an inhibitory G - protein 
analagous to Gs. Rodbell and his colleagues were able to show that GTP bimodally 
regulated adenylyl cyclase activity [Rodbell, 1980]. In the absence of stimulatory 
hormone, guanine nucleotides are able to inhibit adenylyl cyclase and whilst this 
inhibition is not so dramatic as the stimulation ( usually amounting to some 30 - 70 % 
diminuation), it is well established for a number of hormones. Like the stimulatory 
ligands, inhibition requires GTP and divalent cation. In addition,the inhibition is 
dependent upon the monovalent cation Na+ [Northup, 1985].
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Identification of a G - protein as being involved in the inhibitory arm of 
hormonal control of adenylyl cyclase was obtained in a similar manner to that for Gc.
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Bordetella Pertussis, the causitive agent of whooping cough, produces a number of 
exotoxins, one of which islet activating protein ( IAP), or more commonly pertussis 
toxin, was shown to exert its effects by abolishing the hormonal inhibition of adenylyl 
cyclase. This toxin functions by transfer of an ADP - ribose group to an appropriate 
acceptor site on the GTP - sensitive element of the inhibitory pathway. Using the toxin 
in conjunction with radiolabelled NAD+ revealed specific incorporation of label into a 
41 kDa polypeptide in membranes of rat C6 - BUI glioma cells when analysed using, 
autoradiography. This labelled protein was presumed to be the inhibitory G - protein, 
Gi[Katada&Ui, 1982].
Purification of Gs from rabbit liver in the absence of fluoride, to prevent 
subunit dissociation yielded a 41 kDa G - protein associated with py in a 10 x excess 
over Gs [Northup, 1985]. Katada & Ui had previously shown that pretreatment of 
membranes from bovine brain with pertussis toxin abolished hormonal inhibition of 
adenylyl cyclase and that this was associated with a toxin - specific ADP - ribosylation 
of a 41 kDa polypeptide [ see Section 2.10. ]. When the 41 kDa protein which co 
- purified was incubated with pertussis toxinyt too was a substrate for pertussis
toxin. So the study into the nature of the Py complex led to the isolation of the 
inhibitory G - protein, Gp
G[ co - migrates with Gs during the initial chromatographic steps, but can be 
separated from Gs by either heptylamine - Sepharose or hydroxyapatite column 
chromatography [Bokoch et al., 1983; Codina et al., 1983]. This protein has 
subsequently been purified to homogeneity from a number of sources [Northup, 1985].
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1. 4. 1. Isolation, purification and characterization of G£ .
G0 was discovered by a number of groups simultaneously when attempts to 
purify Gi from brain yielded a doublet of polypeptides with Mr of 39 and 41 kDa 
[Stemweis & Robishaw, 1984; Neer et al., 1984; Milligan & Klee, 1985]. The 
initial purification protocol utilised the same procedures used to purify Gs and Gj 
from rabbit liver [Northup et al., 1980; Stemweis et al., 1981; Bokoch et al.,
1983] and Gs from turkey erythrocytes [Hanski et al., 1981]. Essentially, 
membranes from bovine brain were solubilized and the extract subjected to a series of 
column separation techniques including anion - exchange chromatography, gel 
filtration and finally hydrophobic chromatography using heptylamine - Sepharose. 
The purification was monitored by the ability of the column eluates to bind GTPyS, 
an indication of the presence of a G - protein. Analysis of this type led to the isolation 
of two proteins from bovine brain which were responsible for most of the observed 
GTPyS binding and accounted for 1.5 % of the total membrane protein [Stemweis & 
Robishaw, 1984]. When the mobilities of the two proteins were compared using 
high resolving SDS - PAGE analysis, they appeared to differ. These were tentatively 
identified as the 41 kDa G^a subunit and the 39 kDa G0a  subunit, designated as 
such from simply being the " other" G - protein [Stemweis & Robishaw, 1984], 
Both of these polypeptides were shown to be excellent substrates for mono - ADP - 
ribosylation by pertussis toxin with each protein incorporating approximately 1 mol 
ADP - ribose / mol of a  subunit indicating the properties of Gj and G0 to be 
extremely similar. The possibility that G0 might have been a proteolytic fragment of 
Gf. was discounted when analysis of the time course of digestion of the two 
polypeptides with trypsin and of their products gave markedly different results. G0 
was digested rapidly to a polypeptide of 38 kDa which was remarkably stable to
2 6
further digestion even after 6 hours exposure to trypsin. On the other hand G[ rapidly 
digested to polypeptides of 39 and 38 kDa. However, these polypeptides did not 
display the same stability as the 38 kDa fragment from G0 and were digested to 
polypeptides of about 30 kDa, with total digestion occurring within 6 hours. Gi 
purified from brain andGj from liver appeared to be digested with the same trypsin 
profile [Stemweis & Robishaw, 1984]. Subsequently, Neer was able to demostrate 
that purified preparations of G0 displayed a measurable GTPase activity and that 
G0a  was found to be associated with a py complex, which was apparently identical 
to those isolated with the a  subunits of Gf and Gs, confirming it to be one of the ' 
classical' G - proteins [Neer et al., 1984].
The identity of G0 as a separate polypeptide, distinct from Gj, was obtained 
immunologically. Gierschik and his collaborators were able to obtain an antiserum 
raised against a purified preparation of G - proteins from bovine brain consisting 
primarily of holomeric Gj and G0 which had been treated with 6M urea. This 
antiserum, termed RV3, reacted specifically with the a  subunit of G0 and with the 
common p subunit but not with either Gsa  or Gja [Gierschik et al., 1986b]. 
Previously this group was able to generate a polyclonal antiserum, termed CW6, 
which was raised against purified transducin and cross - reacted with bovine brain Gj 
[Pines et al., 1985] however, this antiserum did not recognize brain G0a  providing 
evidence that G0 could not be derived directly from G{ by proteolytic cleavage. 
Experiments with mixtures of antisera CW6 and RV3 revealed a doublet on 
immunoblots, comprising G0oc and Gjot, confirming distinct identities for these 
proteins [Gierschik etal., 1986b].
Antiserum RV3 provided a useful tool for investigating both the distribution 
of G0 and in its quantitation , Immunoreactivity on western blots with this antiserum 
was observed in membranes prepared from the brains of a number of vertebrate
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species including frog, chicken, human and rat [Gierschik et al., 1986b]. Indeed, 
antiserum RV3 also identified G0  in membranes of the neuroblastoma x glioma 
hybrid cell line NG108 -15 but was unable to detect G0  in membranes from C6  BUI 
glioma cells [Milligan et al., 1986]. Assessment of the relative amounts of Gj and 
G0  in bovine brain cortical membranes from quantitative immunoblotting with 
antisera RV3 and CW6 , showed that the ratio of G0a  to G^a in these membranes 
was approximately 5 :1 . Thus using the data obtained from these antisera it would 
appear that G0a  accounts for almost 1 % of the total membrane protein in bovine 
brain cortex [Gierschik et al., 1986b]. Applying the same quantitation procedure 
Milligan was able to assess the levels of G0  in NG108 -15 cells as 3.8 pmol G0 oc/ 
mg membrane protein protein [Milligan et al, 1986].
As well as antibodies generated against the ternary G0  complex, other 
researchers have produced antisera directed against either the isolated a  subunit 
[Huff et al., 1985; Tsai et al., 1986; Homburger et al., 1987] or against peptide 
regions deduced from the primary amino acid sequences [Mumby et al., 1986; 
McArdle et al., 1988; Eide et al, 1987].
As purification protocols have improved, the number of identified G - 
proteins has increased. Detailed examination of fractions containing pertussis toxin - 
sensitive G - proteins during purifications from bovine brain have indicated the 
presence of two distinct populations of G0a  [Goldsmith et al., 1988a]. These forms 
differed in isoelectric point and as such could be resolved on high performance ion 
exchange resins. However, a number of different anti - G0  antisera were unable to 
discriminate between the isoforms. More detailed characterization of these G0  forms 
has revealed the existence of up to four discrete proteins all displaying G0  
immurioreactivity. Lang has reported the isolation of two forms of immunoreactive
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G0  from bovine brain which, when subjected to in situ peptide mapping, revealed 
the presence of distinct peptides for each of the isolated proteins [Lang, 1989].
Although it was not possible to distinguish immunologically between the G0  
isoforms, they appeared to migrate with different mobilities on high resolving SDS - 
PAGE gels. Katada was recently able to purify and isolate four proteins from bovine 
brain which displayed G0  immunoreactivity. Each a  subunit was characterized by 
immunoblot analysis and were distinguishable from each other by their Mono Q column 
elution profile. To discount the possibilty that the different elution profiles of the 
G0a  subunits might be due to different py subunits tightly associated with their a
subunits, purification was performed in the presence of GTPyS and Mg^+, >■'
\
conditions which allow for subunit dissociation [Kobayashi et al., 1989].
Subsequent analysis of the four G0(X isoforms by means of peptide mappings after 
their proteolytic digestions and kinetic properties resulted in the proteins being put into two 
subgroups, each consisting of a pair of similar a  subunits [Inanobe et al., 1990].
These two groups of G0o might correspond to the products of the two types of G0  
gene products isolated by Jones & Reed [Jones & Reed, 1987] ( see below), the 
difference within the groups being some form of post - translational modification.
1. 4. 2. The molecular biology of G^.
Recently much effort has been put on the cloning of cDNAs coding for the 
various G - protein a  subunits. Screening of cDNA libraries from a variety of 
sources has produced the isolation of a number of G0a  clones. Itoh was able to 
produce a partial sequence for G0a  by screening a cDNA library from rat C6  BUI 
cells with a synthetic probe corresponding to a 17 peptide sequence obtained from 
amino acid sequence analysis of trypsin - digested purified G0 cc. This G0a  clone 
encoded a sequence of 310 amino acid residues that lacked the amino terminal region 
of the protein [Itoh et al., 1986]. By screening a rat olfactory neuroepithelium cDNA
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library with an oligonucleotide probe, Jones & Reed managed to isolate 32 
recombinant clones encoding five distinct G - protein a  subunits including one which 
encoded a complete G0a  [Jones & Reed, 1987]. This G0  clone, termed G3 1 , 
encoded the additional 44 amino - terminal residues absent from the previously 
reported sequence. Furthermore the comparable protein sequences were identical 
although the nucleotide sequences did differ at one position. Simultaneous* with 
these studies, the sequence of G0a  was determined from a bovine retinal cDNA 
clone [Van Meurs et al., 1987]. Comparison of this nucleotide sequence with the 
partial cDNA clone for rat G0<x revealed a 92 % identity in both the coding and the 3' 
- untranslated regions. From 67 differences in codons between the species there were 
only six differences in the corresponding amino acid sequences, five of them being 
conservative substitutions [Van Meurs etal., 1987].
A number of groups have used oligodeoxynucleotide probes for analysis of 
G0a  mRNA in different tissues. Jones & Reed found that their G0cc probe 
hybridized to two messages of 4.1 and 4.5 kilobases [Jones & Reed, 1987]. In 
contrast Brann and coworkers found that their probe labelled three mRNA species, 
the most abundant having a size of 3.5 kilobases. As expected, this message was 
highly expressed in brain although it could be weakly detected in peripheral tissues 
[Brann et al., 1987]. Using in situ hybridization as a probe to map the occurence of 
G - protein mRNA, Largent and coworkers were able to demonstrate that the mRNA 
species encoding G0a  had a more limited distribution throughout rat brain than the 
- mRNA for either Gsa  or the p subunits [Largent et al., 1988]. Prominent G0a  
message expression occurred in only a few areas such as the claustrum, endopiriform 
nucleus and the Purkinje cells of the cerebellum. These mRNA localisations were 
consistant with the distribution of the G0a  protein determined by 
immunohistochemical analysis [Worley et al., 1986] t
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The development of specific antisera has provided the means whereby the
tissue distribution of G0a  can be readily assessed. Early studies indicated G0a  to be 
primarily located in nervous tissue. Indeed the initial attempts at purifying G0  used
bovine brain as the source of the protein [Stemweis & Robishaw, 1984; Neer etal., 
1984; Milligan & Klee, 1985]. Using antiserum RV3, raised against purified G - 
proteins and shown to recpgnize G0, Gierschik and coworkers were able to identify 
this protein in the cerebral cortex from a number of sources including frog, chicken,
rat and human [Gierschik et al., 1986b]. However, in accordance with the in situ
(
hybridization studies, the concentration of G0a  in the brain is not homogenous. 
Regional distribution in bovine brain revealed that GqOC is more abundant in the 
frontal cortex, thalamus and hypothalamus than in medulla and pons [Gierschik et 
al., 1986b; Asano et al., 1987]. Using a specific G0a  antiserum, Chang and 
coworkers were able to demonstrate the levels of this protein in rat brain was low 
before birth but increased after birth and reached the full adult level at four weeks of 
age [Chang et al., 1988].
Several peripheral neuronal or related tissues also display G0  cross - 
reactivity with specific antisera. Brain stem and spinal cord, although containing 
G0 a, appear to do so in subtantially lower amounts than do forebrain structures 
[Gierschik et al., 1986b], and several components of the autonomic nervous system 
including the enteric nervous system, superior cervical ganglion and adrenal medulla 
displayed strong Gq immunoreactivity [Terashima et al., 1988].
Although predominantly located in nervous tissue, G0  has been been 
identified in a number of non - neuronal sources, for example in kidney [Huff et al.,
1985], retina [Terashima et al., 1987] and skeletal muscle [Toutant et al., 1990]. A 
number of groups have also reported G0a  immunoreactivity in heart [Liang et al., 
1986; Luetje et al., 1987], however since G0  reactivity has been demonstrated in 
peripheral nervous tissue this may, in part, be due to tissue innervation.
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Immunoreactivity to G0a  is not confined to mammalian systems. It has been 
detected in tissues such as frog brain [Gierschik et al., 1986b], sea urchin eggs 
[Oinumura et al., 1986] and Drosophila central nervous system [Thambi et al.,
1989; de Sousa et al., 1989].
Screening of zxenopus laevis oocyte cDNA library with synthetic 
oligonucleotide probes complementary to conserved regions of different G - protein 
a  subunits detected a number of positive cDNA clones. The determination of a 
nucleotide sequence of one of the cDNAs included the total sequence coding for a 
354 amirio acid protein that was 89 % identical to the sequence of rat G0 a, the 
differences occuring in that region postulated to interact with receptors as well as 
effectors [Olate et al., 1989]. Recently, Yoon and coworkers were able to 
characterize a drosophila gene encoding a G - protein a  subunit isolated from a 
genomic library screened using bovine transducin a  subunit cDNA as a probe [Yoon 
et al., 1989]. The gene encoded for two proteins each of 354 amino acids which 
differed in seven residues in the amino - terminal region and had deduced amino acid 
sequences c* 81 % identical to G0 a.The total genomic region encompassed by 
this gene was very large. The four genomic fragments sequenced, which contained 
all the coding sequences for the two gene products, were found to span a region of 
about 26 kilobases. When added to the 3' - noncoding and the 5’ - regulatory 
regions, the gene spanned some 40 kilobases, about twice the size of the largest 
reported Ga gene, that of Gsa  [Kosaza et al., 1988]. The report by Yoon and 
colleagues contained the first evidence of the heterogeneity of G0a  on a molecular 
level with the two proteins being generated from alternative splicing of a single gene 
[Yoon et al., 1989]. More recently, the production of G0a  isoforms produced by 
differential splicing of mRNA has been observed in a mammalian system. Screening 
of a hamster insulin - secreting tumor cell cDNA library for G0cx revealed the
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presence of two inserts each coding for a distinct G0 oc. One of the GoOC cDNAs 
encoded for a protein identical to that cloned previously from rat and bovine tissues, 
whilst the other encoded for a protein that appeared to be derived from an 
alternatively spliced mRNA. This novel cDNA coded for a protein that is identical to 
G0oc in its first two - thirds and differed in the remaining carboxyl third of the 
polypeptide [Hsu et al., 1990].
1. 4. 3. The function of G^.
Since its initial purification from bovine braii^particular emphasis has been 
placed in' attempting to assign a role for G0 a. Immunohistochemical analysis of the 
distribution of G0a  in brain slices revealed that the localisation of G0<x corresponded 
in many areas with those of protein kinase C thus suggesting a major role for this G - 
protein, as the so called Gp, in the regulation of the phosphatidylinositol pathway 
[Worley et al., 1986]. However it should be noted that whilst some ligands exert 
their effects in a pertussis toxin sensitive manner as might be expected if G0a  was 
the G - proten involved in this system, other ligands appear to interact with this 
system in a pertussis toxin insensitive manner. For example, the chemoattractant 
peptide FMLP activates phospholipase C via a G - protein in human leukaemic HL60 
cells and furthermore this activation is sensitive to pertussis toxin [Kikuchi et al.,
1986]. However the responses of liver cells to vasopressin and angiotensin II 
[Pobiner et al., 1985] and of 1321N1 human astrocytoma cells to muscarinic 
agonists such as carbachol [Hepler & Harden, 1986] have been demonstrated to be 
insensitive to pertussis toxin treatment suggesting that G0a  is not involved in the 
coupling of receptors to the phosophatidylinositol pathway.
The earliest studies into the function, not only of G0 a, but indeed of the all 
of the pertussis toxin - sensitive G - proteins involved the use of various y
reconstitution systems and purified preparations of the G - proteins. Florio &
Stemweis were able to demonstrate that preparations of Gia and G0a  from bovine 
brain reconstituted into phospholipid vesicles interacted with muscarinic receptors 
from the same source [Florio & Stemweis, 1985] although no major differences 
were observed between the G - proteins in this assay. This was taken a step further 
when Haga observed GTP - sensitive high - affinity binding of acetylcholine to 
purified porcine brain muscarinic receptors reconstituted into phospholipid vesicle 
with the three major brain pertussis toxin substrates (Gila, G i2a , G0 a ) [Haga et 
al., 1989]. A number of other receptors have been reconstituted with purified G0a  
into phospholipid vesicles including the a 2  - adrenergic [Cerione et al., 1986], Ji -  
opioid [Ueda et al.,1988] and prostaglandin E2  [Negishi et al., 1988] receptors.
Pertussis toxin pretreatment of cells abolishes the effects of those receptors which 
interact with pertussis toxin - sensitive G - proteins. Kurose and coworkers were 
able to reconstitute purified Gj which had been previously ADP - ribosylated with pertussis ; 
toxin and show that any previous interaction with the muscarinic receptor was now 
lost [Kurose et al., 1986]. Reconstitution of purified G - protein a  subunits into 
membranes prepared from pertussis toxin - treated cells has been shown to restore 
the effects of ligand activation. In membranes of NG108 -15 cellsjrestoration of 
receptor - stimulated GTPase activity with the 8  - opioid DADLE [Milligan & Klee,
1985] and with bradykinin [Higashida etal., 1986] was observed upon 
reconstitution with purified preparations of G0  and G\.
Reconstitution assays involving application of purified G - protein a  subunits 
into whole cells pretreated with pertussis toxin have shed most light on the 
identification of a function for G0 a.
Several experiments point to the involvement of a G - protein in the action of 
certain receptors that inhibit a certain class of voltage - dependent Ca^+ channels in a 
number of neuronal cell types. Chick dorsal root ganglia cells ( DRG) display
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noradrenaline l  and GAB A - induced inhibition of voltage - dependent Ca^+ channels 
which, because they are blocked by pertussis toxin and are inhibited by intracellular , 
application of GDPpS, appear to be mediated through a G - protein [Holz et al.,
1986]. NG108 -15 cells also appear to contain such a class of voltage - dependent 
Ca2+ channels which can be inhibited by noradrenaline [ Docherty & McFadzean,
1989] and opioid peptides [Tsunoo et al., 1986; Hescheler et al., 1987; McFadzean 
& Docherty, 1989 ]. Hescheler and colleagues were able to show that abolition of 
D ADLE - mediated inhibition of the Ca^+ channel with pertussis toxin could be 
reversed with intracellular application of purified G^a and G0 a. Since G0a  was 10 
times more potent than Gja, the authors suggested that the former was more likely to 
be involved in coupling the opioid receptor to the Ca^+ channel [Hescheler et al.,
1987]. These findings were strengthened when McFadzean and collaborators were
able to demonstrate the ability of a G0a  antiserum to abolish the noradrenaline - induced 
inhibition of the Ca^+ channel in these cells [McFadzean et al., 1989]. Similarly 
Ewald was able to reverse the pertussis toxin abolition of neuropeptide Y - mediated 
inhibition of voltage - sensitive Ca^+ channels in rat DRG with perfusion of GTP 
and purified G0a  into the cell [Ewald et al., 1988]^Another approach has been to 
make use of single identified invertebrate neurones. Harris - Warrick and colleagues 
recently demonstrated that dopaminergic inhibition of voltage - sensitive Ca^+ 
channels in snail neurones is mediated via a pertussis toxin - sensitive G - protein 
[Harris - Warrick et al., 1988]. Pertussis toxin - catalysed ADP - ribosylation 
identified a single substrate for the toxin, which was identified by a polyclonal GqCC - 
specific antiserum raised against bovine brain G0 a. The snail G0a  was not identical 
to mammalian G0 a, as it migrated more slowly in SDS - PAGE but when the G0a  
antiserum was microinjected into the neurone it was able to block the effect of 
dopamine on the Ca^+ channels and the effects of pertussis toxin were overcome by 
the introduction of purified G0 a.
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The intermediate level of complexity of the fruit fly D . melanogaster, its 
sophisticated genetics and the production of mutants has allowed for its use in 
dissecting particularity complex biological processes. In a recent report, Guillen and 
coworkers studied the expression of a G0oc - like protein in a number of memory and 
learning drosophila mutants, such as turnip, rutabaga and dunce. They found that 
fruit fly form of G0a  was overexpressed in these mutants when compared to normal 
flies, the olfactory mutant smellblind and the the visual mutants sevenless, ora and 
norp A., thus implying ; a role, at least in drosophila, for G0oc in learning and 
memory. Furthermore, the overexpression appeared to be sex - dependent in at least 
one of the mutants, with the male rutabaga mutant containing twice the levels of 
G0cc when compared to the female [Guillen et al., 1990].
The subcellular localisation of particular G - proteins may have a role in 
determining its function. Since the known function of the G - proteins, including G0, 
would appear to be the passage of information across the plasma membrane, this
requires the physical location of those G - proteins to be at, or near, this site. However, 
recent studies have indicated a more widespread distribution.
Using affinity - purified polyclonal antibodies to the a  subunit of G0, Gabrion 
and collaborators have investigated the ultrastructural localisation of this polypeptide in 
cultured and adult murine neurons [Gabrion et al., 1989]. They were able to 
demonstrate that G0  was located both on the cytoplasmic face of the plasma membrane 
lining the cell body, especially in sites of cell to cell contact but was not detected at the 
inner face of either the pre - or post - synaptic membranes. They suggested that G0  would 
not be involved in transducing signals at the synapse but more probably modulated 
synaptic function by controlling the activity of effectors localised outside of the synaptic 
densities. In a parallel study, the same group was able to demonstrate the presence of 
GqCX in the choroid plexuses protruding in the third and fourth ventricle of murine brain
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which they subsequently localised to the apical membranes and suggested that G0oc 
might be involved in the transduction of signals from the cerebrospinal fluid to the 
ependymal cytoplasm [Peraldi et al., 1989]. The distribution of GqCX in this region of 
the brain appears to correlate well with that of the Na+ /  K+ ATPase, an enzyme known 
to play an important role in the production of cerebrospinal fluid.
Neural connection during brain development appears to be extremely complex. 
The distal tip of neuronal processes, a structure termed the growth cone, is critical for 
transduction of extracellular siganls into directed growth. A recent report investigated 
the interaction of G0a  in the'growth cone with GAP ( Growth Associated Protein) 43, 
an intraneuronal protein whose expression is closely associated with axonal growth 
[Strittmatter et al'., 1990]. They noted G0a  to be a major growth component and that 
GAP 43 enhanced GTPyS binding to G0a  and proposed that the sequence homology 
between GAP 43 and G - protein - linked transmembrane receptors allowed GAP 
43 to mimic the receptor activation of G0 oc, thus promoting the production of some 
form of intracellular signal.
1. 4. 4. Modifications in the GqQL subunit.
In common with other G - proteins, the a  subunit of G0  is able to undergo 
certain post - translational changes. In astrocytoma cells that had been metabolically 
labelled with [^H] myristate, Buss and coworkers were able to specifically 
immunoprecipitate the a  subunits of two forms of Gj incorporating [^H] myristate, 
whereas immunoprecipitated Gsa  and the p subunit did not appear to contain the [^H] 
label. Myristate was also detected by chemical analysis of fatty add in Gia and G0oc 
from bovine brain [Buss et al., 1987].Similarly, Schultz and coworkers identified 
myristate as a component of purified G0 a, postulating the site of attachment to be the 
amino - terminal glycine residue of the protein [Schultz et al., 1987]. Mumby and 
collaborators have recently shown myristoylation in a number of G - protein a
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subunits, including G0 a, in monkey kidney COS cells which had been transfected with 
cytomegalovirus - based expression vectors encoding these various a  subunits 
[Mumby et al., 1990]. In this study incorporation of [^H] myristate into Gsa  was not 
observed, a reflection perhaps due the lack of a serine residue at position 6  of the 
primary translation product, which is a common feature of myristoylated proteins. 
Myristoylation of G0a  was blocked in the COS cells when an alanine was substituted 
for the amino - terminal glycine, as was the association of the protein with membranes 
suggesting that a possible role for myristate may be in the targetting of these proteins 
into the plasma membrane. The observation that overexpressed a  subunit in these cells 
is associated with the membrane if it can be myristoylated may be consistant with this 
[Mumby etal., 1990].
Although phosphorylation of purified Gj by both protein kinase A [Watanabe 
et al., 1988] and the tyrosyl kinase activity of the insulin receptor [Zick et al., 1987; 
O’Brien et al., 1988] has been demonstrated, no information has been forthcoming 
about the possible phosphorylation of GqCX. Close examination of the primary amino 
acid sequence of G0a  deduced from the cloning studies of Jones & Reed [1987] 
revealed none of the sequence motifs for phosphorylation by either protein kinase A 
[XRRXS*X] or protein kinase C [XRXXS*XRX], where S* is the phosphate 
acceptor serine residue, R is the specific arginine and X is the less essential residue [ 
for review on protein kinase recognition sequence motifs see Kemp & Pearson, 1990].
1. 5. Recent advances in G - protein methodology.
The extreme homology of the a  subunits has led to the development of a 
number of methodological techniques used to identify and assess the functions of 
individual G - proteins.
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1. 5. 1. Identification and resolution of individual G - proteins.
Early studies characterized the a  subunits of the heterotrimeric G - proteins 
upon their ability to be mono ADP - ribosylated by certain bacterial toxins, the most 
common being cholera toxin and pertussis toxin. Inability to assign functionality to 
particular G - proteins because of the lack of specific probes led to the production of 
antisera against these proteins.
The availabilty of relatively large amount of purified transducin allowed for the 
generation of the first polyclonal antiserum [Gierschik et al., 1985]. This antiserum 
was shown to cross - react with a 41 kDa pertussis toxin substrate isolated from bovine 
brain ( now referred to as G jl) but did not identify a 39kDa pertussis toxin - sensitive 
protein ( G0 ) [Pines et al., 1985; Gierschik et al., 1986b]. G0  was susequently 
identified as a distinct polypeptide when a polyclonal antiserum raised against a mixture 
of Gjloc and G0 a, purified from bovine brain, identified it but not G jla  [Milligan & 
Klee, 1985]. Mumby and coworkers were the first to produce a series of antipeptide 
antisera against synthetic peptides corresponding to sequences of individual G - protein 
a  subunits obtained from corresponding cDNAs [Mumby et al., 1986] and the use of 
these probes has identified a number of novel G - proteins [Spiegel, 1988; Milligan, 
1988; Milligan, 1990].
Measurement of the enhanced rate of GTPase activity of a membrane in 
response to agonist has, since the early days of research into G - protein interactions, 
provided a means of direct assessment of the interaction of a receptor with a G- protein. 
Indeed Cassel & Selinger used this approach in an avian erythrocyte system to 
demonstrate the interaction of the (3 - adrenergic receptor with a G - protein [Cassel & 
Selinger, 1976]. In general, greater success has been achieved using GTPase studies 
for receptors linked to pertussis toxin - sensitive G - proteins [Koski & Klee, 1981;
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Aktories & Jakobs, 1981]. This is presumably due to the higher abundance of these 
proteins and their greater enzymic activity. As with other methodological techniques to 
study these proteins, the lack of specificity of pertussis toxin has made it difficult to 
specify receptor activation of particular pertussis toxin - sensitive G - proteins. The 
existence of specific antisera has helped address this problem.For example, 
preincubation of NG108 -15 cell membranes with an antiserum directed against Gj2a 
completely abolished the ability of an opioid agonist to stimulate high - affinity GTPase 
activity [McKenzie & Milligan, 1990]. Clearly the use of such antisera will aid in the 
determination of G - protein specificity in the future.
Another recently developed assay for determining interactions between 
receptors and G - proteins is based upon agonist promoted exchange of guanine 
nucleotide. In the resting state, the a  subunit has GDP in the nucleotide - binding site. 
Occupation of a G - protein - linked receptor is the signal for an exchange of GDP for 
GTP and subsequent dissociation of the heterotrimeric G - protein allowing the now 
activated a  subunit to interact with its appropriate receptor. However, Gierschik and 
Jacobs noted that activation of myeloid differentiated HL 60 cells with the chemotatctic 
peptide FMLP caused the marked stimulation in the cholera toxin - catalysed ADP - 
ribosylation of a 40 kDa membrane protein in the absence of added exogenous guanine 
nucleotide [Gierschik & Jacobs, 1987]. This phenomenon was also noted in 
membranes of NG108 -15 cells where the addition of saturating amounts of the 
synthetic enkephalin D ADLE also produced a marked increase in the cholera toxin - 
catalysed ADP - ribosylation of a 40 kDa protein in the absence of guanine nucleotide 
but had no effect on the cholera toxin - catalysed ADP - ribosylation of Gsa  [Milligan 
& McKenzie, 1988]. A possible explanation for these observations is that the 40 kDa 
protein observed in each case is that G - protein with which the appropriate receptor 
interacts. Under the conditions of the assay, as the agonist causes release of GDP from 
the nucleotide - binding site, there is no available GTP to fill the empty site and the G - 
protein is in such a conformation that it has become a weak substrate for cholera toxin.
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It is pertinent to note that all of the G - proteins identified thus far have an invariant 
arginine residue in a position in the primary sequence equivalent to that which is the site 
of cholera toxin - catalysed ADP - ribosylation in Gsa. This residue is close to a 
section of the primary sequence which forms part of the nucleotide - binding site and 
the maintenance of this arginine is of extreme importance for G - protein GTPase 
activity [Landis et al., 1989].
1. 5. 2. Identification of G • protein - linked receptors.
At this time about 80 distinct receptors which can be activated by around 40 
hormones and neurotransmitters appear to function via a guanine nucleotide - binding 
protein. It would be reasonable to assume that many more G - protein - coupled 
receptors will be identified in the fullness of time. A number of these receptors have 
been purified and cloned including five types of muscarinic receptor, four opsins, two 
(3 - and three a  - adrenergic receptors, a substance K receptor and two dopamine D2 
receptors [for review see Bimbaumer et al., 1990]. Analyses of these sequences show 
that all of the G - protein - coupled receptors belong to a superfamily of proteins that 
have seven transmembrane spanning regions and have an extracellular amino terminus 
and an intracellular carboxyl terminus [Dohlman et al., 1987].
It was the early experiments of Rodbell and coworkers into the effect of guanine 
nucleotides to decrease the affinity of glucagon - binding to its receptor that led to the 
proposal of the invovement of G - proteins in mediating receptor - effector coupling 
[see Rodbell, 1980]. It was susequently noted that guanine nucleotide effects on p - 
adrenergic receptor binding were confined to agonists and not antagonists [Maguire et 
al., 1976]. Detailed analysis of ligand binding indicated that agonists were able to 
recognise two conformations of the receptor with different affinity, whilst antagonist 
affinity for the two forms appeared to be very similar if not identical. Furthermore,
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addition of GTP analogues such as GppNHp or GTPyS reduced the ability of agonists, 
but not antagonists, to compete for radiolabelled antagonist binding sites. Thus, in the 
presence of guanine nucleotides a low affinity state of receptor for agonist was adopted, 
whereas in the absence of guanine nucleotides the receptor demonstrated a higher 
affinity for agonist These observations led De Lean and coworkers to propose the 
ternary complex model, where in the unstimulated state, the inactive G-protein a  
subunit may interact with receptor, leading to the agonist promoted formation of a high 
- affinity ternary complex. In the presence of guanine nucleotides,which activate Ga, 
the ternary complex is destabilised and both agonist and G-protein are able to dissociate 
from receptor [DeLean et al., 1980]. Although the ternary complex model was 
originally proposed to account for the effect of guanine nucleotides on agonist binding 
to receptors linked to stimulation of adenylyl cyclase, ligand binding experiments 
performed on receptor signalling systems linked to the inhibition of adenylyl cyclase 
yielded similar results [Koski & Klee, 1981] and led to the general conclusion that if 
the affinity of receptor for agonist is altered by the presence of guanine nucleotides, 
then that receptor functions through activation of a G-protein. Thus historically, the 
guanine nucleotide sensitivity of agonist binding affinity has often provided the initial 
suggestion that a particular receptor interacts with a G - protein.
Although this approach is limited in as much as it can yield little information as 
to the molecular nature of the G - protein involved, it can be used in conjunction with 
other techniques to yield further information. Binding studies performed on membranes 
from cells which had been pretreated with pertussis toxin [Kurose et al., 1983; Hsia 
et al., 1984] show that agonist affinity of antagonist displacement was reduced when 
compared to membranes of untreated cells. Furthermore, addition of non - hydrolysable 
GTP analogues was not able to further reduce agonist affinity for the receptor, 
indicating that pertussis toxin pretreatment had modified the relevant G - protein in such 
a manner that it now appeared to be functionally uncoupled from its receptor. Since
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ADP - ribosylation by pertussis toxin allows for the transfer of an ADP - ribose onto a 
cysteine residue close to the C - terminus of those G - proteins that are substrates, it 
was proposed that this C - terminal region was likely to represent a key domain for the 
interaction of the G - protein with its receptor [Masters et al., 1986]. Evidence for this 
proposal has been forthcoming. Interaction of rhodopsin and Tdl can be attenuated 
with both an anti - Tdl C - terminal antiserum [Cerione et al., 1988] and with synthetic 
peptides which form that part of the primary sequence of the a  subunit [Hamm et al.,
1988]. More recently, McKenzie & Milligan were able to demonstrate that affinity of 
binding of radiolabelled DADLE, a specific 8  - opioid agonist, to membranes of 
NG108 -15 cells which had been pretreated with pertussis toxin was reduced when 
compared to untreated cells, although the number of sites was not affected [McKenzie 
& Milligan, 1990]. To define further which of the pertussis toxin - sensitive G - 
proteins was involved in the transduction of the DADLE signal in these cells, 
membranes were preincubated with antipeptide antisera directed against the C - 
terminus of a number of G - protein a  subunits and their effect on the ability of a single 
concentration of DADLE to bind specifically to the 8  - opioid receptor was assessed. 
Only the IgG fraction from the antiserum which specifically identified Gj2a in these 
cells converted the receptor to a state which displayed reduced affinity for agonist.
1. 5. 3. G - protein - effector interactions.
Of the three elements that constitute signal transduction units ( receptors, G - 
proteins, effectors), the effectors are the least understood in molecular terms. These 
include adenylyl cyclase, the cGMP phosphodiesterase of retinal systems, 
phospholipase C, phospholipase A2  and several classes of ion channels including K+ 
and Ca^+ channels. Thus measurement of the changes brought about by ligand or by 
direct activation of the G - proteins upon the levels of the various second messengers is 
a valid method to investigate cellular signalling events.
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In common with other methodologies, the main drawback in using changes in 
the levels of second messengers as an index of G - protein involvement is lack of 
information about specificity. Although the the involvement of a G - protein may be 
implicated in the transduction of information from a specific receptor to an effector, the 
molecular nature of the G - protein involved is still unknown. The use of agents such as 
pertussis toxin may narrow the choice of involvement. For example, Katada & Ui 
showed that a^ - adrenergic receptors were able to mediate inhibition of adenylyl 
cyclase in pancreatic islet cells and that treatment with pertussis toxin attenuated the 
inhibition, thus the effect of the toxin was to uncouple the G - protein involved from its 
receptor [Katada & Ui, 1979; Katada & Ui, 1981]. Knowing that the G - protein 
involved in this inhibition was a pertussis toxin substrate cut down the number of 
possible candidates, but still the molecular identity of the adenylyl cyclase inhibitory G 
- protein was unknown. Opioid inhibition of adenylyl cyclase in NG108 -15 cells has 
been shown be mediated via a pertussis toxin - sensitive G - protein [Klee et al.,
1985]. NG108 -15 cells contain three pertussis toxin - sensitive G - proteins ( G^2a,
Gj3a, G0cx) [McKenzie & Milligan, 1990] and, in theory, any one or combination 
thereof of these polypeptides could be the one involved in opioid - mediated inhibition 
of adenylyl cyclase. McKenzie & Milligan, using specific antipeptide antisera generated 
against the C - terminus of those G - proteins present in these cells, were able to 
demonstrate that only the antiserum which recognises G|2a  was able to attenuate the 
opioid - mediated inhibition of adenylyl cyclase [McKenzie & Milligan, 1990]. This 
approach is not limited to only adenylyl cyclase. As well as 8  - opioid receptors, the 
NG108 -15 cell has been shown to expresses 0*2 ~ adrenergic receptors which also 
mediate the inhibition of adenylyl cylase. Both opioid peptides [Hescheler et al., 1987] 
and noradrenaline [Docherty & McFadzean, 1989] also act to inhibit voltage - sensitive 
Ca^+ channels in a pertussis toxin - sensitive manner in these cells. McFadzean and 
coworkers were further able to demonstrate marked attenuation of the noradrenaline - 
mediated inhibition of the channel upon microinjection of an antipeptide antiserum
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raised against the C - tenninus of G0 a, implying a role for this protein in coupling 
adrenoreceptors to the calcium channel in these cells [McFadzean et al., 1989].
1. 6. Transcriptional Regulation.
Control at the level of transcription is probably the major way in which gene 
expression is regulated in eukaryotes. The information encoded in DNA cannot in itself 
be used as a template for protein synthesis but must be first transcribed into mRNA. In 
eukaryotes, mRNA is synthesized by the enzyme RNA polymerase II. RNA 
polymerase II alone cannot accurately initiate transcription in vitro on purified 
templates unless supplemented with a number of protein transcription factors able to 
provide recognition of and specificity for minimal promoter DNA sequences.
1. 6. 1. Transcription factors.
Transcription factors can be subdivided into two broad categories, general and 
promoter specific. General transcription factors have been shown to interact with a 
promoter sequence which consists of a TATA motif and associated cap site. A number 
of transcription factors are associated with this promotor including factor TFUD from 
HeLa cell fractions [Sawadogo & Roeder, 1985], a 38 kDa protein called SII isolated 
from Ehriich ascites cells [Sekimizu et al., 1981] and chicken ovalbumin upstream 
promotor factor [Sagami et al., 1986]. Since these transcription factors recognize a 
common motif, selectivity of the control of gene expression must be controlled by other 
more specific factors.
Promotor - specific transcription factors whilst sharing some of the promotors 
of the more general subtype are able to interact with unique promotor sequences giving 
a greater control to selective switching - on of particular genes. Included in this family
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is the Spl transcription factor which binds to a GC - rich promotor region containing 
the sequence motif GGGCGG [Dynan & Tijan, 1983]. The Spl binding site occurs in 
many other viral and cellular promoters where it may act with other promotor motifs 
such as the CCAAT box. For example, the herpes simplex virus thymidine kinase 
promotor has two Spl binding sites surrounding a CCAAT box and all three elements 
are required for maximal promotor activity [Jones et al., 1985]. Both the Spl sites and 
the CCAAT box are usually located in a similar position, about 40 - 100 base pairs 
from the start of the initiation sequence.
1. 6 . 2. Regulation of Gene Expression Bv cAMP.
An increasing number of cAMP - regulated genes have been isolated and 
characterized. These genes appear to have a number of common characteristics. They 
are expressed in tissues which are responsive to hormones or regulatory factors, and 
their rate of transcription is rapidly altered by cAMP. The promotor region of several of 
these genes have been isolated and and their cAMP regulatory elements ( CRE) defined 
using functional analysis of detailed deletions through the region and by mutations in 
specific bases within it. Using such a strategy, Short and his coworkers were able to 
show that the 5' flanking region of the gene for the cytosolic form of 
phosphoenolpyruvate carboxykinase ( PEPCK) ( E.C. 4.1.1.32 ) from the rat contains 
a CRE. They were able to identify this as a 47 - base pair region with a 12 - base pair 
core sequence [ CTTACGTCAGAG ] which had homology with four other cAMP - 
regulated genes. Deletion in this sequence resulted in the loss of db cAMP - sensitive 
production of the enzyme [Short et a l , 1986].
Similar experiments have identified functional CREs in a growing number of 
genes incuding those encoding for somatostatin, proenkephalin and vasoactive 
intestinal peptide [for review see Roesler et al., 1988]. In the pheochromocytoma cell
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line PC12 the protein binding to the CRE has a molecular weight of 43 kDa and is 
phosphorylated in vitro by the catalytic domain of cAMP - dependent protein kinase. 
Treating PC12 cells with forskolin also results in increased phosphorylation and this 
correlates with transcriptional induction of cAMP - dependent genes [Montminy & 
Bilezikjian, 1987].
Again it would seem that a number of such regulatory elements acting in cohort 
is needed in the control of gene expression. The PEPCK promotor - regulatory region 
contains a CRE and a CCAAT box. Functional analysis of deletions through this region 
of DNA has shown that removal of the CCAAT element results in a marked reduction 
in the rate of basal transcription of the enzyme as well as an attenuation in the level of 
induction by cAMP [Short et al., 19861].
More recently a different cAMP - responsive element was identified. This 
sequence, termed Activator Protein 2 ( AP2) binding site was initially shown to be a 
basal transcription enhancer in the human metallothionein DA promotor [Mitchell et 
al., 1987] and subsequently as an inducible enhancer when addition of forskolin 
produced elevated levels of transcription of p - globin in transfected HeLa cells 
[Imagawa et al., 1987]. It should be noted however that transcription from this 
promotor was also increased in response to phorbol esters which activate protein kinase 
although addition of both produced an additive effect.
The consensus sequence for the AP2 element [ CCCCAGGC ] is associated 
with a number of genes including human growth hormone and rat prolactin [Roesler et 
al., 1988].
1. 6 . 3. Regulation of Gene Expression By Glucocoticoids.
The induction of of gene expression by a number of glucocorticoids is a
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common observation. The PEPCK gene contains two glucocorticoid regulatory 
elements ( GRE) within its* promotor region. Both of these regions contain the 
sequence motif TGTCCTCCCC and the presence of both elements is not required for 
dexamethasone stimulation of expression of the PEPCK gene [Short et al., 1986]. Up 
regulation of the P - adrenergic receptor in response to glucocorticoid has been shown 
as a consequence of an increase in transcription. Using Northern blot analysis, it was 
demonstrated that the P2  ~ receptor mRNA levels increased in a hamster vas deferens 
cell line exposed to dexamethosone in culture [Collins etaL, 1988]. Several putative 
GREs have been located in the non coding regions of the P2  - adrenergic receptor gene, 
one of which in the 5' - untranslated region being obligate for glucocorticoid sensitivity 
[Malbon. & Hadcock ,1988].
There are several instances of glucocorticoid regulation of the levels of Gs. In a 
rat pituitary cell line, GH3 , exposure to dexamethosone caused a 5 - fold increase in the 
mRNA for Gsa  and a 2 - fold increase in the membrane - bound Gsa  polypeptide and 
that the glucocorticoid - induced enhancement of adenylate cyclase activity in these cells 
was in part due to the increased expression of Gsa. [Chang & Bourne, 1987]. Chronic 
coricosterone administration to normal rats resulted in the increase in the cerebral cortex 
of both the mRNA for Gsa  and in the amount of the protein itself as assessed by 
immunoreactivity on immunoblots and ADP - ribosylation by cholera toxin [Saito et 
al., 1989]. In contrast such treatment tended to decrease both the levels of GjOC mRNA 
and of the immunoreactivity of the protein itself. The levels of G0a  and p subunit 
immunoreactivity and mRNA were not affected by the treatment. Although these results 
are preliminary, they suggest that the role of cAMP and other agents in the control of 
transcription of the Ga genes may prove to be an important junction at which to 
regulate the levels of the various G - proteins themselves.
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MATERIALS AND METHODS.
2. 1. Materials,
2. 1. 1. Chemicals,
Sigma Chemical Co. Ltd.. Poole. Dorset.
KLH, trypsin, ATP, DADLE, DALAME), arginine hydrochloride, nonidet P - 
40, gelatine, Tween 20, 0 - diansidine, hydrogen peroxide, triethanolamine 
hydrochloride, theophylline, BSA, 7 - deoxycholic acid, bromophenol blue, NAD+, 
NEM, TEMED, Amberlite MB -1, Coomassie Blue R - 250, silver nitrate, 
formaldehyde, ouabain, cAMP, 8 - Bromo cAMP, PGEj, Freund's complete adjuvant, 
Freund's incomplete adjuvant, cholera toxin.
Gibco Life Technology, Paisley, UK.
All tissue culture solutions, with the exception of foetal bovine serum.
Imperial laboratories. West Portwav. Andover. Hants. UK.
Foetal bovine serum.
Prolabo, Paris. France.
2  - mercaptoethanol.
Koch Light Ltd. Haverhill. Suffolk. UK.
DMSO.
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Mav & Baker Ltd. Dagenham. UK.
Ammonium persulphate.
Porton Products. Porton Down, Salisbury. Wilts. UK.
Pertussis toxin.
BCL, Lewes, East Sussex, UK.
2-deoxy thymidine, GTP, Db cAMP, DTT, AppNHp, creatine kinase, 
phosphocreatine.
Calhiochem Corporation. San Diego. California. USA.
Forskolin.
National D iagnostics/ Aylesbury. UK.
Ecoscint scintillation fluid.
Pharmacia LKB . Milton Kevnes. UK.
Ampholine pH 3 -10  and ampholine pH 5 - 6.5.
All other laboratory chemicals were of analytical grade and obtained from BDH 
Ltd. Poole. Dorset. U.K.
2. 1. 2. Radiochemicals.
Amersham International nlc.. Amersham. UK.
[2,8 - ^H] Adenosine 3': 5' cyclic monophosphate ( product no. TRK 559). 
Sp. activity 40 - 60 Ci /  mmol.
Guanosine 5' - [ y -  ^ P ]  triphosphate ( product no. PB 144).
5 0
Sp. activity 10 Ci /  mmol.
Rabbit Ig, [ ^ 1] _ labelled whole antibody ( from donkey) ( product no. IM
134).
Sp. activity 750 -3000 Ci /  mmol.
NEN Research Products, Du Pont (UK) Ltd,, Stevena2e. UK.
Nicotinamide adenine dinucleotide, di(triethylammonium) salt, [adenylate - 
32p] ( product no. NEG - 023 ).
Sp. activity 10 - 50 Ci / mmol.
Enkephalin (2 - D - alanine - 5 - D - leucine), [tyrosyl-3,5 - ^H(N)] ( product 
no. NET-648).
Sp. activity 30 - 50 Ci /  mmol.
2. 1. 3. Peotide sources.
A full list of the peptide sequences, their locations on the G - proteins and the 
resultant antisera is given in Table 2.1.
Peptide NKLEDGIS AAKDVK ( which resulted in antiserum IM1) was 
synthesized by Dr. A.I. Magee at NIMR, Mill Hill, London.
Peptides MSELDQLRQE ( antiserum BN1) and KNNLKECGLY ( antiserum 
I3B ) were synthesized by Biomac Ltd, Glasgow, UK.
All other peptides used were synthesized by Dr C.G. Unson, The Rockerfeller 
University, New York, USA.
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2,.iq.4t__Qijier Antisgra
Antiserum HP A, which was raised against a mixture of purified G0a  and (3 
was a kind gift from Dr. H. Ploegh and Dr. L. van der Voom, Division of Cellular 
Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Antisera LE2 and AS7 were kind gifts from Dr. A. M. Spiegel, National 
Institutes of Health, Bethseda, MD, USA.
2. 1. 5. Purified Gjiand G& subunits, -
The mixture of purified Gi and G0  from rat brain used in these studies was 
prepared by the method of [Milligan & Klee, 1985].
,2i-2y Animals.
New Zealand White rabbits were purchased commercially and maintained by the 
Physiology department animal house. Rat and mouse brains were obtained from stock 
animals in the Physiology department animal house which were sacrificed by means of 
cervical dislocation.
2. 3. Antibody production.
All the antisera used were prepared according to the method of [Goldsmith et 
al., 1987]. Pre - immune samples were taken from each of the animals prior to 
injection. These were checked for any cross reactivity. All the animals used to produce 
antisera showed no such cross reaction.
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2. 3. 1. Peotide conjugation.
10 mg of keyhole limpet haemocyanin and 3 mg of the particular peptide needed 
were dissolved in 1 ml of 0.1 M Na phosphate buffer (pH 7.0). 0.5 ml of 21 mM 
glutaraldehyde was then added dropwise with stirring and the combined 1.5 ml was 
incubated overnight at room temperature. This was then mixed with an equal volume of 
Freund's complete adjuvant and sonicated for 20 seconds.
2. 3. 2. Immunization of the rabbits.
Immediately after sonication the resultant emulsion was injected in 0.5 ml 
aliquots into multiple subcutaneous sites in a New Zealand White rabbit Immunizations 
were normally performed simultaneously into 2  rabbits in order to maximize successful 
antibody production. After four weeks each animal received a booster immunization 
with material prepared identically except that one-half as much peptide and KLH were 
injected in Freund's incomplete adjuvant
2. 3. 3. Serum harvesting.
Two weeks after the booster injections the animals were bled from the ear 
veins and subsequently bled at monthly intervals. The blood was collected into glass 
universals and allowed to clot overnight at 4 °C. The serum was removed from the clot 
and subjected to centrifugation at lOOOg 4 for 5 minutes on a Beckman TJ - 6  
centrifuge in order to remove any remaining erythrocyte traces. The serum was then 
aliquoted in 0.25 ml volumes and stored at -80 °C.
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2. 4, Tissue culture.
2,.,4t \ t Cell culture conditions.
Neuroblastoma x glioma hybrid cells, NG108 -15, were a kind gift from Dr 
W. Klee ( NIH, Bethseda, Maryland, US.A.). The cells were grown in continuous 
culture according to the method of [Hamprecht et al., 1985] in sodium bicarbonate 
(0.375 % (w/v)) buffered Dulbecco's Modified Eagle’s Medium containing foetal 
bovine serum (10 % (v/v)), 2 mM L - glutamine, 1001.U./ ml penicillin, 100 |ig /m l 
streptomycin. The medium was further supplemented with HAT ( Hypoxanthine, 
Aminopterin, Thymidine) at final concentrations of 0.1 mM, 10 jiM and 16 |iM 
respectively.
The cells were grown in monolayer culture in 75 cm^ sterile tissue culture 
flasks ( Bibby Science Products, Stone, Staffordshire, UK.) containing 10 ml of the 
the above medium. The flasks were incubated at 37 °C in a VSL incubator ( Scodab), 
gassed with a final O2  : CO2  ratio of 95 % : 5 % and allowed to reach confluency. 
Medium was changed when deemed necessary, usually every 2 days.
2. 4. 2. Splitting of confluent cell cultures.
Each flask of confluent cells was usually split 1: 5 into new flasks. The 
medium was removed and 3 ml of a trypsin solution consisting 0.1 % (w/v) trypsin, 10 
mM glucose, 0.67 mM EDTA was added. Trypsin treatment was terminated, when all 
the cells were detached from the flask, by addition of 7 ml of the 10 % FBS- 
supplemented DMEM medium. The cells were decanted into a sterile 50 ml conical 
polypropylene centrifuge tube ( Elkay Products Inc., Shrewsbury, Mass., USA.) and 
spun on a bench top centrifuge at lOOOg for 5 minutes. The supernatant was then 
carefully discarded leaving a tightly packed pellet of cells at the bottom of the tube. The 
pellet was resuspended thoroughly in 5 ml of the incubation medium and 1 ml added to
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new flasks containing 9 ml of fresh medium. The flasks were then placed in the 
incubator and the medium changed when necessary.
2. 4. 3. Freezing down and storage of cells.
Cells were frozen down and stored in liquid N2  in order to maintain a stock of 
cells with as early a passage number as possible. After trypsinization and centrifugation 
the cell pellet was resuspended in 8 % (v/v) DMSO in foetal bovine serum, 1 ml for 
every confluent flask, and put in sterile freezing vials ( Costar, 205 Broadway, 
Cambridge, Mass. USA.) in 1 ml aliquots. The cells were frozen slowly to avoid 
formation of ice crystals in the cells by placing the vials in polystyrene containers with 
cotton wool and leaving overnight at -80 °C. The vials were then transferred to liquid 
N2  vats and stored until needed.
2. 4. 4. Recovery of cells after freezing.
Vials were removed from liquid N2  storage and warmed up quickly in a 37 °C 
water bath. The whole contents of one vial were put into a 75 cm^ flask containing 10 
ml of the 10 % FBS-supplemented DMEM medium and placed in the incubator. The 
medium was replaced next day with fresh and the cells were then used as required.
2. 4. 5. Preparation of differentiating agents.
The various agents were made up on the day of use as a 10 x stock, i.e. 10 mM 
Db cAMP or 8 - Bromo cAMP, 100 pM forskolin or PGEj in 2 % FBS-supplemented 
DMEM. These were filtered through a 0.22 uM filter ( Coming Glass Works, Coming, 
NY, USA. ) and collected in a sterile 50 ml centrifuge tube. 1 ml was then added to 
each flask as described below in section 2. 4. 6  .
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2. 4. 6 . Treatment of cells with differentiating agents.
Cells were differentiated by incubating for 6 days in a variety of agents. These 
were Db cAMP or 8 - Bromo cAMP at a final concentration of 1 mM and forskolin or 
PGEj at a final concentration of 10 juM.
Confluent flasks of cells were split 1: 5 using the trypsin method described 
above. After centrifugation the supernatant was discarded and the pellet resuspended in 
DMEM medium supplemented with 2 % FBS instead of 10 %. 1 ml of the cell 
suspension was added to flasks containing 8 ml of 2 % FBS-supplemented DMEM and 
1 ml of the particular differentiating agent made up in 2 % FBS-supplemented DMEM 
as a 10 x stock.
2. 4. 7. Treatment of cells with pertussis toxin
To obtain membranes which had been previously pretreated with pertussis 
toxin, cells were incubated for 24 hours with 100 ng /  ml pertussis toxin and the cells 
harvested as described in section 2. 4. 8 .
The toxin was not thiol - activated as is the case for in vitro pertussis toxin 
treatment ( see section 2. 10 .3.).
2. 4. 8 . Harvesting of cells.
Cells were normally harvested 6  days after incubation with the differentiating 
agent. The cells were gently washed off the surface of the flasks using a pasteur pipette 
and collected in a 50 ml conical centrifuge tube on ice. The cell suspension was 
centrifuged at lOOOg at 4 °C for 5 min on a Beckman TJ - 6  bench top centrifuge.
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The supernatant was discarded and the cell pellet was resuspended in 30 ml ice - cold 
PBS (0.2 g /  L KC1; 0.2 g /  L KH2  P04 ; 8 g /  L NaCl; 2.16 g /  L Na2 HP04.7 H2 0) 
and spun as before. This procedure was repeated twice. The resultant washed cell paste 
was stored at -80 °C until needed.
2. 5. Preparation of crude plasma membrane fraction.
Membranes were prepared following the method of [Koski & Klee, 1981]. 
Frozen cell pastes were thawed and resuspended at 4 °C in 2 ml of the homogenization 
buffer (10 mM Tris - HC1, pH 7.5, containing 0.1 mM EDTA). All subsequent 
procedures took place at 4 °C. The cells were then homogenized with 20 strokes of a 
ground - glass tissue grinder. Homogenates were placed in a Beckman Ti 50 rotor and 
centrifuged at 500 x g for 10 minutes in a Beckman L5 - 50B ultracentrifuge to remove 
nuclei and unbroken cells. The supernatant from this spin contained the membrane 
fraction. The pellet was discarded and the supernatant centrifuged at 48000 x g for 10 
minutes using the same rotor and centrifuge. The supernatant was discarded, the pellet 
resuspended in 5 ml of the homogenization buffer and recentrifuged for 10 minutes at 
48000 x g. Again the supernatant was discarded and the pellet resuspended in the 
homogenization buffer at a protein concentration of 1 - 2 mg /  ml. This was then 
aliquoted into volumes of 100 ul and stored at -80 °C until used. Crude plasma 
membranes from rat or mouse brain were prepared as above using brain cortex from 
animals which had been sacrificed by means of cervical dislocation.
2. 6. Determination of protein concentrations.
Protein concentrations were determined by the method of [Lowry et al., 1951] 
using BS A as a standard. The samples were read at 750 nm on an LKB Biochrom 
Ultraspec II spectrophotometer.
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2. 7. Preparation of samples for SDS - polyacrylamide gel
electrophoresis ( SDS - PAGE ).
2. 7. 1. TCA / deoxvcholate precipitation of samples.
An appropriate amount of the crude membrane preparation was taken ( between 
25 jig and 150 jig of membranes depending on the experiment) and placed on ice in an 
1.5 ml eppendorf centrifuge tube. Samples with a volume of over 100 jllI were spun for 
5 min at 12000 rpm on a Hettich Mikro Rapid /  K centrifuge. The supernatant was 
carefully removed and the pellet resuspended in 20 |il of 10 mM Tris - HC1 (pH 7.4), 
0.1 mM EDTA. All samples were then treated as follows. 6.5 jil of 2 % (w/v) 7 - 
deoxycholic acid, sodium salt was added to each tube followed by 750 jil of double 
distilled H2 O then 250 jil 24 % TCA. The samples were briefly vortex mixed and spun 
in a Hettich Mikro Rapid /  K centrifuge for 20 min at 12000 rpm. After centrifugation 
the supernatant was carefully discarded and the pellet neutralized with 20 pi 1 M Tris 
base. Preparation was complete upon addition of 20 jil " Laemmli sample buffer " (50 
mM Tris - HC1 (pH 8.0) with 30 % (w/v) urea, 5 % (w/v) SDS, 6  % (w/v) DTT and 
0.01 % (w/v) bromophenol blue. The sample was then ready for loading onto the gel.
2. 7. 2. NEM treatment
If separation of G - proteins with very similar molecular weights was required 
on SDS - PAGE then the samples were first alkylated according to the method 
described in [Stemweis & Robishaw, 1984] then run out on 12.5 % SDS - PAGE gels.
An appropriate amount of the crude membrane preparation was taken ( again 
this was between 25 and 150 pg depending on the experiment being performed ) and 
placed on ice in a 1.5 ml eppendorf centrifuge tube. The samples were spun for 5 min
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at 12000g on a Hettich Mikro Rapid /  K centrifuge. The supernatant was removed 
and the pellet resuspended in 20 pi 10 mM Tris - HC1 (pH 7.4), 0.1 mM EDTA. 10 jlxI 
of 5 % (w/v) SDS, 50 mM DTT was added and each sample was incubated at 90 °C 
for 5 min. The samples were briefly cooled on ice, 10 pi of 100 mM NEM added to 
each tube and the samples left at room temperature for 20 min. 20 pi of " Laemmli 
sample buffer " ( section 2. 7 .1 .) was added and the samples loaded onto the gel.
2,  SDS - Polyacrylamide gel electrophoresis.
2. 8. 1. SDS nolvacrvlamide gel electrophoresis. Lower resolving pels 
- 10 % (w/v) polvacrvlamide gels.
Gels were performed using the method of [Laemmli, 1970] on slab gels. The 
gel plates were 180 mm by 160 mm with spacers of 1.5 mm or 2.5 mm when running 
gels in 2-dimensions. The slabs were run as a part of a Bio-Rad Protean I 
electrophoresis apparatus ( Bio-Rad Laboratories Ltd, Watford, Herts.). Separating 
gels contained 10 % (w/v) acrylamide and 0.27 % (w/v) bisacrylamide with 0.375 M 
Tris - HC1 (pH 8.8), 0.1 % (w/v) SDS, 0.033 % (v/v) glycerol, 0.0003 % (v/v) 
TEMED and 0.0004 % (w/v) ammonium persulphate. The final volume used was 24 
ml with the 1.5 mm spacers and 36 ml with the 2.5 mm spacers.
2. 8. 2. Lower resolving gels. 12.5 % (w/v) Polvacrvlamide gels.
When higher resolution of proteins within a narrow molecular weight range was 
needed 12. 5 % (w/v) SDS - PAGE gels were run instead of 10 % gels. The gels were 
also longer in order to maximize detection of molecular weight differences. The 
dimensions of the gel plates were 160 mm by 200 mm with spacers of 1.5 mm and mn 
as part of a Bio-Rad Protean II electrophoresis system. Separating gels contained 12.5
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% (w/v) acrylamide and 0.0625 % (w/v) bisacrylamide with 0.375 M Tris - HC1 (pH 
8 .8), 0.1 % (w/v) SDS, 0.033 % (v/v) glycerol, 0.0003 % (v/v) TEMED and 0.0004 
% (w/v) ammonium persulphate. The final volume used was 36 ml per slab. The upper 
stacking gel was exactly as described in section 2. 8. 4. and gels run at the same 
conditions as for the 10  % slabs.
2. 8. 3. Preparation of SDS - Urea PAGE gels.
SDS - Urea PAGE gels were prepared as described by [Schnefel et al., 1988]. 
To 50 ml 8 M urea was added 2.5 g of Amberlite MB -1 monobed resin [ wet mesh 16 
-50 ] as a deionizing step. The resultant slurry was allowed to slowly mix on a bench 
top stirrer for 1 hour after which time the slurry was then filtered through Whatman 3 
mm chromatography paper. The deionized urea ( final concentration 4 M ) was then 
included as part of a 12. 5 % (w/v) SDS - PAGE gel. The upper stacking gel was 
exactly as described in section 2. 8. 4. and gels run under the same conditions as 
for the 10 % slabs.
2. 8. 4. Upper Stacking Gels.
The upper stacking gels contained 3 % (w/v) acrylamide and 0.08 % (w/v) 
bisacrylamide with 0.125 M Tris - HC1 (pH 6 .8), 0.1 % (w/v) SDS, 0.0005 % (v/v) 
TEMED and 0.001 % (w/v) ammonium persulphate. Samples were loaded onto the 
gels using a Hamilton syringe (Hamilton Co., Reno, Nevada.).
2. 8. 5. Electrophoresis Running Buffers.
The running buffer contained 25 mM Tris - HC1 (pH 8.5), 0.192 M glycine and 
0.1 % (w/v) SDS. Electrophoresis was towards the anode at 25 mA per slab until the 
bromophenol blue dye fronts were 0.5 cm from the bottom.
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2. 9. Staining of SDS - PAGE gels.
.2,. %. It Coomassie Blue stain.
Gels were soaked for 1 hour in 0.25 % (w/v) Coomassie Blue R - 250,45 % 
(v/v) methanol, 10 % (v/v) acetic acid and then destained overnight in 45 % (v/v) 
methanol, 10  % (v/v) acetic acid.
2. 9. 2. Silver staining.
Gels were silver stained according to the method of [Morrissey, 1981]. Gels 
were prefixed for 30 min in 50 % (v/v) methanol, 10 % (v/v) acetic acid followed by 5 
% (v/v) methanol, 7 % (v/v) acetic acid again for 30 min. Gels were then placed in 10 
% (v/v) gluteraldehyde for 30 min after which time they were rinsed in distilled water 
and left overnight in a large volume of distilled water. Next day the gels were soaked in 
5 p.g /  ml DTT for 30 min. This solution was poured off and, without rinsing, 0.1 % 
(w/v) silver nitrate was added and left for 30 min. Gels were rinsed rapidly with a small 
amount of distilled water then with a small amount of developer (50 |il of 37 % (v/v) 
formaldehyde in 100 ml 3 % (w/v) sodium carbonate) and finally left to soak in the 
developer. Development was stopped, when the desired level of staining was achieved, 
upon addition of 12 ml 2.3 M citric acid and agitating for 10 min. The gels were then 
transferred to distilled water for storage and photography or dried down for 
autoradiography ( see section 2. 10. 5.).
2. 10. Mono ADP - rihosvlation of membranes hv bacterial toxins.
Mono - ADP ribosylation of G - proteins was performed essentially by the
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method of [Hudson & Johnson, 1980].
2. 10. 1. Materials
Cholera toxin was purchased from Sigma Chem. Co. Ltd., U. K. and kept as a 
1 mg/ml stock at 4 °C in buffer consisting 50 mM Tris - HC1 ( pH 7.5), 200 mM 
NaCl, 3 mM NaN3, 1 mM Na^DTA.
Pertussis toxin was obtained from Porton Products, Ltd., U.K. and stored at - 
20 °C as a 0.44 mg/ml stock in a solution consisting 50 mM phosphate buffer ( pH 7.2 
), 500 mM Naci with 50 % (v/v) glycerol.
2. 10. 2. Preactivation of cholera toxin.
Cholera toxin was preactivated upon addition of an equal volume of 100 mM 
DTT. This was gently mixed and allowed to sit at room temperature for 1 horn. 5 j l l I  of 
this ( containing 2.5 ug of the preactivated toxin) was added to each sample to be ADP 
- ribosylated.
■2t.JQt .3t Preactivation of pertussis toxin.
Pertussis toxin was preactivated in exactly the same way as cholera toxin. 5 |il ( 
containing 1.1 ug of the preactivated toxin ) was added to each incubation tube.
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2. 10. 4. Mono - ADP rihosvlation of crude membrane fractions hv 
cholera toxin and pertussis toxin.
25 - 50 (Xg of membrane protein was normally used for each sample to be ADP 
-ribosylated. To the membranes was added a cocktail containing 20 mM thymidine, 0.1 
mM GTP, 250 mM K2PO4  (pH 7.0), 1 mM ATP, 20 mM arginine hydrochloride. The 
cocktail also contained 2 }iCi [32p] NAD+ per incubation tube and the total volume in 
each tube was 50 (il. The incubation was started upon addition of the appropriate 
preactivated toxin to each of the tubes. These were placed in a 37 °C water bath for 90 
min. The incubation was terminated by placing the tubes on ice and subsequent TCA - 
deoxycholate precipitation as described in section 2 .7 .1 . The samples were then 
subjected to SDS-PAGE as described in section 2. 8.
2 , iQt 5, AtftpradiQgraphy^
Destained gels from toxin - catalysed ADP - ribosylation experiments and 
containing [32p] labelled proteins were dried onto Whatman 3mm filter paper under 
suction from an electric vacuum pump attached to a Bio - rad model 583 gel drier. 
Autoradiography was at -80 °C for an appropriate time on Kodak X - omat S x - ray 
film in a Kodak X - o - made cassette with intensifying screens. Films were developed 
on a Kodak X - o - mat developing machine. Bands corresponding to signals on the 
films were sometimes excised and Cerenkov - counted in order to quantitate the 
samples. Immunoblots to autoradiographed were wrapped in cling film and directly 
placed onto film then autoradiographed and the X - ray film developed as for the gels.
2. 11. Two - dimensional gel electrophoresis.
This was performed essentially according to the method of [O’Farrell et al., 
1977] as modified by [Goldsmith et al., 1988a], the first dimension being the
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isoelectric focussing step whilst the second dimension was conventional SDS page as 
described in section 2. 8 . Both first and second dimensions were run as part of a 
Bio-Rad Protean I electrophoresis apparatus.
2. 11. 1. Preparation of samples for isoelectric focussing.
150 }ig of the crude membrane preparation was spun at 12000 rpm for 5 min on 
a Hettich Mikro Rapid / K centrifuge. The supernatant was carefully removed and the 
pellet resuspended in 15 |il of solubilizing buffer consisting of 5 mM K2 CO3 , 20 mM 
DTT and 1 % (v/v) nonidet P - 40. This was incubated on ice for 60 min after which 
time the samples were centrifuged as before. 10  fil of each supernatant was removed 
and added to a tube containing 20 jil of " 2 - D sample buffer " (9.2 M urea, 5 % (v/v) 
BME, 8 % (v/v) nonidet P - 40,1.6 % (v/v) ampholine pH 5 - 6.5, 0.4 % (v/v) 
ampholine pH 3 -10). Samples were stored at -20 °C until needed.
.21„ U , 2t Casting of isoelectric focussing tube gels.
The IEF first dimension gel were poured to a height of approximately 10 cm in 
glass tubes of 1 mm diameter. The gel mixture contained 9.2 M urea, 2 % (v/v) nonidet 
P - 40, 4 % (w/v) acrylamide, 0.24 % (w/v) bisacrylamide, 4 % (v/v) ampholine pH 5 
- 6.5,1 % ampholine pH 3 -10,0.05 % (v/v) TEMED and 0.01 % (w/v) ammonium 
persulphate. Gels were overlaid with double distilled water and allowed to set Upon 
setting the water was replaced with an overlay of 30 jil of the " 2 - D sample buffer " ( 
see section 2.11.1.) and allowed to equilibrate for 30 min.
2. 11. 3. Application of sample to the IEF tube gel.
After equilibration the " 2 - D sample buffer " was replaced with a fresh 30 jllI.
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The sample was then carefully overlayed onto the gel using a Hamilton syringe. This 
was followed by a 20 jil layer of " 2 - D sample buffer " which had been diluted 1 :1  
with water. A final overlay with 20 mM NaOH was applied.
2. 11. 4. Running conditions for IEF gels.
Gels were loaded onto a Bio-Rad protean I electrophoresis apparatus. The 
lower tank was filled 10 mM orthophosphoric acid. The upper chamber contained 20 
mM NaOH. Electrophoresis was towards the anode at 500 V for 15 hours. After 
electrophoresis the gels were removed and equilibrated for 1 hour in 62.5 mM Tris - 
HC1 (pH 6 .8 ) containing 2.3 % (w/v) SDS, 5 % (v/v) BME, 10 % (v/v) glycerol, 0.1 
% (w/v) bromophenol blue and then stored at -20 °C until used. Running the tube gels 
in the second dimension was as described in section 2 . 8 .
2. 11. 5. Measurement of p H gradients.
An additional first - dimension tube gel was prepared in parallel with those on 
which the samples were loaded and run at the same time as the experimental gels. After 
electrophoresis the gel was cut into 1 cm pieces and each placed in a small vial. To each 
piece was added 1 ml of boiling distilled water and the vials were stoppered tighdy. 
After two hours the vials were vortex - mixed and the pH of the resulting solution was 
measured with a thin pH electrode.
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2. 12. Immunological methods.
2. 12. 1. Electroblotting of proteins onto nitrocellulose.
Transfer of proteins from 1 - dimension or 2 - dimension gels onto 
nitrocellulose and susequent incubation with antisera was essentially by the method of 
[Towbin et al., 1979]. Proteins which had been separated on 1 - or 2 - dimension gels 
were transferred onto nitrocellulose using an LKB 2005 Transphor electroblotting unit 
The cassette to hold both the gel and the nitrocellulose during transfer was prepared as 
follows. A sponge pad was soaked in blotting buffer (25 mM Tris (pH 8.3) containing 
192 mM glycine and 20 % (v/v) methanol and placed in the lower part of the cassette. 
All subsequent loading procedures were done with the cassette totally submerged in 
blotting buffer to prevent formation of any air bubbles within the cassette which would 
prevent successful transfer of the proteins from the gel. A piece of Whatman 3mm 
chromatography filter paper with dimensions slightly larger than the gel was placed on 
the sponge. The gel was next placed in the cassette followed by the nitrocellulose sheet 
( Anderman & Co., Ltd., Surrey, U.K.) then a similar piece of Whatman 3mm filter 
paper. Another sponge completed the sandwich. The cassette was closed and inserted 
into the electroblotting apparatus. The proteins were then subjected to electrophoresis 
towards the anode at 1.5 A for 2 hours. 1 - dimension blots were then treated 
differently from 2  - dimension blots.
2. 12. 2. Incubation with antisera of gels only run in the first 
dimension.
After electrophoresis the nitrocellulose sheet with the blotted proteins was 
transferred into a dish and covered with 100 ml blocking buffer consisting of 3 % (w/v) 
gelatine in TBS (20 mM Tris - HC1 (pH 7.5), 500 mM NaCl). The blot was incubated 
for 2 hours at 30 °C after which time the gelatine /  TBS was completely washed off
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using copious amounts of double distilled water and then incubated overnight with 
antiserum appropriately diluted into TBS containing 1 % gelatine (w/v) at 30 °C. This 
first antiserum was normally the specific anti - G - protein antiserum. Next day the 
blots were first washed thoroughly with double distilled water to remove all the 
unbound antiserum then with two washes each of 5 minutes with TBS containing 0.05 
% (v/v) Tween 20 and finally with two washes each of 5 minutes with TBS. The blots 
were then incubated at 30 °C for 2 hours in the 2nd antisera mix. This consisted of 
TBS with 1 % (w/v) gelatine and a 1:200 dilution of a commercial horseradish 
peroxidase - conjugated donkey anti - rabbit IgG ( Scottish Antibody Production Unit, 
Carluke, Scodand). After this last incubation the blot was washed with double distilled 
water, then TBS containing Tween 20 and finally with TBS exactly as before.
2. 12. 3, Incubation with antisera of gels run in 2 dimensions.
\
After transblotting ( section 2 .12.1 .) the blots were transferred to a dish, 
covered with blocking buffer comprising of 5 % (w/v) gelatine in PBS and incubated 
for 2 hours at 30 °C. The gelatine was then completely washed off using double 
distilled water. The first antiserum was then added and the blots incubated overnight at 
30 °C. This antiserum was the anti - G - protein antiserum and was appropriately 
diluted in PBS containing 1 % (w/v) gelatine and 0.2 % (v/v) nonidet P - 40. Next day 
the blots were first washed thoroughly with double distilled water to remove all the 
unbound antiserum and then with two washes each of 5 minutes with PBS containing 
0.2 % (v/v) nonidet P - 40. The blots were then incubated at 30 °C for 2 hours in the 
2nd antisera mix consisting of PBS with 1 % (w/v) gelatine, 0.2 % (v/v) nonidet P - 40 
and 1 : 2 0 0  dilution of the horseradish peroxidase - conjugated donkey anti - rabbit 
IgG. After this last incubation the blots were washed as before with double distilled 
water then 2 washes each of 5 minutes with PBS /  nonidet P - 40 and finally with 2 
washes each of 5 minutes with PBS.
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2. 12. 4. Development of Immiinoblots.
Detection was identical for both 1 - and 2 - dimension blots. Blots were each 
placed in a dish containing 40 ml 10 mM Tris - HC1 (pH 7.5). To this was added 1 ml 
1 % (w/v) newly prepared O - diansidine. Development was initiated upon addition of 
2 0  jil of stock hydrogen peroxide and was terminated by pouring off the developer and 
adding water. Assessment of the relative intensity of the G - protein subunits as 
indicated by intensity of immunoblot staining was carried out by analysing scans of a 
film positive of the blot on a Bio - Rad 620 video densitometer linked to an Olivetti M24 
personal computer.
2. 12. 5. rll i l l  - labelled donkey anti - rabbit immunoglobulin overlay 
technique.
After development the blots were placed in a dish containing 50 ml PBS with 1 
% (w/v) gelatine and 0.2 % (v/v) nonidet P - 40 spiked with 5 p.Ci [ -^ I]  . labelled 
donkey anti - rabbit immunoglobulin and incubated for 1 hour at 30 °C. The blots were 
then washed thoroughly with double distilled water to remove all the unbound label and 
then with two washes each of 30 minutes with PBS. The blot was allowed to dry, the 
immunoreactive bands ( and appropriate blanks) were excised and counted on an LKB 
1275 minigamma counter.
2. 13. Assay of high - affinity GTPase activity.
High affinity GTPase measurements were obtained using the method of [Cassel 
& Selinger, 1976]. Preparation of the assay tubes was carried out at 4 °C and each 
incubation was done in quadruplicate. 5 \ig of crude membrane was resuspended in 
100 |il of an incubation cocktail with final concentrations as follows : 1 mM ATP, 1
mM ouabain, 10 mM AppNHp, 100 mM NaCl, 5 mM MgCl2 , 2 mM DTT, 0.1 mM 
EDTA, 20 mM Tris - HC1 (pH 7.5), lpM GTP, 5 mM phosphocreatine and 5 units of 
creatine kinase. Each assay tube also contained 50000 cpm of [ y - 32 pj GTP and 
drugs as appropriate. Incubations were for 10 min at 37 °C after which time the 
incubation was terminated by the addition of 900 pi of ice cold 5 % (w/v) activated 
charcoal in 20 mM orthophosphoric acid. Each sample was immediately vortex - mixed 
and centrifuged at 3000gf for 20 min on,a Beckman TJ - 6  bench top centrifuge. 0.5 
ml of the supernatant was removed and Cerenkov counted in an LKB counter using a 
wide open channel setting.
2. 14. Assay of adenvlvl cvclase activity.
2. 14. 1. Sample incubation.
Adenylyl cyclase activity was assayed by the method of [Houslay et al.,
1976]. All preparatory work was carried out at 4 °C and the assay was performed in 
triplicate. 20 pg of crude membrane preparation was placed in a 1.5 ml eppendorf 
centrifuge tube. To this was added 50 pi of an assay cocktail comprising 50 mM 
triethanolamine hydrochloride (pH 7.4), 2 mM EDTA, 10 mM MgSC>4 , 20 mM 
theophylline, 2 mM DTT, 14.8 mg/ml phosphocreatine, 0.5 mg/ml creatine kinase,
1.25 mg/ml BSA, 0.3 mM ATP, 0.2 mM GTP. Since the final assay volume was 100 
pi for each tube this cocktail was essentially a 2 x stock. Forskolin at a final 
concentration of 10 pM was added as well as the appropriate drug to be studied.
Double distilled water was added to give a final volume of 100 pi.
The samples were then incubated at 30 °C for 10 minutes and the reaction 
terminated by placing the tubes in a boiling bath for 5 minutes. Precipitated protein was 
pelleted by centrifugation at 12000g for 5 minutes on a Hettich Mikro Rapid /  K 
centrifuge. 50 pi of the supernatant was removed for cAMP determination. These
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samples were stored at -20 °C until needed.
2. 14. 2. cAMP determination.
Determination of cAMP content in samples was based on the competition 
binding assay of [Brown et al., 1972] as modified by [Tovey et al., 1974]. All 
subsequent procedures were performed at 4 °C.
A series of unlabelled cAMP standards were prepared in assay buffer 
consisting 50 mM Tris - HC1 ( pH 7.4 at 4 ° C ), 4 mM EDTA. These ranged from 0 - 
320 pmoles /  ml. Stock [^H] - cAMP (5 ,8  - - adenosine 3*: 51 - cyclic
monophosphate) in ethanol was diluted in assay buffer to give approximately 500000 
cpm / ml. 100 jil of this was placed in a 1.5 ml eppendorf centrifuge tube containing 50 
jil assay buffer. To each tube was added 50 |il of either appropriate cAMP standard or 
sample prepared as described in section 2.14.1.100 jil cAMP binding protein ( 
prepared from bovine heart by the method of [Rubin et al., 1974] and a kind gift from 
Professor M.D. Houslay) diluted 1: 70 in assay buffer was then added to each tube. 
The tubes were gently vortex mixed and incubated at 4 °C for 2 - 3 hours. 10 minutes 
before the end of the incubation a charcoal suspension consisting 2% (w/v) GSX-100 
charcoal, l%(w/v) BSA in ice cold assay buffer was prepared. This suspension was 
gently mixed at 4 °C until needed.
0.25 ml of the charcoal suspension was added to each tube at the end of the 
incubation period. The tubes were vortex mixed and the charcoal pelleted by 
centrifuging at 4 °C for 4 minutes at 12000 ipm on a Hettich Mikro Rapid /  K 
centrifuge. 0.4 ml of the supernatant was removed, placed in vials containing 7 ml 
ecoscint scintillation fluid and counted in an LKB 1219 Rackbeta scintillation counter 
with an RIA curve fitting facility. This automatically constructed a standard curve,
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calculated the cAMP content of each sample and expressed it in pmoles /  ml sample. 
Routinely the sensitivity of the binding assay was between 0.25 and 8 pmoles /  ml 
sample.
2. 15. Assay of opiate receptor binding in crude plasma membrane 
fractions.
Saturation binding studies were performed by the filtration method of [Pert & 
Snyder, 1973] as modified by [McKenzie & Milligan, 1990].
150 jig of membrane fraction was resuspended at 4 °C in a cocktail consisting 
10 mM Tris - HC1 (pH 7.5), 50 mM sucrose, 20 mM MgCl2  and an appropriate 
amount of [^H] - DADLE to a final volume of 250 jil. Studies were carried out with 
the concentrations of the radioligand of 0 - 20 nM. Non-specific binding of the ligand 
to the opiate receptor was assessed using parallel tubes containing an excess (1 0  |iM ) 
non-labelled DADLE or DALAMID. Appropriate blank values were determined using 
buffer instead of membrane fraction. All assay points were performed in quadruplicate. 
Incubations were carried out at 25 °C for 30 minutes after which time the tubes were 
transferred onto ice and quickly filtered through Whatman GF /  C glassfibre filters. 
Each filter was washed 3 times with ice-cold buffer. The filters were soaked overnight 
in 10 ml ecoscint scintillation fluid prior to liquid scintillation counting on an LKB 
1219 rackbeta counter.
2. 16. Treatment of NG108-15 membranes with alkaline phosphatase.
Alkaline phosphatase treatment of membranes were performed essentially by the 
method described by [Stadel et al., 1988].
800 units /  ml of this enzyme (Sigma) was added to membranes (150 Jig) of 
dibutyryl cAMP differentiated NG108-15 cells in 10 mM Tris /  HC1 ( pH 9.8), 0.1 
mM EDTA, lOmM MgC^ to a final volume of 10 pi and incubated for 30 minutes at 
37 °C. The incubation was stopped upon addition of an equal volume of a solubilizing 
buffer consisting 10 mM K2 CO3 , 40 mM DTT, 2 % (v/v) Nonidet P - 40 (2  x normal 
solubilizing buffer) and left on ice for 1 hour. The samples were then subjected to 2 - 
D immunoblot analysis as described in section 2 .11 .1 .
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The peotide sequences used to generate a series of antipeptide antisera 
directed anainst the various subunits of the G - proteins.
Intiserum  Peptide Used G-protein sequence Antiserum
Iden tifies
)C1 ANNLRGCGLY G0a  345-354 G0a
)N1 GCTLSAEERAALERSK Gna  1-16 G ao 0
Ml NLKEDGISAAKDVK G0a  22-35 GQa
3B KNNLKECGLY G ^ a  345-354 G{3a
lS7 KENLKDCGLF T d la  341-350 T dla, Td2a
G [la, Gj2a
N1 MSELDQLRQE P 1-10 pi
E2 LERIAQSDYI G{2a  160-169 Gi2a
dl the above antisera were produced acccording to the method of Goldsmith et al.
987 as described in section 2. 3. Amino acids are represented using the one letter 
ode.
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Chapter 3.
CHARACTERIZATION OF ANTIPEPTIDE ANTISERA DIRECTED 
AGAINST A FAMILY OF G - PROTEINS.
3. 1. Introduction.
The extreme homology of the primary amino acid sequences of the a  subunits 
of the G - proteins has required the need for more selective probes to be employed in 
their definitive identification and for subsequent investigation into their function. The 
ability of bacterial toxins to catalyze the ADP - ribosylation of the G - protein a  
subunits was, for some time, the only method for the specific identification of the a  
subunits in membranes. This method has a number of limitations, not the least of which 
is the relative lack of specificity of pertussis toxin for its G - protein substrates.
Currently the most convenient approach for the identification of the G - proteins 
involves the use of specific antisera raised against either isolated proteins or more 
recently against peptide sequences unique to that particular G - protein as deduced from 
conventional protein sequencing or analysis of cDNA clones. Mumby et al. were the 
first to produce such a series of antipeptide antisera and were able to demonstrate that 
these antisera displayed greater specificity for particular G - proteins on immunoblots 
than did antisera raised against purified G - protein a  - subunits [Mumby et al., 1986].
Such information has made it possible to generate a series of specific 
antipeptide antisera directed against regions of known importance in a number of G - 
proteins such that not only can these antisera be used to identify a particular G - protein, 
they can also be used to probe their function.
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This study involved use of such a series of specific antisera to investigate the 
expression of particular G - proteins during morphological differentiation of NG108 - 
15 cells and functional changes resulting as a consequence. A number of the antisera 
used were kind gifts from other laboratories but several were produced' in h o u seA s 
such it is important that the antisera be fully characterized. The results presented in 
chapter 3 detail the generation of these antisera and determination of their specificity.
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3. 2. Results.
3. 2. 1. Characterization of donated antisera.
The antisera used in the experiments to be described in this study can be 
conveniently placed into two main groups for the purposes of their characterization.The 
first group comprised those antisera generated in other laboratories and which were 
kind gifts. As a consequence these antisera have been fully characterized elsewhere in a 
series of published articles [see below]. The antisera in this group consist of HPA, AS7 
and LE2.
The second group contained those antisera which were produced in our 
laboratory specifically for this and other studies by our research group. These antisera 
were raised in New Zealand White rabbits against a conjugate of the appropriate peptide 
coupled to keyhole limpet haemocyanin with glutaraldehyde using the method of 
Goldsmith et al., 1987 as described in section 2. 3. Included in this group are 
antisera IM1, OC1, ONI, SGI and I3B.
A full list of the antisera used, the peptide sequences which they were raised to 
and the G - proteins that they recognize is given in Table 2.1.
3. 2. I. (a). Antiserum A§7,
Antiserum AS7, although raised against the C - terminal decapeptide of Tdla, 
has been shown to recognize G jla  and Gj2a [Goldsmith et al., 1987]. This is 
because these two G - proteins share an identical C - terminal sequence and this 
sequence differs by only one conservative change from that of the C - terminus of Tdl 
[Milligan, 1988]. Antiserum AS7 has been fully characterized and used previously in a 
number of studies. [Goldsmith et al., 1987; Gawler et al., 1987 ; Falloon et al.,
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1986; Milligan et al., 1987b].
Our laboratory has also produced an antiserum against this peptide sequence. 
This antiserum named, SGI, has been shown to recognize G jla  and Gj2oc in both rat 
adipocytes and rat cerebral cortex [Mitchell et al., 1989] and is, in general, equivalent 
to antiserum AS7. Recent work in our laboratory has used this antiserum instead of 
AS7, however all of the work on Gj 2a in NG108 -15 cells described in this study 
used antiserum AS7.
3. 2. 1. (b) Antiserum LE2.
Antiserum LE2 was produced when it became clear from cDNA studies that 
there was more than one form of " Gj " [Goldsmith et al., 1987]. This second cDNA, 
corresponding to Gj2a, was cloned from a variety of cDNA libraries including those 
produced from rat C6  BUI glioma [Itoh et al., 1986], mouse macrophage [Sullivan et 
al., 1986] and human monocyte [Didsbury et al., 1987] cells. The sequence encoded 
a 355 amino acid protein which at the time of publication had not been identified. This 
antiserum was raised against an internal sequence ( residues 160 -169) in the predicted 
primary structure of Gf2a. This sequence differed in three residues from the 
corresponding region in G^la and the resultant antiserum reacted stongly with a 40 kDa 
protein highly abundant in membranes of human neutrophils andpresent in lower levels 
in brain [Goldsmith etal., 1987]. This antiserum is specific in its identification of 
Gj2a and was later used to identify this protein as the major pertussis toxin substrate in 
C6  BUI rat glioma cells [Milligan et al., 1988].
3. 2. 2. Characterization of antiserum I3B.
Antiserum I3B was produced in our laboratory against a peptide sequence
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corresponding to the carboxyl terminal decapeptide of Gj3a. This antiserum been fully 
characterized [Mitchell et al., 1989; McKenzie & Milligan, 1990; Milligan, 1990].
3. 2. 3. Production of antisera directed against the a  subunit of G^.
The cDNA sequence for the a  subunit of G0  has been obtained from a number 
of sources including rat olfactory neuroepithelium [Jones & Reed, 1987], bovine retina 
[Van Meurs et al., 1987] and rat glioma C6  cells [Itoh et al., 1986; Itoh et al., 1988]. 
These studies revealed the primary sequence of G0a  to consist of 354 amino acid 
residues which have 82 % identity with G jla. Using this sequence information it was 
possible to generate three distinct antisera raised against peptide sequences in GQa  of 
supposed importance in G - protein function The first antiserum produced was IM1 
which was raised against amino acids 22 -35 of G0 a. This antiserum was assessed by 
its ability to discriminate between the a  subunits of " Gj " and G0  in a mixture of these 
polypeptides purified from bovine brain, a tissue known to be rich in these particular 
proteins. This was achieved by performing mixing experiments with antiserum AS7 
and comparing the mobility of immunoreactive polypeptides on immunoblots. It should 
be noted that antiserum AS7 is able to recognize Gjla, the predominant form of Gja in 
brain, and Gj2a equally well. However under the conditions of the experiments to be 
described these proteins were not separated from each other and appear as a single 
immunoreactive band on the blots whereas G0a  is quite clearly separable from the Gja 
mixture under the conditions used.
3. 2. 3. (a). Characterization of antiserum IM1.
A mixture of G0a  and Gja purified from bovine brain [Milligan & Klee,
1985], a kind gift from Dr. G. Milligan, was resolved by SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted with antisera AS7, IM1 or a mixture of the two as
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described in sections 2. 7. & 2. 8 . The mixture of the two antisera identified two 
polypeptides of 39 and 40 kDa [Fig. 3.1.]. However each antiserum individually 
identified only a single immunoreactive species. Antiserum AS7 recognized the 40 kDa 
polypeptide ( G ia ) whereas IM1 recognized the 39 kDa species ( G0 oc).
The above experiment was essentially repeated using membranes prepared from 
rat brain cortex. 25 \ig of a crude membrane fraction was first alkylated using NEM to 
maximize the separation between Gja and G0a  [Stemweis & Robishaw, 1984] and 
was again resolved by SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted with 
antisera AS7, IM1 or a mixture of the two [Fig. 3. 2.]. The mixture of the two 
antisera identified two polypeptides of 39 and 40 kDa respectively with antiserum AS7 
identifying a single band at 40 kDa and IM1 recognizing a polypeptide at 39 kDa.
Antiserum IM1 has been further characterized [Goldsmith et al., 1988a] where 
it was used in conjunction with a number of other antisera to identify G0a  in two 
dimensional analyses of the purified protein and of the in vitro translated products of 
cDNAs encoding G0 a .
3. 2. 3. (b). Characterization of antiserum PCI.
Antiserum OC1 was raised against a peptide sequence comprising the last ten 
amino acids of the C -terminus of G0 a. The resulting antiserum was screened using the 
same procedures as noted above for antiserum IM1. A sample of crude membrane 
fraction from rat brain cortex was first alkylated with NEM, resolved by SDS - PAGE ( 
10 % (w/v) acrylamide) and immunoblotted with antisera AS7, OC1 or a mixture of 
the two [Fig. 3.3.]. The mixture of the two antisera again identified two 
polypeptides of 39 and 40 kDa with antiserum AS7 identifying a single band of 40 kDa 
and OC1 recognizing a polypeptide of 39 kDa.
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Figure 3. 1.
Antisera AS7 and IM1 identify mutually exclusive polypeptides within a 
mixture of purified G - proteins.
A mixture of purified Gj and G0  (330 ng) was subjected to NEM treatment 
resolved on SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted using 
antiserum AS7 ( A ), IM1 ( C ), or a mixture of these two antisera ( B ) [sections 2. 
7. 2., 2. 8 . & 2. 12.]. Both antisera were used at 1 : 200 dilution. Similar results 
were obtained in 3 other experiments.
Figure 3. 2 .
Antisera AS7 and IM1 identify mutually exclusive polypeptides in rat 
brain membranes.
Membranes (25 jig ) from rat brain cortex were subjected to NEM treatment 
resolved on SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted using 
antiserum AS7 ( A ), IM1 ( C ), or a mixture of these two antisera ( B ) [sections 2. 
7. 2., 2. 8 . & 2.12.]. Both antisera were used at 1 : 200 dilution. Similar results 
were obtained in 3 other experiments.
Figure 3. L
Figure 3. 2.
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Figure 3. 3.
Antisera AS7 and 0C1 identify mutually exclusive polypeptides in ra t 
brain membranes.
Membranes (25 jig) from rat brain cortex were subjected to NEM treatment 
resolved on SDS PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum 
AS7 ( a ) (1: 300 dilution), OC1 ( c ) (1:1500 dilution), or a mixture of these two 
antisera ( b ) [sections 2. 7. 2., 2. 8 . & 2. 12.]. Similar results were obtained in 
3 other experiments.
Figure 3. 3.
3. 2. 3. (c). Characterization of antiserum ONI.
Antiserum ONI was raised against a peptide sequence corresponding to the first 
16 amino acids of the N - terminus of G0 a. This antiserum was again screened with 
the mixing experiments described above for antisera IM1 and OC1.
Samples from a crude membrane preparation were first treated with NEM, 
resolved by SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted with antisera 
AS7, ONI or a mixture of the two [Fig. 3. 4.]. The mixture of the two antisera again 
identified two polypeptides of 39 and 40 kDa respectively with antiserum AS7 
identifying a single band at 40 kDa and ONI recognizing a polypeptide at 39 kDa.
3. 2. 3. fd). Antisera IM1. PCI and ONI recognize a single 39 kDa 
polypeptide.
Samples from a crude rat brain membrane preparation were subjected to NEM 
treatment resolved on SDS - PAGE on a single gel and immunoblotted using antiserum 
IM1 (1 ) ,  OC1 ( 2 ), or ONI ( 3 ). From Fig. 3. 5. it can be seen that each of the 
antisera recognized a single immunoreactive species which had the same mobility on 
this gel.
These mixing experiments demonstrate that each of the presumed G0oc antisera 
recognizes a single polypeptide of 39 kDa and that this immunoreactivity is distinct 
from that seen with antiserum AS7 which recognizes the a  subunits of Gjl and Gj2. 
Immunoblotting with a purified preparation of Gi /  Gq showed that antiserum IM1 
reacted with G0 a. Analysis of the immunoreactive species seen with antisera IM1,
ONI and OC1 on a single gel shows the mobility of each reactive species to be
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Figure 3. 4.
Antisera AS7 and ONI identify mutually exclusive polypeptides in rat 
hrain membranes.
Membranes (25 jig ) from rat brain cortex were subjected to NEM treatment 
resolved on SDS PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum 
AS7 ( a ) (1: 300 dilution), ONI ( c ) (1:1500 dilution), or a mixture of these two 
antisera ( b ) [sections 2. 7. 2., 2. 8 . & 2. 12.]. Similar results were obtained in 
3 other experiments.
Figure 3. 4.
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Figure 3. 5.
Antisera IM1. P C I and ONI recognize a single 39 kDa polypeptide.
Membranes (25 |ig ) from rat brain cortex were subjected to NEM treatment 
resolved on SDS PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum 
IM1 (1 )  (1: 200 dilution), OC1 (2  ) (1: 1500 dilution), or ONI (3  ) (1: 1500 
dilution) [sections 2. 7. 2., 2. 8 . & 2. 12.]. Similar results were obtained in 2 
other experiments.
Figure 3. 5.
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identical.
3. 2. 3. (e). Characterization of antiserum HPA.
Antiserum HPA was the only antiserum used in this study which was not 
raised against a peptide sequence. This antiserum was raised by immunization of a 
rabbit with a mixture of holomeric pertussis toxin - sensitive G - proteins which were 
purified from bovine brain. It contains populations of antibodies which recognize the p 
subunit associated with G - proteins as well as the a  subunit of G0.
Membranes from rat brain were resolved upon SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted using either antisera IM1, AS7 or HPA or a 
combination of mixtures of these antisera [Fig. 3. 6 .]. The mixtures of antisera HPA 
and AS7 [lane a] and IMI and AS7 [lane c] identified two distinct polypeptides in the 
region of 40 kDa. By contrast the mixture of antisera HPA and IMI [lane b] identified 
but a single polypeptide in this region. Antiserum HPA also identified a band at 36 kDa 
corresponding to the p - subunit.
3. 2 . 4. Generation of the B subunit antiserum. BN1.
Classical G - proteins exist as heterotrimers consisting of a,p and y  subunits. 
Although the p and y  subunits are not covalently linked to each other, the native 
proteins cannot be dissociated without denaturation and therefore form a single 
functional unit under all physiological conditions. As such the levels of the P subunits 
can be taken as indicative of the py complex.
There are at least two very similar forms of the p subunit one of 36 kDa ( 
termed p i ) and one of 35 kDa ( p2) in mammalian cells [Stemweis & Robishaw,
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Figure 3. 6.
Antiserum HPA specifically identifies O^g.
Membranes (25 jig ) from rat brain cortex were subjected to NEM treatment 
resolved on SDS PAGE (10 % (w/v) acrylamide) and immunoblotted with ( a ) a 
mixture of antiserum HPA (1:2000 dilution) and antiserum AS7 (1:200 dilution),
( b ) a mixture of antiserum HPA (1: 2000 dilution) and antiserum EMI (1: 200 
dilution), ( c ) a mixture of antiserum AS7 (1: 200 dilution) and antiserum IMI (1: 
200 dilution), ( d ) antiserum HPA (1 :  2000 dilution), ( e ) antiserum AS7 (1:
200 dilution), ( f ) antiserum IMI (1 : 200 dilution) [sections 2. 7. 2., 2. 8 . & 
2.12.]. Similar results were obtained in 3 other experiments.
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1984; Winslow et al., 1986]. In most tissues the (31 form is the predominant form, 
while the p2 is a minor component [Woolkalis & Manning, 1987]. The amino acid 
sequence of both forms has been deduced from cDNA analysis and have been shown to 
be some 90 % identical [Fong et al., 1987; Gao et al., 1987]. Using these sequences 
it was decided to produce an antipeptide antisera raised against residues 1 - 1 0  from the 
N - terminus of the (31. The resulting antiserum BN1 was compared against antiserum 
HPA which has been shown to contain a population of antibodies directed against the (3 
subunit.
Samples from a crude rat brain membrane preparation were subjected to NEM 
treatment, resolved on SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted 
using antiserum HPA ( A ) or BN1 ( B ) [Fig. 3. 7.]. Both antisera recognized a 
single band of 36 kDa corresponding to the (3 subunit and HPA also recognized GQa.
3. 2. 5. Cross - reactivity of G - protein antisera.
Possible cross - reactivity of the G - protein antisera must be considered 
carefully. As more G - proteins are identified the possibility of these proteins having 
sufficient identity with those already defined cannot be discounted. With two 
exceptions, the antisera used in this study do not, to the best of current knowledge, 
cross - react with any G - protein other than the polypeptide for which it was designed 
to identify. Antiserum I3B has been shown to identify a single polypeptide of some 41 
kDa in membranes of rat adipose tissue and rat glioma C6  BUI cells. Furthermore 
when northern blots of total RNA from adipose tissue were probed with a synthetic 
deoxyoligonucleotide complementary to Gj3a, the probe hybridized to a single single 
RNA of 3.4 kilobases [Mitchell et al., 1989] thus confirming the presence in this 
tissue of Gi3a. However when membranes from rat cerebral cortex were
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Figure 3. 7.
Antisera HPA and BN1 recognize the same 36 kDa nolvnentide.
Membranes (25 |!g ) from rat brain cortex were subjected to NEM treatment, 
resolved on SDS PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum 
HPA ( a ) (1 : 2000 dilution) or BN1 ( b ) (1 : 200 dilution) [sections 2. 7. 2., 2. 
8 . & 2.12.]. Similar results were obtained in 2 other experiments.
Figure 3. 7.
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immunoblotted with antiserum I3B, two immunoreactive species were noted [Milligan, 
1990]. The cross - reactivity of this antiserum was further examined.
Fig. 3. 8. shows membranes of rat glioma C6 BUI cells (lanes 2, 4) which 
express high levels of Gi2a and substantial quantities of Gf3a but not G0a  and 
membranes of rat cerebral cortex (lanes 1, 3) which have high levels of G jla  and 
G0a  and lower levels of Gj2a and Gj3oc which were resolved on SDS - PAGE and 
immunoblotted using either antiserum SGI ( panel A ) or antiserum I3B ( panel B ). 
Antiserum I3B identified a 41 kDa polypeptide in C6 cells ( Gf3a) but in cerebral 
cortex, while low levels of Gj3a were noted ( panel B, lane 1 ), the antiserum also 
identified a 39 kDa protein ( G0 a ) which was not detected in C6 BUI membranes 
showing that I3B cross - reacts with both Gj3a and G0a  but not with G^la or Gj2a. 
The converse is also true, antiserum OC1 which was raised against the corresponding 
C - terminal sequence of G0a  displayed a slight cross - reactivity with Gf3a under 
conditions which are able to resolve Gj3a from G0 a. Since all of the experiments to be 
described in this study rely on corroboration with other G0a  antisera which do not 
recognize Gf3a, this cross - reactivity, although noted, can be disregarded.
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Figure 3. 8.
Antiserum T3B cross - reacts with Gj3 and 
QlO ,
Membranes of rat glioma C6  BUI cells ( lane 2 : 100 jig, lane 4 : 50 jig) 
and of rat cerebral cortex ( lane 1:100 jig, lane 3 : 50 jig ) were subjected to NEM 
treatment, resolved on SDS PAGE (12.5 % (w/v) acrylamide) and immunoblotted 
using either antiserum SGI ( panel A ) or antiserum I3B ( panel B ).
Figure 3. 8.
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3. 3, Discussion.
Recognition by specific antisera remains the best approach in the identification 
of individual G - proteins. Originally these antisera were produced using purified 
preparations of holomeric G - proteins. However these attempts were not always 
successful and relied upon the protein purification protocols available, purification to 
homogeneity of the individual G - proteins being technically very demanding. Indeed 
the use of a mixture of pertussis toxin - sensitive G - proteins isolated from brain 
resulted in the generation of antisera which recognized the |3 subunit and G0a  but 
showed no cross - reactivity against Gj(x [Gierschik et al., 1986b; Huff et al., 1985], 
although recently the generation of a polyclonal anti - G^  antiserum using purified brain 
Gj as an antigen has been reported [Katada et al., 1987].
An alternative approach has been to utilise the tools afforded by recent advances 
in molecular biology. Information from cDNAs corresponding to the various G - 
proteins has led to the production of a series of antipeptide antisera directed against 
short synthetic peptides which can be predicted to be present in particular G - proteins.
The results detailed in this chapter describe the production of several antipeptide 
antisera directed against a number of G - proteins using distinct peptide sequences 
determined from analysis of cDNA studies from a number of sources [Jones & Reed, 
1987; Lochrie & Simon, 1988]. The resultant antisera were characterized by their 
ability to recognize purified preparations of G - protein a  subunits, by comparison of 
mobility of various G - proteins on high - resolving SDS - PAGE in membranes with 
defined G - protein status and by agreement of recognition with other well characterized 
antisera. Those antisera raised against sequences found in the a  subunit of G0, namely 
IM1, OC1 and ONI, were shown to immunoreact on western blots with a single 
polypeptide of 39 kDa which could be identified as being G0 a.
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It was also possible to generate such an antipeptide antiserum directed aganst 
the |3 subunit. The resulting antiserum, BN1, was raised against a peptide sequence of 
10 amino acids found at the amino terminal end of the pi form of this protein. This 
sequence contains only one conservative difference between pi and p2, pi having an 
aspartate residue in position 5 as opposed to a glutamate in the same position of P2. 
Immunochemical differences between the p subunits have been noted. Some transducin 
P antisera have been shown to cross react preferentially with pi [Roof et al., 1985; 
Evans et al., 1987] and an antiserum raised against a synthetic peptide representing 
residues 130 -145 of pi was shown to identify pi but not P2 [Mumby et al., 1986].
Although the antisera displayed very little cross - reactivity between them, 
antiserum I3B, which identified Gi3a, was shown to cross - react to some degree with 
GqCC. Gj3a has a predicted protein sequence from cDNA analysis which shows that it 
is more closely related to G^la (94 % identity) than is Gj2a. However although 
antiserum AS7 recognizes G jla  and Gj2a equally well, it does not react with Gj3a 
[McKenzie & Milligan, 1990] even though its' C - terminal ten amino acids are highly 
similar to those of Gfl<x and Gj2a having only two conservative changes. Furthermore 
antiserum I3B does not react with G jla  or Gf2a but does cross - react with G0awhich 
is probably a reflection of the antigenic importance of the aromatic C - terminal tyrosine 
residue which Gj3a and G0 a, but not G fla and G^2a, have as a common feature 
[Milligan, 1990]. Antiserum OC1 which was raised against the carboxyl decapeptide of 
G0a  and contains this same immunogenic tyrosine residue displayed a slight cross - 
reactivity with Gj3a. This cross - reactivity and its implications are further discussed in 
chapter 6 .
92
Chapter 4.
ELEVATED LEVELS OF THE GUANINE NUCLEOTIDE ■ BINDINCx 
PROTEIN Ga«  ARE ASSOCIATED WITH cAMP ■ INDUCED 
DIFFERENTIATION OF NG108 ■ 15 CELLS.
.Chapter_-4.»
ELEVATED LEVELS OF THE GUANINE NUCLEOTIDE ■ BINDING 
PROTEIN G o^c ARE ASSOCIATED WITH cAMP ■ INDUCED 
DIFFERENTIATION OF NQ108 - 15 CELLS.
4. 1. Introduction.
Modulation in the levels of G - proteins can be achieved under a variety of 
conditions. A number of clinical disorders appear to display changes in the amounts of 
G - proteins and this can be manifest in altered signal transduction. Levine and 
coworkers have been able to show that in type la - pseudohypoparathyroidism there is a 
reduced expression of Gsa  as indicated by the reduced concentrations of mRNA 
encoding for this protein in affected fibroblasts [Levine et al., 1988] and in plasma 
membranes of hepatocytes isolated from streptozotocin - induced diabetic rats markedly 
lower levels of Gjoc were recorded in comparison to control animals [Gawler et al., 
1987].
A number of immunological and biochemical investigations have clearly 
indicated that the distribution of G0a  is essentially restricted to nervous and endocrine 
tissue [Homburger et al., 1987; Asano et al., 1988a]. By employing a highly 
sensitive immunoassay, Murayama and colleagues were able to demonstrate that levels 
of G0a  were enhanced in the cerebrospinal fluid of patients with a variety of 
neurological disorders. These included meningitis which showed a 48 % increase in 
G0a  and encephalitis which displayed a 100 % enhancement [Murayama et al., 1989].
Alterations in the amounts of various G - proteins in developing tissues has 
also been observed. An increase in G0a  occurs during the onset of functional
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parasympathetic innervation of the chick heart. This increase, of up to 50 %, was 
noted, first in whole heart and then in membranes prepared from atrial and ventricular 
tissue, between days 10 to 20 of embryonic development [Luetje et al., 1987; Liang et 
al., 1986].
Differentiation of 3T3 - LI fibroblasts into adipocytes by treatment with IBMX 
and dexamethasone is accompanied by increases of up to 48 % in the levels of G0a  in 
membranes prepared from these cells [Gierschik et al, 1986a; Watkins et al., 1987] 
which led to the suggestion that G0  may be involved in the control of cell proliferation.
The neuroblastoma x glioma hybrid cell line, NG108 -15, a commonly used 
system in neurobiology, was generated by cell fusion of the 6  - thioguanine - resistant 
clonal mouse neuroblastoma cell, N18TG2 and the bromodeoxyuridine - resistant rat 
glioma cell, C6  BUI, selection and cloning. These cells have been shown to express a 
wide range of receptors for various neurotransmitters and hormones, which can be 
demonstrated to couple to a number of distinct second messenger effector systems and 
ion channels [for review see Hamprecht et al., 1985]. Amongst the transmembrane 
signalling systems studied in most detail are the stimulation and inhibition of adenylyl 
cyclase [Klee et al., 1985] and the regulation of voltage - sensitive calcium channels 
[Tsunoo etal., 1986].
NG108 -15 cells are able to undergo morphological differentiation upon the 
addition of agents which function to elevate intracellular concentrations of cAMP. 
Under such conditions the cells withdraw from the cell cycle, take on a more rounded 
appearence and produce a number of neurite outgrowths. Differentiated NG108 -15 
cells are commonly used for electrophysiological experimentation because they are 
more amenable to to penetration by microelectrodes and are more electrically excitable 
than the undifferentiated cells. Differentiation also results in a number of biochemical
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changes in these cells. Vallano and Beaman - Hall noted an increase in the levels of a 
type II calcium /  calmodulin - dependent protein kinase, implicated in a number of 
cellular events, in NG108 - 15 cells differentiated with db cAMP [Vallano & Beaman - 
Hall, 1989] and Canithers and collaborators observed the up - regulation of an 
angiotensin in  selective receptor that mediated phosphatidylinositol breakdown in 
NG108 -15 cells that had been differentiated with DMSO [Carrithers et a l 1990]
NG108 -15 cells have been shown to contain a variety of G - proteins 
including Gs and a number of the pertussis toxin substrates including Gj2, G^3 and G0 
[Milligan et al., 1989; Milligan er al., 1986; McKenzie et al., 1988; McKenzie & 
Milligan, 1990 ].
The work described in chapter 4 outlines an investigation into alterations in 
the levels of GQa  which occur with cAMP - induced differentiation of NG108 -15 
cells
9 5
4. 2. Results.
4. 2. 1. Pharmacological treatment of NG108 - 15 cells.
The neuroblastoma x glioma hybrid cell line, NG108 -15, is able to undergo 
morphological differentiation when subjected to prolonged exposure to a variety of 
pharmacological agents which, as a common mode of action, elevate the levels of 
intracellular cAMP. Fig. 4.1. (a) shows some subconfluent, non - differentiated 
NG108 - 15 cells which were photographed 3 days after splitting from a confluent 
culture. These cells, which have been grown in a reduced foetal bovine serum 
concentration of 2  % (v/v) as a parallel control to the differentiated cells, will be termed 
control cells in the series of experiments to be described. Fig. 4.1. (b) shows cells 
which have been incubated for 6  days with 1 mM db cAMP, a membrane permeable 
cAMP analogue and one of the most commonly used differentiating agents.These cells 
can be seen to have undergone pronounced morphological changes and will be termed 
the differentiated cells in the work to be described. The cells have stopped dividing, the 
cell bodies have grown and there has been the production of a network of neurite - like 
outgrowths. Failure to reduce the concentration of foetal bovine serum, in this case 
from 10 % (v/v) to 2 % results in the loss in the ability of db cAMP to cause 
differentiation of the cells. The reasons for this are unknown at present No observable 
changes in the levels of any of the G - proteins studied were seen on simply reducing 
the concentration of serum without the addition of the cAMP analogue
The morphological changes seen upon differentiation were not exclusive to db 
cAMP. Cells grown in 8 - bromo cAMP, another cAMP analogue; forskolin, which 
directly activates adenylyl cyclase or prostaglandin Ej, which acts via a cell surface 
receptor and Gs to stimulate adenylyl cyclase all produced these morphological changes 
[see Table 4.1. for a list of agents and the concentrations used to differentiate the 
cells].
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Figure 4. 1. (a).
Morphological appearance of control NG108 - 15 cells in tissue 
culture.
Control NG108 -15 neuroblastoma x glioma hybrid cells were grown as 
described in section 2. 4.1. The cells had been maintained in tissue culture for 
3 days when these photographs were taken. The scale bar is equivalent to 10 J i m .
Figure 4. 1. CaV
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Figure 4. l.(b).
Morphological appearance of db cAMP - differentiated NG108 - 15 cells 
in tissue culture.
Db cAMP - differentiated NG108 -15 neuroblastoma x glioma hybrid cells 
were grown as described in section 2. 4. 6 . The differentiated cells had been 
maintained in the presence of db cAMP (ImM) for 6  days when these photographs 
were taken. The scale bar is equivalent to 10 fim.
Figure 4. l.fhV
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Table 4. 1.
List of agents and the concentrations used to differentiate NG108 - 15
cells.
Treatment Final concentration
DbcAMP ImM
Forskolin 10 |iM
Prostaglandin El 10 |iM
8-bromo cAMP 1 mM
NG108 - 15 cells were maintained for 6  days in the absence or presence of agents 
which elevate intracellular cAMP levels, as detailed in sections 2. 4.1. and 2. 4. 
6.
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All the variously treated cells were harvested and crude plasma membrane 
fractions were prepared as described in section 2. 5. When subjected to resolution 
by SDS - PAGE and subsequent staining with Coomassie Blue, the membranes from 
the control cells and from cells from each of the treatments appeared to be extremely 
similar [Fig. 4.2.] suggesting there to be no gross changes in the major protein 
constituents of the plasma membrane upon differentiation.
4. 2. 2. Mono ADP - ribosvlation of NG108 - 15 cell membranes using 
pertussis toxin.
Bordetella pertussis, the causitive agent of whooping cough is able to produce 
a number of exotoxins one of which, islet activating protein or more commonly 
pertussis toxin, has been shown to modulate the receptor - mediated control of cAMP 
production [Katada & Ui, 1979; Katada & Ui, 1981]. Pertussis toxin contains an ADP 
- ribosyltransferase activity which is now known to catalyse the transfer of an ADP - 
ribose moiety from an NAD+ substrate onto the a  subunit of a number of G - proteins 
including the various Gj's and G0. The site of pertussis - toxin catalysed ADP - 
ribosylation in all of these G - proteins is a conserved cysteine residue located four 
amino acid residues from the C - terminus [Milligan, 1988]. The use of [ ] NAD+
as a substrate allows for the visualisation, when subjected to gel electrophoresis 
followed by autoradiography, of polypeptides which are specifically ADP - ribosylated 
by this toxin.
Membranes from control cells and from cells differentiated with the various 
agents were subjected to such an analysis using pertussis toxin and [ ^ P ]  NAD+, the 
rationale being that any changes in the G - protein profile brought about by 
differentiation might manifest themselves as changes in the amount of radioactive label 
incorporated into the membrane. Autoradiography of the resultant gel demonstrated
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Figure 4. 2.
SDS - PAGE analysis of membranes from control and cAMP - 
differentiated NG108 - 15 cells.
Membranes (25 jig) of control (a) and cAMP - differentiated (b - e) cells were 
subjected to deoxycholate /  TCA precipitation followed by resolution under denaturing 
conditions by SDS - PAGE (10 % (w/v) acrylamide) as described in section 2. 8 . 
1. The resultant gel was stained with Coomassie Brilliant Blue [section 2. 9.1.]. 
The position of marker proteins of known molecular weights are indicated. All cells 
were differentiated for 6  days with 1 mM db cAMP (lane b); 1 mM 8 - bromo cAMP
(c); 10 uM forskolin (d); 10 uM PGEj (e).
Figure 4. 2.
markedly elevated incorporation of radioactive label over the control membranes into 
the 39 - 40 kDa region with each of the treatments [Fig. 4. 3.]. The 39 - 40 kDa 
region being that in which the G - proteins of interest are known to occur. This increase 
was quantified by excision of the relevant areas of the gel and subsequent scintillation 
counting. Table 4 .2. summarizes the results obtained from ADP - ribosylation of 
control and differentiated membranes from 4 different samples assessed in this way. 
There was a 2 - 3 fold increase in incorporation of label with each treatment. Since this 
data represents incorporation of radioactivity into a broad band with Mr of 39 - 40 kDa 
, it must be taken as indicative of a combination of GjCC and G0a  as their separation by 
molecular weight is not possible using 10 % (w/v) acrylamide SDS - PAGE gels.
Separation of the major pertussis toxin substrates is however possible using a 
modified gel system consisting of a SDS - PAGE resolving gel containing 12.5 %
(w/v) acrylamide with 0.0625 % (w/v) bisacrylamide and with samples which had first 
been alkylated with NEM as described in sections 2. 7. 2. & 2. 8 . 2.
Control and db cAMP differentiated NG108 -15 membranes were treated with 
pertussis toxin and [^P] NAD+ , subjected to alkylation with NEM then resolved on 
the 12.5 % gel and autoradiographed for forty eight hours. Two polypeptides of 
apparent Mr of 39 kDa and 40 kDa were labelled in the presence of pertussis toxin 
[Fig. 4. 4.]. These are likely to represent the a  subunits of G^2 and G0.
From Fig. 4.4. it can be seen that there was relatively little difference in the 
incorporation of radioactivity into the 40 kDa polypeptide between the control and 
differentiated membranes. However, a marked increase in incorporation was noted in 
the 39 kDa polypeptide in membranes of the db cAMP - treated cells when compared to 
membranes of untreated cells. Densitometric analysis of the autoradiograph showed 
there to be a 4.6 fold [ from 7.9 to 36.0 arbitary units ] increase in optical density in the
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Figure 4. 3.
SDS - PAGE analysis of membranes of untreated and cAMP - 
differentiated NG108 - 15 cells subjected to mono ADP - ribosvlation 
with pertussis toxin.
Membranes (25 jig) of untreated (A,D) and cAMP - differentiated NG108-15 
(B,C,E,F) cells were ADP - ribosylated with [^P ] NAD+ and pertussis toxin for 90 
min as described in section 2.10. 5. Samples were recovered by deoxycholate / 
TCA precipitation, resolved using SDS - PAGE (10 % (w/v) acrylamide) and 
autoradiographed as described in section 2. 8 . Lanes A, D, untreated cells, lane B, 
cells treated with 8 - bromo cAMP (1 mM), lane C, with prostaglandin Ej (10 fiM), 
lane E, with db cAMP (1 mM), lane F, with forskolin (10 jjM). Similar results were 
obtained in 3 other experiments.
Figure 4. 3.
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Table 4. 2.
Pertussis toxin - catalysed ADP - ribosvlation of membranes of 
untreated and cAMP - differentiated NG108 - 15 cells.
Treatment [32P] ADP-ribose incorporated % of cpm
into 39 +40 kDa band in untreated
(cpm) membranes
Experiment 1
Untreated 912 ± 22 100
Dibutyryl cAMP (1 mM) 2215 ±236 243
Forskolin (10 fiM) .1804±.160 198
Experiment 2
Untreated 504 ± 22 100
Prostaglandin El (10 pM) 1212 ± 30 276
8 -bromo cAMP (1 mM) 1393 ± 26 240
The autoradiograph described as Fig. 4.3. was used as a template to locate the 
radioactivity at approximately 40 kDa which was excised from the dried gel and 
determined by liquid scintillation counting. No radioactivity was incorporated into 
polypeptides of this approximate size in the absence of pertussis toxin. Data for the cpm 
are means ± S.E. (n=4). The cells were maintained in the differentiating agents for 6  
days.
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Figure 4. 4.
High - resolution SDS - PAGE analysis of membranes from control 
and db cAMP - differentiated NG108 - 15 cells subjected to mono 
ADP - ribosvlation with pertussis toxin .
Membranes (25 jig) of control (A, B) or db cAMP - differentiated (ImM, 6  
days) (C) NG108-15 cells were incubated with [3^P] NAD+ and in the absence (A) 
or presence (B,C) of pertussis toxin for 90 min as described in section 2.10.
5. Samples were subjected to NEM treatment [section 2. 7. 2.], recovered by 
deoxycholate / TCA precipitation and finally resolved using SDS - PAGE (12.5 % 
(w/v) acrylamide ) as described in section 2. 8 . and autoradiographed. Similar 
results were obtained in 2  other experiments.
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db cAMP - treated cells perhaps reflecting a significant increase in the levels of the 39 
kDa polypeptide.
4. 2. 3. Pertussis toxin treatment of NG108 - 15 membranes in vitro 
results in the total pool of being ADP - rihosvlated.
There are particular difficulties in using data from ADP - ribosylation studies as 
a means of quantitatively assessing changes in the amounts of the G - proteins in the 
cells. It has been noted that, depending on the tissue under investigation, less than the 
theoretical maximal degree of ADP - ribosylation may occur. In brain for example, the 
substrate NAD+ can be degraded by NAD+ - glycohydrolases present and hence is not 
available as a substrate for the toxin [Milligan et al., 1987a]. Although no attempt has 
been made to directly assess this enzymic activity in NG108 - 15 cells, the possibility 
that the alterations observed in labelling of the G - proteins were artifactual was 
investigated. Cell membranes prepared from control cells were treated with pertussis
'¥) 4-toxin and [ P ] NAD as described in section 2.10. 4. These samples and 
others which had not been pertussis toxin - treated were resolved on SDS - PAGE (10 
% (w/v) acrylamide) and immunoblotted with antiserum OC1 which recognizes G0a  
[Fig. 4. 5.]. It can be seen from this experiment that the immunoreactive species 
migrated more slowly in membranes that had been treated with pertussis toxin. This 
reduction in mobility is likely to be due to the increase in molecular weight caused by 
the addition of the ADP - ribose moiety by the toxin.
Another conclusion to draw from this experiment is that since there is a single 
immunoreactive band of G0a  in the pertussis toxin - treated samples then it implies that 
all of the available G0a  in these membranes has indeed become ADP - ribosylated thus 
validating attempts to quantify changes in their levels during differentiation by excision
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Figure 4. 5.
Immunoblotting of membranes from control and pertussis toxin - 
treated NG108 - 15 ceils with antiserum P C I.
Control cell membranes (A) and membranes which had been ADP - 
ribosylated with pertussis toxin and [ 32p ] NAD+ for 90 min (B) as described in 
section 2.10. 5. were subjected to deoxycholate /  TCA precipitation followed 
resolution by SDS - PAGE (10 % (w/v) acrylamide) under denaturing conditions 
and subjected to immunoblotting as described in sections 2. 7. 1. , 2. 8 . & 2. 
12. using antiserum OC1 (1 :  5000) as the primary agent 100 }ig of membrane 
protein was used in each lane. Similar results were obtained in 2 other experiments.
Figure 4. 5.
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of the labelled bands and their subsequent liquid scintillation counting.
Although the site for ADP - ribosylation for GqOC is within the epitope 
identifiedby antiserum OC1, pertussis toxin treatment of the membranes did not reduce 
the ability of this or any of the other anti - G0a  antisera used, to recognize the protein. 
Immunoreactivity before and after pertussis toxin treatment appears to be identical
The nature of the guanine nucleotide bound to a G - protein can substantially 
alter the rate of pertussis toxin - catalysed ADP - ribosylation. In the presence of the 
GDP analogue GDPpS, the rate of ADP - ribosylation of G^a in rat glioma C6  cells 
was some four times greater than in an equivalent experiment with the GTP analogue 
GTPyS [Milligan, 1987], the implication being that pertussis toxin is better able to 
interact with the holomeric GDP - bound form of the G - protein than with the 
monomeric GTP - bound form. This conclusion has been supported by the observation 
that G0a  is a poorer substrate for pertussis toxin when it is separated from its py 
subunit complex. This is reversed upon addition of purified py back into the system 
[Neer et al., 1984]. This problem of potential changes in the levels of Py subunits 
during differentiation is addressed below.
4. 2. 4. Construction of standard curves for quantitation of 
immunoblots with the various G^a antisera.
Since pertussis toxin catalysed ADP - ribosylation of G - proteins can be 
modulated by a number of factors other than the absolute levels of the a  subunit, other 
means of assessing G - protein identity and their status within the plasma membrane 
were utilised.
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The primary amino acid sequences of at least 10 G - protein a  subunits have 
been identified by cDNA cloning although not all of the corresponding proteins have 
yet been purified [Jones & Reed, 1987; Tanabe, 1985; Lochrie et al, 1985]. Using the 
information gained from these analyses it is possible to generate a variety of selective 
probes which can be used in the identification of the individual G - proteins. A series of 
such probes have been developed, namely antipeptide antisera, which have been shown 
to be mono - specific in their identification of several G - proteins. These antisera were 
raised by the method described by Goldsmith et al., [1987] against a number of 
peptide sequences known to be unique for particular G - proteins and have been 
characterized extensively in Chapter 3. Amongst these antisera are a number which 
were raised against particular sequences of G0a  [see Table 2.1,]. These antisera, 
namely IM1, OC1 and ONI, were used in determining the degree of modulation of 
G0a  observed when NG108 -15 cells are morphologically differentiated. This 
involved subjecting the membranes to the western or immunoblotting technique 
[Towbin et al., 1979] described in section 2.12. This procedure involves 
resolving membranes on a conventional SDS - PAGE gel and electroblotting the 
proteins onto a sheet of nitrocellulose. The nitrocellulose is first incubated with the anti 
- G - protein antisera then with a second antisera which can recognize the first antisera. 
This second antibody normally contains a detection apparatus of some kind. In the 
experiments to be described the second antisera used was a commercial donkey anti - 
rabbit IgG which is linked to a horseradish peroxidase activity. Visualization of the G - 
protein is achieved using orthodiansidine as a substrate and hydrogen peroxide as the 
reaction catalyst
It was elected to tiy and overcome the problem of quantitation of protein with 
the antisera in two ways. Firstly by densitometric analysis of the resulting immunoblots 
and comparing changes in immunoreactivity relative to an arbitrary value for the control 
and secondly to charge the immunoblots with [ ^ 1] - labelled donkey anti - rabbit
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immunoglobulin, excise the bands and count on a Gamma counter. However for any 
of these techniques to be valid it was first necessary to construct a standard curve using 
a range of amounts of membranes in order to find the optimum amount of protein to be 
used in subsequent experiments.
4. 2 . 4. (a). Antiserum IM1.
A range of amounts of membrane protein, from 10 - 250 fig, was subjected to 
analysis by immunoblotting with antiserum IM1 [Fig. 4. 6 . (a)]. IM1 was raised 
against amino acids 22 - 35 from the amino terminus of the a  subunit of G0  [see Table 
2.1.] and is specific in its recognition of this G - protein.
This blot shows increasing immunoreactivity with increasing amounts of 
membranes with a maximum signal occurring at between 200 - 250 pg of protein 
resolved. It should also be noted that there was hardly any immunoreactivity noticeable 
below 100 ug. This preliminary analysis suggests that the optimal amount of protein to 
see any changes in the levels of G0a  on an immunoblot using this antiserum lies 
between 1 0 0  and 2 0 0  ug.
It is possible however to get a more quantitive analysis of immunoblot data by 
densitometrically scanning a film positive taken from the blot [see section 2 . 1 2 .
4.]. Computer analysis of the scan can be used to give an indication of the relative 
amounts of GQa. Fig. 4. 6 . (a) was subjected to densiometric scanning and 
computer analysis. The results are plotted graphically as Fig. 4. 6 . (b). This figure 
also appears to give an optimal range of between 100  and 2 0 0  pg protein in which to 
see any differentiation - induced changes in the levels of GQa. This blot was then 
probed with [ ^ 1] - labelled donkey anti - rabbit immunoglobulin as described in 
section 2. 12. 5. and counted. The results were plotted as Fig. 4. 6 . (c). This 
data appears to correlate with that obtained from the densiometric analysis of the blot. It
110
Figure 4. 6. (a).
Immunoblotting of NG108 ■ 15 membranes with antiserum IM1 to 
determine optimal loading for detection of modulations in G^a .
Various amounts of control NG108 -15 membranes were subjected to 
deoxycholate / TCA precipitation followed resolution by SDS - PAGE (10% (w/v) 
acrylamide) under denaturing conditions and subjected to immunoblotting as described 
in sections 2. 7. 1. , 2. 8 . & 2. 12. Antiserum IM1 ( 1: 200 dilution) | was used 
as the primary reagent. Lane a contained 10 pg membrane protein; lane b, 25 pg; lane 
c, 50 pg; lane d, 100 pg; lane e, 150 pg; lane f, 200 pg; lane g, 250 pg. Similar 
results were obtained in 3 other experiments.
Figure 4. 6. (a).
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Figure 4. 6. (b).
Quantitative analysis of immunoblot with antiserum IM1 showing
ontimal loading of NG108 - 15 membranes: Densitometric scanning.
The immunoblot shown previously as Fig. 4. 6. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as 
changes in immunoreactivity relative to an arbitrary control value.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
| sample corresponding to 100  ug membrane protein and are the mean of three separate 
I experiments ± S EM.
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Figure. 4. 6. (c).
Quantitative analysis of immunoblot with antiserum IM1 showing 
optimal loading of NG108 - 15 membranes : f l3 i .Il - labelled 
donkey anti - rabbit immunoglobulin overlay.
The immunoblot shown previously as Fig. 4. 6 . (a), was analysed using 
the [125]] - labelled donkey anti - rabbit immunoglobulin overlay technique as 
described in section 2.12. 5. The immunoreactive bands were excised as 
counted on a gamma counter. The results are presented graphically as the DPM 
obtained with each of the different amounts of membrane protein analysed.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
sample corresponding to 100  ug membrane protein and are the mean of three separate 
experiments ± SEM.
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gives an optimal range in which to see any modulations in the levels in G0a  caused by 
morphological differentiation of between 1 0 0  and 2 0 0  jug protein.
Although antiserum IM1 has been characterized and is specific in its 
identification of GQa, it was important to corroborate any results obtained with this 
antiserum with the other available G0a  antipeptide antisera. The antisera used were 
OC1 which was raised against the extreme carboxy terminal sequence of GQa  and 
ONI which was raised against the sequence at its amino terminus [see Table 2.1.]. 
Both of these antisera have been characterized in chapter 3.
4. 2 . 4. (b). Antisera P C I & ONI.
Antisera OC1 and ONI were subjected to the same standard curve analysis as 
IM1. Figs. 4. 7. (a) and 4. 7. (b) show the blots and subsequent densitometric 
analysis for antiserum OC1 whereas Fig. 4. 7. (c) shows the results from the 
[125j] _ labelled donkey anti - rabbit immunoglobulin overlay for this antiserum.
Figs. 4. 8 . (a), 4. 8 . (b) and 4. 8 . (c) shows the same analysis for antiserum 
ONI. Increasing amounts (10 - 250 p g ) of control membranes were used and 
immunoblotting was identical to that for IM1. Both of these antisera appeared to fall 
within the range of protein amounts obtained from the results with IM1 although it 
should be noted that both OC1 and ONI show greater immunoreactivity for GQa  than 
IM1 and as such were used at a greater dilution (1:5000 compared to 1: 200 for IM1).
From the above experiments it was decided to investigate any changes in G0a  
immunoreactivity with differentiation using 10 0  pg of plasma membrane fraction in a 
series of immunoblots with the various GQa  - specific antisera.
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Figure 4. 7. (a).
Immunoblotting of NG108 - 15 membranes with antiserum OC1 to 
determine optimal loading for detection of modulations in G^a .
Various amounts of control NG108 -15 membranes were subjected to 
deoxycholate /  TCA precipitation followed resolution by SDS - PAGE (10 % (w/v) 
acrylamide) under denaturing conditions and subjected to immunoblotting as 
described in sections 2. 7. 1. , 2. 8 . & 2. 12. Antiserum OC1 ( 1 : 5000 
dilution) was used as the primary reagent Lane A contained 10 pg membrane 
protein; lane B, 25 pg; lane C, 50 pg; lane D, 100 pg; lane E, 150 pg; lane F, 200 
pg; lane G, 250 tig. Similar results were obtained in 3 other experiments.
Figure,.,4i-7. (a),
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Figure 4 t 7t (fr)t
Quantitative analysis of immunoblot with antiserum OCt showing 
optimal loading of NG108 ■ 15 membranes : Densitometric scanning.
The immunoblot shown previously as Fig. 4. 7. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as 
changes in immunoreactivity relative to an arbitrary control value.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
sample corresponding to 100  ug membrane protein and are the mean of three separate 
experiments ± S EM.
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Figure 4. 7. (c).
Quantitative analysis of immunoblot with antiserum P C I showing 
optimal loading of NG108 - 15 membranes : r ll5 n  - labelled 
donkey anti - rabbit immunoglobulin overlay.
The immunoblot shown previously as Fig. 4. 7. (a), was analysed using 
the [125]] _ labelled donkey anti - rabbit immunoglobulin overlay technique as 
described in section 2.12. 5. The immunoreactive bands were excised as 
counted on a gamma counter. The results are presented graphically as the DPM 
obtained with each of the different amounts of membrane protein analysed.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
sample corresponding to 100  ug membrane protein and are the mean of three separate 
experiments ± SEM.
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Figure 4. 8. (a).
Immunoblotting of NG108 - 15 membranes with antiserum ONI to 
determine optimal loading for detection of modulations in G ^a.
Various amounts of control NG108 -15 membranes were subjected to 
deoxycholate /  TCA precipitation followed resolution by SDS - PAGE (10 % (w/v) 
acrylamide) under denaturing conditions and subjected to immunoblotting as 
described in sections 2. 7. 1. , 2. 8 . & 2. 12. Antiserum ONI ( 1 : 5000 
dilution) was used as the primary reagent Lane A contained 101ig membrane 
protein; lane B, 25 pg; lane C, 50 pg; lane D, 100 pg; lane E, 150 pg; lane F, 200 
pg; lane G, 250 pg. Similar results were obtained in 3 other experiments.
Figure 4. 8. (a).
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Figure 4. 8. fb).
Quantitative analysis of immunoblot with antiserum ONI showing 
optimal loading of NG108 - 15 membranes with : Densitometric 
scanning.
The immunoblot shown previously as Fig. 4. 8 . (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as 
changes in immunoreactivity relative to an arbitrary control value.
!
i
| Inset. Results were expressed graphically as a percentage of the value obtained for the 
j sample corresponding to 100  ug membrane protein and are the mean of three separate 
; experiments ± SEM.
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Figure 4. 8. (c).
Quantitative analysis of immunoblot with antiserum ONI showing 
optimal loading of NG108 - 15 membranes : 1125.11 - labelled 
donkey anti - rabbit immunoglobulin overlay.
The immunoblot shown previously as Fig. 4. 8 . (a), was analysed using 
the [125i] - labelled donkey anti - rabbit immunoglobulin overlay technique as 
described in section 2.12. 5. The immunoreactive bands were excised as 
counted on a gamma counter. The results are presented graphically as the DPM 
obtained with each of the different amounts of membrane protein analysed.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
sample corresponding to 100  ug membrane protein and are the mean of three separate 
I experiments ± SEM.
D
PM
2001
Figure 4. 8. (cV
300
300200100
ug membrane protein
200 H
ON1
100 H
0 100 200 3 0 0
ug membrane protein
120
4^-5^_Im m unoblot analysis in the modulations in the levels of 
upon morphological differentiation.
Initial experiments were performed using antiserum IM1. Fig. 4. 9. (a), 
shows the results of one such immunoblot. In this experiment 100 pg of plasma 
membrane fraction prepared from the control cells and from each of the treatments were 
immunoblotted with 1: 200 dilution of antiserum IM1. It can be seen that there is a 
marked increase in immunoreactivity with this antiserum in the membranes from all of 
the cells treated with the various differentiating agents when compared with the control. 
Densitometric scanning analysis of this blot revealed there to be at least a doubling in 
immunoreactivity in each of the treated cells [Fig. 4.9. (b).]. This confirms the data 
obtained from the ADP - ribosylation studies which suggested that the increase in 
labelling observed upon differentiation was indeed due to an increase in the amounts of 
G0a  in the plasma membrane. Immunoblots of membranes from cells treated with the 
various agents with the other available GQa  antisera revealed a similar picture. The 
control membranes and the cAMP - differentiated membranes were immunoblotted 
using antiserum OC1 [Fig. 4. 10. (a).] and antiserum ONI [Fig. 4. 11.
(a).].Densitometric analysis of the immunoblots obtained in both of these experiments 
revealed there to be a marked increase in immunoreactivity with each of the treatments 
thus confirming with these other antisera that there is indeed an increase in the levels of 
GQa in these cells upon differentiation [Figs. 4. 10. (b). & 4. 11. (b).].
4._2,_jL_Construction of standard  curve analysis for immunoblot 
quantitation with the antisera raised against the B subunit.
G - proteins exist as heterotrimeric complexes consisting of a  and p / y 
subunits. Since in all physiological situations the y subunit remains tightly associated 
with p, detection of the p subunit can be taken as indicative of the py complex. The py
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Figure 4t.A.-(a)i
Immunoblotting of membranes of untreated and cAMP - differentiated 
NG108-15 cells with antiserum IM1 to detect G^a.
Membranes (100 pg) of control (A,D) and cAMP - differentiated NG108 - 15 
(B,C,E,F) cells were resolved by SDS - PAGE (10%  (w/v) acrylamide), transferred 
to nitrocellulose and immunoblotted using antiserum 1:200 dilution of IM1. Lanes A, 
D, untreated cells, lane B, cells treated with 8 - bromo cAMP (1 mM); lane C, with 
prostaglandin E^ (10 pM); lane E, with db cAMP (1 mM); lane F, with forskolin (10 
pM). Similar results were seen in 4 further experiments.
Fi2 ure 4. 9. (a).
Figure 4. 9. (b).
Ouantitatiye_analYsis of control and cAMP - differentiated NG108 - 15 
cells with antiserum IM1: Densitometric scanning.
The immunoblot shown previously as Fig. 4. 9. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as changes 
in immunoreactivity relative to an arbitrary control value. Lanes A, D contain 
membranes from untreated cells. The other lanes represent cells differentiated with 8 - 
bromo cAMP (1 mM), lane B; PGEi (10 pM), lane C; db cAMP (1 mM), lane E; 
forskolin (10 pM), lane F.
Inset. Densitometric analysis of membranes from each of the variously treated NG108 
-15 cells immunoblotted with antiserum IM1 was performed. Results are expressed as 
a percentage of an arbitrary control value of 1 0 0% given to untreated cells and represent 
the mean of 4 separate experiments ± S.E.M. Lane 1 contains membranes from 
untreated cells; lane 2, cells treated with ImM db cAMP; lane 3,1 mM 8 - bromo 
cAMP; lane 4,10 uM PGEi; lane 5,10 uM forskolin.
Ar
ea
 
O.
D.
 (%
 
co
nt
ro
l)
Eigm;?. A ..2 , ft).
400
:l 300
200
100
543
300 -i
200 H
100 H
123
Figure 4. 10. (a).
Immunohlotting of membranes of untreated and cAMP ■ differentiated 
NG108 - 15 cells with antiserum PCI to detect
Membranes (100 |ig) of control (A,D) and cAMP - differentiated NG108 -15 
(B,C,E,F) cells were resolved by SDS - PAGE (10 % (w/v) acrylamide), transferred 
to nitrocellulose and immunoblotted using antiserum OC1 (1: 5000 dilution) as the 
primary reagent Lane B, cells differentiated with db cAMP (1 mM); lane C, with 
forskolin (10 |±M); lane E, with 8 - bromo cAMP (1 mM); lane F, with prostaglandin 
E i (10 pM). Similar results were seen in 4 further experiments.
Figure 4. 10. (a).
Figure 4. 10, Ob).
Quantitative analysis of control and cAMP - differentiated NG108 - 15
cells with antiserum OC1: Densitometric scanning.
The immunoblot shown previously as Fig. 4.10. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as changes 
in immunoreactivity relative to an arbitrary control value. Lanes A, D contain 
membranes from untreated cells. The other lanes represent cells differentiated with db 
cAMP (1 mM), lane B; forskolin (10 (iM), lane C; 8 - bromo cAMP (1 mM), lane E; 
PGE1 (10 pM), lane F.
Inset. Densitometric analysis of membranes from each of the variously treated NG108 
-15 cells immunoblotted with antiserum OC1 was performed. Results are expressed as 
a percentage of an arbitrary control value of 10 0% given to untreated cells and represent 
the mean of 4 separate experiments ± S.E.M. Lane 1 contains membranes from 
untreated cells; lane 2, cells treated with ImM db cAMP; lane 3,1 mM 8 - bromo 
cAMP; lane 4,10 uM PGEi; lane 5,10 uM forskolin.
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Figure 4. 11. (a).
Immunoblotting of membranes of untreated and cAMP ■ differentiated 
NG108 - 15 cells with antiserum ONI to detect G^ot.
Membranes (100 fig) of control (1) and cAMP - differentiated NG108 -15 
(2,3,4,5) cells were resolved by SDS - PAGE (10 % (w/v) acrylamide ), transferred 
nitrocellulose and immunoblotted using antiserum ONI (1:5000 dilution) as the 
primary reagent. Lane 2, cells differentiated with db cAMP (1 mM); lane 3,with 8 - 
bromo cAMP (1 mM); lane 4, with forskolin (10 jiM); lane 5, with prostaglandin E | 
(10 fiM). Similar results were seen in 4 further experiments.
F i g u r e  4 ,  1 1 ,  f a ) t
Figure 4. 11: (b).
Quantitative analysis of control and cAMP - differentiated NG108 - 15 
cells with antiserum ONI: Densitometric scanning.
The immunoblot shown previously as Fig. 4.11. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as changes 
in immunoreactivity relative to an arbitrary control value. Lane 1 contains membranes 
from untreated cells. The other lanes represent cells differentiated with db cAMP (1 
mM), lane 2; 8 - bromo cAMP (1 mM), lane 3; forskolin (10 pM), lane 4; PGE^ (10 
jiM), lane 5.
Inset. Densitometric analysis of membranes from each of the variously treated NG108 
-15 cells immunoblotted with antiserum ONI was performed. Results are expressed as 
a percentage of an arbitrary control value of 1 0 0% given to untreated cells and represent 
the mean of 4 separate experiments ± S.E.M. Lane 1 contains membranes from 
untreated cells; lane 2, cells treated with ImM db cAMP; lane 3,1 mM 8 - bromo 
cAMP; lane 4,10 uM PGEi; lane 5,10 uM forskolin.
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complex has been shown to be necessary for pertussis toxin to ADP - ribosylate G0a  
and as such examination of the levels of p subunit and on any observed changes in 
those levels upon differentiation must be considered. The approach used was again to 
utilise the immunoblotting technique with antiserum BN1 as the primary reagent. BN1 
was raised against a peptide sequence at the extreme N - terminus of the pi subtype of 
the p subunit [see Table 2.1]. The standard curve approach used with the other 
antisera was again employed in order to ascertain the optimal amount of membrane to 
be used in subsequent immunoblots. 10 - 250 jig of protein was immunoblotted using 
antiserum BN1 [Fig. 4.12. (a)] and subjected to densitometric analysis exactly as 
before [Fig. 4.12. (b)]. This yielded a range of protein values of between 100 and 
2 0 0  jig in which any modulation in the levels of P subunit upon differentiation would 
be observed. This was confirmed using the [ ^ 1 ]  - labelled donkey anti - rabbit 
immunoglobulin method [Fig. 4. 12. (c)] .
4. 2. 7. Immunoblot analysis of modulation in the levels of the B 
subunit upon morphological differentiation.
Modulation in the levels of the p subunit has been shown to occur in a number 
of instances. In rat adipose tissue, hypothyroidism has been shown to be associated 
with an increase in the steady state levels this protein [Milligan et al., 1987b]. More 
recently Ros and coworkers have shown that adrenalectomy results in a loss of the P 
subunit by up to 50 % in rat fat cells and that dexamethosone treatment reverses the 
decline as assessed by quantitaive immunoblotting and northern analysis [Ros et al., 
1989a; Ros et al., 1989b]. However as no genomic clones for the P subunit have 
been isolated as yet, there is no indication as to the genomic regulation of this protein 
although the presence of a glucocorticoid responsive element (GRE) is inferred.
1 0 0  jig of membranes prepared from control cells and from the differentiated 
cells were subjected to immunoblotting with antiserum BN1 [Fig. 4.13.]. Only a
128
Figure 4. 12. (a).
Immunoblotting of NG108 - 15 membranes with antiserum BN1 to
determine optimal loading for detection of modulations in ft ■ 
subun it.
Various amounts of control NG108 -15 membranes were subjected to 
deoxycholate /  TCA precipitation followed resolution by SDS - PAGE (10 % (w/v) 
acrylamide) under denaturing conditions and subjected to immunoblotting as 
described in sections 2. 7. 1. , 2. 8 . & 2. 12. Antiserum BN1 ( 1 : 200 
dilution) was used as the primary reagent Lane A contained 10 jig membrane 
protein; lane B, 25 jig; lane C, 50 jig; lane D, 100 jig; lane E, 150 jig; lane F, 200 
|ig; lane G, 250 jig. Similar results were obtained in 3 other experiments.
Figure 4. 12. (a),
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Figure 4. 12. (h).
Quantitative analysis of immunoblot with antiserum BN1 showing 
optimal loading of NG108 - 15 membranes : Densitometric scanning.
The immunoblot shown previously as Fig. 4.12. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as 
changes in immunoreactivity relative to an arbitrary control value.
| Inset. Results were expressed graphically as a percentage of the value obtained for the . 
| sample corresponding to 100  ug membrane protein and are the mean of three separate 
experiments ± SEM.
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Figure 4. 12. (c).
Quantitative analysis of immunoblot with antiserum BN1 showing 
optimal loading of NG108 - 15 membranes : rl25.Il - labelled 
donkey anti - rabbit immunoglobulin overlay.
The immunoblot shown previously as Fig. 4.12. (a), was analysed 
using the [ ^ I ]  _ labelled donkey anti - rabbit immunoglobulin overlay technique 
as described in section 2.12. 5. The immunoreactive bands were excised as 
counted on a gamma counter. The results are presented graphically as the DPM 
obtained with each of the different amounts of membrane protein analysed.
Inset. Results were expressed graphically as a percentage of the value obtained for the 
sample corresponding to 100  ug membrane protein and are the mean of three separate 
experiments ± SEM.
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Figure 4. 13. (a).
Immunoblotting of membranes of control and cAMP - differentiated 
NG108 - 15 cells with antiserum BN1 to detect p-subunit.
Membranes (100 ug) of control (C) and cAMP - differentiated NG108 -15 
(A,B,D,E) cells were resolved by SDS - PAGE (10 % (w/v) acrylamide), transferred 
to nitrocellulose and immunoblotted as described in sections 2 . 1 2 . 1 . & 2 . 1 2 . 2 . 
using antiserum BN1 (1: 200 dilution) as the primary reagent A single band of 36 
kDa, corresponding to the P subunit which is common to all of the G-proteins was 
observed in all samples, with only minor variations in intensity of the staining. Cells 
differentiated with, lane a, db cAMP (1 mM), lane b, forskolin (10 |iM), lane c, 
undifferentiated cells, lane d, 8 - bromo cAMP (1 mM), lane e, PGE^ (10 pM).
Similar results were obtained in 3 other experiments.
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Figure 4. 13. (b).
Quantitative analysis of control and cAMP - differentiated NG108 - 15 
cells with antiserum BN1: Densitometric scanning.
The immunoblot shown previously as Fig. 4.13. (a), was analysed 
densitometrically. A film positive of the blot was scanned on a Bio - Rad video 
densitometer as described in section 2.12. 4. The results are presented as changes 
in immunoreactivity relative to an arbitrary control value. Lane C contains membranes 
from untreated cells. The other lanes represent cells differentiated with db cAMP (1 
mM), lane A; forskolin (10 JIM); lane B; 8 - bromo cAMP (1 mM), lane D; PGE^ (10 
|iM), laneE.
Inset. Densitometric analysis of membranes from each of the variously treated NG108 
-15 cells immunoblotted with antiserum BN1 was performed. Results are expressed as 
a percentage of an arbitrary control value of 1 0 0% given to untreated cells and represent 
the mean of 4 separate experiments ± S.E.M. Lane 1 contains membranes from 
untreated cells; lane 2, cells treated with lmM db cAMP; lane 3,1 mM 8 - bromo 
cAMP; lane 4,10 uM PGEi; lane 5,10 uM forskolin.
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small change in the levels of the p subunit was observed with any of the treatments 
when analysed densitometrically [Fig. 4.13. (b).].
A major problem in G - protein quantitation has been the lack of suitable
I standards with which to compare the levels of the various G - proteins in the 
! ;  '
membrane. One way round this might be to compare the radioactive incorporation of
the pertussis toxin sensitive G - proteins with the densitometric scans obtained with its
corresponding immunoblot. This would yield information into the relative amounts of
each particular G - protein since pertussis toxin treatment of membranes results in the
total pool being ADP - ribosylated and thus radioactively labelled. Comparison of this
data with the densitometric scans would enable a rough measure of the comparative
levels of the G - protein pool. However, this suggestion has a major drawback;
separation of the labelled proteins on an autoradiograph would have to be such that it
would be possible to excise the relevant bands accurately. The family of pertussis toxin
- sensitive G - proteins have such similar molecular weights that it is not possible at the
present time to perform this operation. Further, the existence of at least three pertussis
toxin substrates in these cells makes this type of analysis even more complicated.
1 3 4
4, 3. Discussion.
The results in this chapter demonstrate that morphological differentiation of 
NG108 -15 cells is accompanied by an elevation in the levels of a pertussis toxin - 
sensitive G - protein as assessed by mono ADP - ribosylation proceedures. This G - 
protein was susequently identified as G0a  when immunoblotting with a series of G0a  
antisera revealed an increase in specific immunoreactivity. Quantitative analysis of these 
blots show appreciable increases in the levels of immunoreactive G0a  with each 
treatment Antiserum OCl recording increases of up to seven times the control level 
[Fig. 4.10. (b).]. No appreciable changes in the levels of the (3 subunit was 
detected.'
The full complement of pertussis toxin - sensitive G - proteins in NG108 -15 
cells has recently been assessed. As well as the a  subunits of G{2 and G0  these cells 
were shown to contain a further pertussis toxin - sensitive G - protein. This protein, 
G|3a, runs above Gj2a upon high - resolving SDS - PAGE. G jla  is either not 
expressed by these cells or it is present in such low amounts that neither the protein nor 
the mRNA coding for it can be detected [McKenzie & Milligan, 1990].
It is generally possible to resolve the pertussis toxin substrates using SDS - 
PAGE since they all appear to have slightly different apparent molecular weights. In 
such a system the mobility of the various a  subunits is such that G0  > G{2 > Gj3. Thus 
under our resolving conditions one might expect to see a third labelled band 
corresponding to G ^ a  in Fig. 4. 4.
One possible reason for its absence in this particular experiment is that perhaps 
Gj3a has not been fully separated from G[2a and as such the upper band on the figure 
represents a mixture of these two proteins. However using exactly these resolving
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conditions. McKenzie & Milligan have been able to show a triplet of labelled proteins 
corresponding to the a  subunits of Gj2, Gj3 and G0  in these cells [McKenzie & 
Milligan, 1990]. Although the triplet was obtained it appears that the Gj3a band is far 
less intense than the other bands indicating either that Gf3a is a poorer substrate for 
pertussis toxin or, more likely, that this protein is present in much lower amounts than 
either Gj2a or G0a  in these cells. However, no reliable information is available about 
the absolute amounts of the G - proteins in these cells. Since pertussis toxin treatment 
results in the ADP - ribosylation of the total pool of substrate [see Fig. 4. 5.] one 
must assume that the amount of label incorporated is directly proportional to the amount 
of protein present in the membrane. This infers that the level of G[3a in NG108 -15 
cells is much lower than the other pertussis toxin substrates and since the exposure time 
of the autoradiograph resulting in Fig. 4.4. was optimized to observe the separation 
of Gj2a from G0a  it may not have been sufficient to see any signal resulting from 
incorporation of label into Gj3a. Longer exposure of this particular autoradiograph 
resulted in loss of resolution, producing a large diffuse band in which it was not 
possible to see any resolved bands.
One potential drawback in using immunoblotting to investigate changes in the 
levels of GQa  is in its failure to provide absolute values for the amount of this protein 
in the membrane. Largely this is a reflection of the lack of availability of the revelant 
purified proteins for use as standards. It is still a major undertaking to purify 
homogeneous preparations of individual G - proteins and as such this has led to the 
hampering of development of quantitative immunoassays. However, recently a number 
of laboratories have succeeded in producing recombinant protein, derived from cDNA 
clones, which can be be recognised by the various antisera [Goldsmith et al., 1988b; 
Rasnas & Insel, 1988]. It is envisaged that with the development of diagnostic assays 
the present problems involved in quantification of G - proteins in a particular cell or 
tissue will be solved.
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Results to show that increases in the levels of G0a  during neuronal cell 
differentiation is a common phenomenon have recently been presented Asano et al. 
were able to demonstrate that differentiation of PC 12 pheochromocytoma cells with 
nerve growth factor is accompanied by an increase of some 60 - 80 % in G0a  when 
compared to control cells [Asano et al., 1989] and Brabet has shown that treatment of 
the murine neuroblastoma NIE 115 with dimethylsulphoxide results in an increase in 
G0a  immunoreactivity [Brabet et al., 1990].
Despite the virtual identity of reported cDNA sequences for bovine, rat and 
human G0 a, multiple forms of mRNA have been identified [ Itoh et al., 1986; Brann 
et al., 1987; Jones & Reed, 1987; Ovchinnikov et al., 1987; Van Meurs et al., 1987; 
Price et al., 1989]. Investigation into the molecular basis for this heterogeneity 
revealed the isolation of a number of cDNA clones which diverge at the 3' - 
untranslated region and that these differences could, in part, be the basis for the 
observed multipicity in G0a  mRNAs [ Price et al., 1990 ]. The variations in the 
relative amounts of the G0oc mRNAs may also reflect differences in the extent of 
expression of the individual transcripts in specific cell types. Consistent with this idea, 
in situ hybridization [ Brann et al., 1987 ] and immunohistochemical [ Worley et al., 
1986; Chang et al., 1988] studies have revealed that G0a  expression is limited to 
specific cell types.
The occurence of G0a  mRNAs with different 3' - untranslated regions could 
reflect the presence of multiple genes for this G - protein that are nearly identical in the 
51 - untranslated and coding regions but differ in the 3' - untranslated regions. The 
results of Southern blotting of restriction enzyme digests of bovine genomic DNA are, 
however consistent with the presence of a single G0cx gene and that the multiple 
mRNAs may result from alternate splicing of transcripts of this gene [Kaziro, 1990].
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Differential regulation of expression of mRNA and protein corresponding to 
Gsa  and G^a in rat brain cortex has been noted following chronic treatment with 
corticosterone [Saito et al., 1989]. Elevated levels of Gsa  have also been noted in a 
cell line rat pituitary line, GH3 , following exposure to dexamethasone [Chang & 
Bourne, 1987] whilst treatment of 3T3 - LI fibroblasts with dexamethasone, which 
effectively differentiates these cells into adipocytes, results in an initial increase in G0a  
followed by a decrease [Gierschik et al., 1986a]. These results imply that 
glucocorticoid hormones may be able to regulate expression of G - protein genes.
However there is a precedent for cAMP - induced modulation in the levels of G 
- proteins. Differentiation of a human promyelocytic leukemia cell line, HL60, with db 
cAMP or DMSO is accompanied by an increase in the amounts of the a  subunit of Gj2 
[Murphy et al., 1987] and begs the question at what point is gene expression 
controlled by cAMP.
Although the primary amino acid sequences of a large number of the G - 
proteins have been determined using cDNA cloning technology, little is known about 
their genomic organization and transcriptional control. cDNA cloning analysis has 
proved most useful in the identification and characterization of the known G - proteins. 
Since these analyses reveal only the sequence of the final encoded protein and nothing 
of the upstream non - coded regions, very little is known about the regulation of the 
various G - protein genes. Isolation of the complete genomic sequence which would 
include putative promotor regions would be useful.
In a recent paper a number of human genomic clones encompassing the gene for 
Gi2a were isolated from db cAMP differentiated HL60 cells and characterized. Several 
transcriptional elements including a possible AP2 binding site were identified 
[Weinstein et al., 1988]. Analysis of the 5* flanking sequence showed no TATA box
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but did reveal the presence of a GCAAT box and at least five GC boxes which are 
potential DNA binding sites for the transcriptional factor Spl. In this respect the Gf2a 
gene appears to be controlled in a similar way to the so - called " housekeeping " genes 
[Weinstein etal., 1988].
Genomic sequences for G0a  have come from studies on the dgo gene from 
Drosophila melanogaster. This gene, which maps to 47A on the second chromosome 
encodes for two proteins ( termed DGol and DGo2) which are both 354 amino acids 
long but differ in seven amino acids in the amino - terminal region [Yoon et al., 1989]. 
These two polypeptides share 81 % homology with rat G0a  [Jones & Reed, 1987].
Analysis of the genomic clones revealed that there are eight coding exons and 
that the putative transcripts for the two proteins differ in the 5* - noncoding regions and 
the first coding exons but share the remaining six coding exons. The difference in the 
5' - noncoding regions raises the possibilty of differential transcriptional control 
through regulation by different promotors. Indeed consensus sequences for a TATA 
box and a transcription initiation site were found upstream from the translation site for 
the DGol gene product and since the first coding exon for DGo2 is located some 5 
kilobases further upstream from this transcription initiation site, it is highly unlikely that 
these sequences regulate the expression of the DGo2 transcript. Another promotor 
located further upstream very likely regulates the expression of this transcript Closer 
analysis of the 5f - noncoding region of both of the transcripts did not uncover any 
CRE or GRE consensus sequences.
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Chanter 5
CHANCxES IN RECEPTOR FUNCTION ACCOMPANY THE 
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Chapter 5
CHANGES IN RECEPTOR FUNCTION ACCOMPANY THE 
DIFFERENTIAL REGULATION OF G^nt AND G»re TN rih <-AMP - 
TREATED NGI08 - 15 CELLS.
5. 1. Introduction.
Although the subject of much investigation a function for the guanine nucleotide 
- binding protein G0  has still to be clearly elucidated. A number of immunological and 
biochemical studies have shown that distribution of G0a  is essentially restricted to 
neuronal [Gierschik et al., 1986b; Homburger et al., 1987; Asano etal., 1989] and 
endocrine tissues [Terashima et al., 1987; Joumot et al., 1987]. It has been noted that 
the levels of this protein increase in brain during ontogenic development whereas those 
of GjOC remained almost constant at all ages. These observations might suggest that G0  
and Gj participate in different functions in different cell types within the nervous system 
[Milligan et al., 1987c; Asano et al., 1988a; Asano et al., 1989].
Reconstitution experiments have been undertaken to clarify the funtion of G0. It 
was observed that purified preparations of Gja and G0a  were equipotent in their ability 
to interact with partially purified or highly purified muscarinic receptors [Florio & 
Stemweis, 1985; Haga et al., 1986; Kurose et al., 1986] and with GAB A g  
receptors [Asano et al., 1985].
However in some reconstitution models G^a and G0a  were reported to have 
different efficacies. In membranes of the eye- mutant of S49 lymphoma cells, Gja 
activated with GTPyS was found to inhibit adenylyl cyclase, whereas G0a  - activated 
in a similar manner was inactive [Roof et al., 1985]. Similarly Katada and coworkers
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were able to show that activated Gj(X inhibited partially purified Gsa  - stimulated 
adenylyl cyclase whereas activated G0a  had no effect [Katada et al., 1986] thus 
indicating that G0  may not be able to interact with the components of the adenylyl 
cyclase system.
NG108 -15 cells have been shown to express opioid receptors of the 5 
subclass which are able to modulate the inhibition of certain calcium currents. These 
voltage - sensitive Ca^+ channels [ VSCC ] can only be detected in cells differentiated 
with agents which maintain an elevated level of intracellular cAMP. Hormonal 
regulation of the channels appear to be preferentially transduced via G0  [Hescheler et 
fl/., 1987].
It has been established however that these same opioid receptors are able to 
stimulate high - affinity GTPase activity and to inhibit adenylyl cyclase in membranes 
prepared from NG108 - 15 cells [Koski & Klee, 1981]. Preincubation of the 
membranes with affinity - purified antibodies directed against the C - terminal region of 
Gj2a, led to an abolition of opioid - peptide stimulation of high - affinity GTPase 
activity [McKenzie et al., 1988], which led to the conclusion that the opioid receptor 
interacted selectively with Gj2a in these cells.
Clearly there must be some alteration in the ability of the 5 - opioid receptor to 
interact with the efector systems in these cells which is brought about by differentiation 
of the cells. It has already been demonstrated in chapter 4 that morphological 
differentiation of NG108 -15 cells following treatment with a variety of agents which 
act via a common mechanism of raising intracellular cAMP caused an increase in the 
levels of the a  subunit of the guanine nucleotide - binding protein GQ.
The results presented in.chapter 5 looked at potential alterations in the
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transducing elements coincident with db cAMP - induced differentiation of NG108 -15 
cells. Firstly, modulation in the levels of the major pertussis toxin - sensitive G - 
proteins caused by incubation of the cells with db cAMP was more carefully examined 
and secondly, the effects of these changes on opioid - mediated inhibition of adenylyl 
cyclase in these cells were assessed.
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5. 2. 1. Analysis of membranes from control and db cAMP - 
differentiated NG108 - 15 cells with pertussis and cholera toxin.
It was decided to examine what effect morphological differentiation has upon a 
defined signal transducing pathway in NG108 -15 cells. The pathway examined was 
the interaction of the 8  - opioid receptor with Gj2a which results in an inhibition of 
adenylyl cyclase. The membranes used in the experiments to be described were 
produced from a series of incubations with cells cultured and harvested over 5 
passages. This ensured that these membranes were as equivalent as possible. Db cAMP 
was used as the differentiating agent in these experiments simply because it is the most 
common agent used to differentiate these cells and has the largest literature available for 
comparison of results obtained with a number of systems.
NG108 -15 cells in tissue culture were incubated for 6  days with ImM db 
cAMP to produce morphological differentiation as previously described [see section
2. 4. 6 .]. Membranes prepared from these cells were resolved on SDS - PAGE (10 
% (w/v) acrylamide). Subsequent staining with Coomassie Brilliant Blue revealed no 
major changes in the protein profile with differentiation, an observation agreeing with 
results discussed previously [see Fig. 4. 2.].
5. 2. 1. (a). Pertussis toxin.
Membranes were treated with [^P] NAD+ and pertussis toxin and resolved by 
SDS - PAGE (10 % (w/v) acrylamide). An increase in incorporation of label 
compared to the control membranes was observed in the differentiated membranes 
when the gel was subjected to subsequent autoradiography [Fig. 5 .1J. In this
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Figure 5. 1.
SDS - PAGE analysis of membranes from control and dh cAMP - 
differentiated NG108 - 15 cells subjected to mono ADP - rihosvlation 
with either cholera or pertussis toxin.
Membranes (25 jig) of control (a,c,d,f) or db cAMP - differentiated (ImM, 6  
days) (b,e) NG108 -15 cells were ADP - ribosylated with [32p] NAD+ and cholera 
toxin, (a,b) pertussis toxin, (d,e) or without toxin, (c,f) for 90 min as described in 
section 2.10. 5. Samples were recovered by deoxycholate /  TCA precipitation, 
resolved using SDS - PAGE (10 % (w/v) acrylamide) and autoradiographed as 
described in section 2. 8 .1 . Similar results were obtained in 5 other experiments.
Figure 5. 1.
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particular experiment the radioactivity incorporated, upon cutting and counting the 
appropriate bands, was 753 cpm in the control cells compared to 1233 cpm for the 
differentiated cells, an increase of some 64 %. This figure agrees well with the increase 
obtained in previous experiments [see Table 4. 2.].
5. 2 . 1 . (b). Cholera toxin.
Mono ADP - ribosylation of these membranes with cholera toxin also revealed 
an increase in incorporation of label into membranes of the db cAMP treated cells. 
Membranes (25 fig) were treated with [ P] NAD+ and cholera toxin and resolved by 
SDS - PAGE (10 % (w/v) acrylamide )[Fig. 5.1.]. A broad band was observed at 
around 45 kDa, the position on the gel where one would expect to find radioactivity 
incorporated into Gsa. In this experiment there were 368 cpm in the control 
membranes and 500 cpm in the differentiated membranes, an increase of some 36 %. 
This gave the first indication that modulation of G - proteins other than G0a  may be 
occuring upon morphological differentiation.
5. 2 . 2 . Immunological analysis of membranes from control and db 
cAMP - differentiated NG108 - 15 cells.
Having previously shown that the associated increase in [32p] ADP - 
ribosylation by pertussis toxin in membranes from differentiated cells could be 
accounted for in part by an increase in the levels of GqCX. Attempts were made to assess 
the relevant contributions of the major pertussis toxin substrates, namely the a  subunits 
of G{2 and G0, in membranes of control and db cAMP - differentiated cells by using 
specific antisera which selectively recognize the a  subunits of each of these G - 
proteins.
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Figure 5. 2.
Immunoblotting of membranes of control and db cAMP - differentiated 
NG108 - 15 cells with antisera which discriminate between G; and G^.
Membranes (150 |ig) from (1) control or (2) db cAMP - differentiated (1 mM, 
6  days) NG108 -15 cells were resolved by SDS - PAGE (10 %(w/v) acrylamide), 
transferred to nitrocellulose and immunoblotted as described in sections 2 . 1 2 . 1 . 
and 2 .12 .2 . using either (a) antiserum AS7 (1 : 200 dilution) or (b) antiserum IM1 
(1 : 200 dilution). Similar results were obtained in 3 other experiments.
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5. 2. 2. (a). Antiserum IM1.
Membranes from control and db cAMP treated NG108 -15 cells were resolved 
by SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum IM1 as 
the primary reagent This antiserum, which was raised against a synthetic peptide 
corresponding to amino acids 22 -35 of the a  subunit of G0, identified a 39 kDa 
polypeptide which was more abundant in membranes from the differentiated cells [Fig. 
5. 2. (b).]. This observation confirmed the previous results obtained with the 
variously treated cells and this .antiserum [see Fig. 4.9.]. Densitometric analysis 
showed that antiserum LMl immunoreactivity was increased some 4.3 - fold in 
membranes from differentiated cells, a figure which tallies well with results previously 
obtained with this antiserum and with the other G0a  antisera [see Figs. 4. 9 ., 4.
10. & 4. 11.] .
5. 2. 2. (b). Antiserum AS7.
Membranes from control and db cAMP treated NG108 -15 cells were resolved 
by SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted using antiserum AS7 as 
the primary reagent This antiserum, which recognizes an epitope within the C - 
terminal 10 amino acids of the a  subunit of Gjl and Gj2, identified a 40 kDa 
polypeptide in both control and differentiated membranes. However, staining of this 
band was more intense in membranes of the control cells, indicating the presence of 
higher amounts of a form of Gj(X in these membranes than in membranes of the db 
cAMP - differentiated cells [Fig. 5. 2 (a)]. Densitometric scanning of Fig. 5. 2.
(a) indicated that the amount of the a  subunit of Gj was some 3 - fold lower in 
membranes of the differentiated cells in comparison with the control cells [Fig. 5.
3.]. In a series of different preparations, the levels of Gi<x immunoreactivity with AS7 
was decreased by some 2 -3  fold in membranes from the differentiated cells in 
comparison with the controls when analysed densitometrically.
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Figure 5. 3.
Densitometric analysis of an immunoblot showing membranes from 
control and dbcAMP - differentiated NG108 - 15 cells with antisera 
which discriminate between Gj_and G^.
A film positive of the immunoblot shown as Fig. 5.' A-was scanned 
densitometrically as described in section 2.12. 4. on a Bio - Rad 620 video 
densitometer linked to an Oliveti M24 personal computer. The results are shown 
graphically with the relevant amounts of each G - protein expressed in arbitrary units in 
order to give some indication to the extent that differentiation has on the modulation of 
each particular G - protein.
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5. 2. 2. (c). Antiserum LE2.
Antiserum AS7 was generated against the C - terminal decapeptide of the a  
subunit of rod transducin [ Tdl ]. This antiserum was able to recognize the 
predominant form of Gja in brain, G jla, because there is only one conservative 
amino acid change between it and Tdl a  [Goldsmith et al. 1987]. However Gf2a has 
an identical C- terminal sequence to G jla  and as such cross - reacts with AS7 to the 
same extent as G ila [Milligan, 1988]. To define the molecular identity of the form of 
"Gi" it was decided to utilise antiserum LE2 which has been shown to specifically 
recognize Gi2a but not G ila. This antiserum was raised against a synthetic peptide 
sequence which corresponds to amino acids 160 -169 of the a  subunit of a mouse 
macrophage Gi protein [see Table 2. L] that has been shown to be identical to Gi2a 
[Sullivan et al., 1986; Backlund et al., 1988]. Comparison of this sequence with 
predicted amino acid sequences from cDNA's isolated from rat C6  BUI glioma cells 
and human monocytes has shown complete identity in this region [Sullivan et al..
1986; Itoh et al., 1986; Didsbury et al., 1987]. Antiserum LE2 has been shown not to 
recognize G ila  from brain but does recognize a pertussis toxin substrate in neutrophils 
[Goldsmith et al., 1987].
Membranes from control and db cAMP - differentiated cells were resolved on 
SDS - PAGE (10 % (w/v) acrylamide) and immunoblotted with antiserum LE2 as the 
primary reagent [Fig. 5. 4.]. This antiserum recognized a single polypeptide of some 
40 kDa in NG108 -15 cells. This protein migrated with the same apparent mobility on 
a 12.5 % (w/v) SDS - PAGE gel as the polypeptide identified by antiserum AS7 in 
these cells and indeed immunoblotting of these membranes with a mixture of these 2  
antisera only revealed a single immunoreactive species [data not shown]. This confirms 
other reports that G ila  is either not expressed in these cells or is present in such low 
abundance that neither the protein nor the mRNA encoding this protein can be detected
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Figure 5. 4.
Immunoblotting of membranes of control and db cAMP - differentiated 
NG108 - 15 cells with antiserum LE2.
Membranes (150 fig) from (1) control or (2) db cAMP - differentiated (1 mM, 
6  days) NG108 - 15 cells were resolved by SDS - PAGE (10 % (w/v) acrylamide), 
transferred to nitrocellulose and immunoblotted as described in sections 2.12.1. 
and 2.12.2. using antiserum LE2 (1: 200 dilution) which specifically recognizes the 
a  subunit of Gj2. Similar results were obtained in 3 other experiments.
Figure 5. 4.
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[Milligan, 1988; McKenzie & Milligan, 1990]. Thus antiserum AS7 can be used in 
these cells as a specific means of detecting Gj2a.
When compared to membranes from untreated cells it can be seen that the 
polypeptide recognized by antiseum LE2 is somewhat less prevalent in db cAMP - 
differentiated cell membranes [Fig. 5.4.]. Densitometric analysis of this particular 
immunoblot revealed that the levels of Gj2a decreased to only some 22 % in the 
membranes of cells differentiated with db cAMP when compared to the controls. This 
parallels the observations seen in the immunoblots with these membranes using 
antiserum AS7 [see Fig. 5 .2 .] and confirms that morphological differentiation of 
these cells with db cAMP results in differential regulation in the amounts of both the a  
subunits of Go and Gi2 .
5. 2. 2. (d). Antiserum HPA.
We have already shown, using a specific antipeptide antisera raised against a 
sequence in the (3 subunit ( antiserum BN1), that differentiation of these cells 
produces little alteration in the levels of the P subunit [see Fig. 4.13.]. Antiserum 
HPA was raised by immunization of a rabbit with holomeric G0  purified from bovine 
brain and as such contains populations of antibodies directed against both the a  subunit 
of G0  and against its associated P subunit This antiserum was used to confirm those 
results already obtained with antiserum BN1.
Membranes from control and db cAMP - differentiated cells were resolved by 
SDS - PAGE (10 % (w/v) acrylamide) immunoblotted with antiserum HPA [Fig. 5. 
5.]. A single immunoreactive species corresponding to the p - subunit was observed. 
Little difference in immunoreactivity between the different membranes could be 
detected, agreeing with the earlier observations with antiserum BN1. As with the
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Figure 5. 5.
Immunoblotting of membranes of control and db cAMP - differentiated 
NG108 - 15 cells with antiserum HPA.
Membranes (150 jig) from (2) control or (1) db cAMP - differentiated (1 mM, 
6  days) NG108 -15 cells were resolved by SDS - PAGE (10 % (w/v) acrylamide), 
transferred to nitrocellulose and immunoblotted as described in sections 2 . 1 2 . 1 . 
and 2.12.2. using antiserum HPA (1 : 200 dilution). Similar results were obtained in 
3 other experiments.
Figure 5. 5.
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antipeptide antisera against the a  subunit of G0  PM1, OC1, ONI], antiserum HPA 
demonstrated elevated levels of G0a  in the db cAMP - differentiated cell membranes 
compared with control cell membranes.
5. 2. 3. Time course of db cAMP - mediated alterations of amounts of 
G^a in membranes NG108 - 15 cells.
SDS - PAGE (10 % (w/v) acrylamide) and subsequent immunoblotting with 
antiserum IM1 of membranes derived from NG108 -15 cells which had been 
differentiated with ImM db cAMP for various times showed that amounts of the a  
subunit of G0  increased throughout the time period used, with particularly marked 
increases of G0a  noted between 3 and 4 days after addition of db cAMP [Fig. 5 .6 ]. 
In contrast, however, amounts of G0a  were not different in untreated cells which were 
harvested at various times after subculture. This is illustrated in lanes (a) and (b) of 
Fig. 5. 6 . where untreated cells harvested at 1 and 6  days after subculture show no 
obvious change in immunoreactivity with this antiserum.
5. 2. 4. Time course of db cAMP - mediated alterations of amounts of 
Gja in membranes NG108 - 15 cells.
Studies on modulation of the levels of Gi2a in response to db cAMP with time 
demonstrated that amounts of immunoreactive Gi2 a  fell throughout the period studied 
[Fig. 5.7.]. As for G0 a, alteration in the amounts of Gj2a was strictly dependent 
on the presence of db cAMP. Growth of NG108 -15 cells in only 2 % (v/v) foetal 
bovine serum, a prerequisite for morphological differentiation (Hamprecht et al.,
1985], but in the absence of db cAMP did not produce any alterations in the levels of 
the a  subunits of either G0  or G[2 demonstrating that such alterations were a specific 
response to the presence of db cAMP [Figs. 5. 6  & 5. 7.]. The optimal 
concentration of db cAMP in order to produce morphological differentiation is 1 mM, at
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Time course of db cAMP - mediated alterations of amounts of the a  - 
subunit of in membranes of NG108 - 15 cells.
Antiserum IM1 (1: 200 dilution) was used as first antibody in an immunoblot 
following resolution of membranes (150 pg) of NG108 -15 cells on SDS - PAGE (10 
% (w/v) acrylamide). Lane a, untreated cells grown in the presence of 10 % (v/v) 
bovine foetal serum, 1 day after subculture, lane b; untreated cells 6  days post 
subculture, lanes c-f, db cAMP-treated cells after 1 (c), 2 (d), 4 (e) and 6  (f) days in the 
presence of ImM db cAMP, lane g, untreated cells grown for 6  days in the presence of
2 % (v/v) foetal bovine serum but without db cAMP.
Inset. The results shown as Fig. 5. 6. were analysed densitometrically and
expressed graphically as a percentage of the control at 0 days.
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Figure 5. 7.
Time course of db cAMP - mediated alterations in the amounts of the a  - 
subunit of G; in membranes of NG108 - 15 cells.
Antiserum AS7 (1:200 dilution) was used as primary antiserum in an 
immunoblot following resolution of membranes (150 jig) of NG108 -15 cells on SDS 
- PAGE (10 % (w/v) acrylamide) . Lane a, cells grown in the presence of 2 % (v/v) 
foetal bovine serum but in the absence of db cAMP for 6  days; lanes b-e, cells grown in 
the presence of 2% (v/v) foetal bovine serum andlmM db cAMP for 6  (b), 4 (c), 2 (d) 
and 1 (e) days; lane f-g, cells grown in. 10 % foetal bovine serum and harvested either 6
(f) or 1 (g) days after subculture..
Inset. The results shown as Fig. 5. 7. were analysed densitometrically and
expressed graphically as a percentage of the control at 0 days.
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0.5 mM it is almost without effect [Hamprecht et a i, 1985].
5. 2. 5. The effect of morphological differentiation upon 5 ■ opioid 
receptor function.
One of the most convenient means to assess the function of a G - protein - 
linked receptor is to measure changes in the levels of second messenger production 
caused by activation of the signalling system by ligand. Amongst those readily 
measured are the production of inositol polyphosphates from receptor - mediated 
polyphosphoinositide hydrolysis and changes in the concentrations of various ions eg 
Ca2+ K+ brought about by modulation of ion channels [for reviews see Bimbaumer 
et al., 1987; Litosch, 1990; Dolphin, 1990]. However the most studied is the positive 
and negative regulation of adenylyl cyclase [Gilman, 1984; Northup, 1985; Gilman, 
1987].
Hormonal regulation of adenylyl cyclase manifests itself in the cellular 
environment as alterations in the levels of intracellular cAMP, changes of which are 
able to be measured using any of a number of sensitive radioassays.
NG108 -15 cells express a wide variety of cell surface receptors [Hamprecht et 
al., 1985], a number of which, including those for opioid peptides and (X2  adrenergic 
agents, are able to mediate the inhibition of adenylyl cyclase [Klee et al., 1985; Sabol 
& Nirenberg, 1979]. The inhibition by 8  opioid agonists requires the presence of both 
GTP and Na+ [Blume et al., 1979] and has been shown to function through a 
pertussis toxin - sensitive G - protein as prior treatment of the cells with pertussis toxin 
produces attenuation of the receptor - mediated inhibition [Kurose et al., 1983].
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Table 5. 1.
Effects of saturating amounts of the opioid peptide DADLE on forskolin 
- stimulated adenvlvl cvclase activity on membranes from control and db 
cAMP - differentiated ( 1 mM. 6  davs ) NG108 - 15 cells.
Prep adenylyl
cyclase activity 
Control db cAMP
differentiated
+ 10 |xM + 10 }iM
DADLE DADLE
1 258 212 328 334
2 190 145 196 210
3 448 382 412 382
4 202 164 290 278
av. 274.5 ±59 225.8 ± 46.7 306.5± 38.7 301 ±32.1
Membranes (20 jig) of control or db cAMP - differentiated NG108 - 15 cells were 
incubated for 10 minutes at 30 °C in the presence or absence of DADLE (10 jiM ) as 
described in section 2.14. The inhibition of adenylyl cyclase is expressed as pmol 
cAMP /  min/ mg protein. The data in the table is from individual experiments performed 
on membranes from 4 separate preparations. Each individual point is expressed as the 
mean of three replicates and the average value for the 4 preparations represents the 
mean ± S.E.M.
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5. 2. 5, (a). Inhibition of adenvlvl cvclase activity bv the opioid peptide 
DADLE is abolished in membranes of db cAMP - differentiated NG108 - 
15 cells.
Differences in 8  - opioid receptor - mediated inhibition of adenylyl cyclase 
activity resulting from differentiation were investigated Measurement of basal activity 
in membranes was not possible given the sensitivity of the assay used and so in order 
to measure any inhibition of adenylyl cyclase activity the membranes were stimulated 
with forskolin, a diterpene compound which directly activates the catalytic domain of 
the enzyme [Seamon et al., 1981]. The method employed in this study, which 
measures the amounts of cAMP as an assessment of cyclase activity, was based on the 
binding - protein assay devised by [Tovey et al., 1974] [see section 2.14.]. This 
entailed incubation of the membrane with ligand and subsequent measurement of the 
cAMP levels with a competition assay using a known, fixed amount of the tritium 
labelled compound and a binding protein which has a high affinity and specificity for 
cAMP.
Forskolin (100 pM ) - stimulated adenylyl cyclase activity in membranes of 
control (274.5 ± 59.0 pmol /  min /  mg protein; mean ± S.E.M., n = 4 ) and db cAMP 
- differentiated (306.5 ± 38.7 pmol /  min /  mg protein; mean ± S.E.M., n = 4 )
NG108 -15 cells was very similar. However this activity was inhibited by a saturating 
concentration (10 pM ) of DADLE by some 21 ± 1 % in the control membranes, 
whereas opioid - mediated inhibition of adenylyl cyclase was essentially abolished in 
membranes of differentiated cells (1 ± 1 % )[Table 5.1.]. Statistical analysis by use 
of student's t test for paired samples within each individual experiment indicated that 
the DADLE inhibition of adenylyl cyclase in control membranes was significant ( P < 
0.005). However, the same analysis of db cAMP - treated membranes revealed no 
significance (P  >0.1). The attenuation of inhibition could be a reflection of the
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Table 5. 2 .
Maximal stimulation of high affinity GTPase activity in response to the 
opioid peptide DADLE in membranes of control and db cAMP 
differentiated ( 1 mM. 6  davs ) NG108-15 cells.
high affinity GTPase activity 
(pmol/min/mg protein)
[DADLE] Control db cAMP
differentiated
0 26.1 ±3.2  25.2 ±3.6
lpM  35.5 ±3.8 27.2 ±3.3
Results represent means ± S.E.M. for 6  independent experiments performed with 
membranes derived from separate cultures.
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decrease in the amounts of Gj2oc, the G - protein demonstrated to be involved in opioid 
- mediated inhibition of adenylyl cyclase.
5. 2. 5. (frl. High affinity GTPase activity stimulated hv the onioirt 
peptide DADLE is attenuated in membranes of db cAMP - differentiated 
NG108 ■ 15 cells.
NG108 -15 cells have been shown to contain a single subset of opioid 
receptors of the 8  subclass which when activated have been shown to stimulate high - 
affinity GTPase activity and inhibit adenylyl cyclase [Sharma et al, 1975; Koski & 
Klee, 1981].
The interaction of agonist with receptor promotes the release of GDP from the 
relevant G - protein and allows the binding of GTP. This is followed by the subsequent 
hydrolysis of GTP by the intrinsic GTPase activity of the G - protein. Measurement of 
this enhanced rate of GTPase activity of a cell in response to agonist thus provides a 
simple, convenient and direct assessment of the interaction of a G - protein with its 
particular receptor. Using the assay described by [Cassel & Selinger 1976], alterations 
in the levels of DADLE - stimulated GTPase activities in membranes from control and 
db cAMP - treated cells were investigated.
_ Stimulation of both control and db cAMP differentiated cell membranes with a 
saturating concentration (1 jjM ) of the synthetic 8  - opioid peptide DADLE produced 
an elevation over the basal level of membrane high - affinity GTPase activity [Table 5. 
2.]. There was no change in the basal GTPase activities between control and the db 
cAMP treated membranes [26.1 ± 3.2 pmol / min /  mg protein compared to 25.2 ± 3.6 
pmol /  min /  mg protein]. There was a significant stimulation of GTP ase activity in the 
control membranes with DADLE [ from 26.1 ± 3.2 pmol /  min /  mg protein to 35.5 ± 
3.8 pmol /  min /  mg protein ] However, no significant increase in GTPase activity was
160
observed in the differentiated membranes upon DADLE stimulation [25.2 ± 3.6 pmol /  
min /  mg protein versus 27.2 ± 3.3pmol /  min /  mg protein ]. Statistical analysis by use 
of Student's t test for unpaired samples indicated that the DADLE stimulation of 
GTPase activity was significantly greater in the control membranes than in the 
differentiated membranes ( P = 0.001). Similar analysis using Student's t test for 
paired samples indicated that within each each individual experiment, DADLE 
stimulation of membrane high affinity GTPase activity in control cell membranes 
produced a statistically significant increase ( P < 0.05). However, response to 
DADLE in the dbcAMP - differentiated membranes was not significant ( P > 0.1).
Dose response curves of GTPase stimulation in response to DADLE indicated a similar 
EC5 0  ( the concentration of agonist giving 50 % of maximal response) of around 10 
nM for the ligand in both the control and the differentiated membranes [Fig. 5 .8 .].
The loss of ligand - stimulated GTPase activity observed with dbcAMP 
differentiation of the cells may simply be a reflection of the reduction in the levels of 
that G - protein which interacts with the receptor, an observation consistant with the 
attenuation of adenylyl cyclase activity seen in these membranes upon differentiation.
The basal GTPase activity in any membrane system is thought to be a composite 
of the hydrolysis of GTP by all the G - proteins within that membrane as well as by 
other enzymic reactions. Thus, the contribution of any particular G - protein to the basal 
GTPase is dependent on both the amount of that particular G - protein and its rate of 
GTP hydrolysis. Since there is no difference in the basal GTPase activities between 
membranes from control and differentiated cells, the contribution to this activity by 
Gj2a and G0a  is either low, such that alterations in the levels of the G - proteins'will 
have no effect or the fact that these proteins are differentially modulated compensates 
for any possible changes.
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Figure.,5t..gt
High affinity GTPase activity stimulated bv the opioid peptide DADLE 
in membranes of control and db cAMP - differentiated NG108 - 15 cells.
The high affinity GTPase activity of membranes (5 jig) from either control cells 
(o-o) or for those which had been treated for 6  days with db cAMP (ImM) (•-•) was 
assessed as described in section 2.13. The data is expressed as the stimulation of 
high affinity GTPase activity by DADLE above that noted for the basal. The data 
represent means ± S.E.M. derived from 4 separate preparations.
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5. 2. 5. (c). Binding of &H1 DADLE to membranes from control and db 
cAMP - differentiated NG108 - 15 cells.
Although the absolute number of receptors was apt to vary to some degree 
between different membrane preparations, analysis of saturation - binding studies using 
[^H] DADLE indicated that membranes from untreated cells contained maximal binding 
of 173.1± 24.6 fmol bound /  mg protein ( mean ± S.E.M., n = 4 ) which decreased to
89.5 ± 13.7 fmol bound / mg protein ( mean ± S.E.M., n = 4 )  upon differentiation [ 
Table. 5. 3. ]. Thus only some 51.7 % of the number of opioid receptors were 
present in in membranes of the db cAMP treated cells compared to the control cells in 
individual sets of membrane preparations
The receptors from both control and differentiated membranes displayed 
equivalent affinities for [ ] DADLE ( control, 2.2 ± 0.3 nM, mean ± S.E.M., n = 5
; differentiated, 2.8 ± 0.3 nM, mean ± S.E.M., n = 4 )  [Fig. 5. 9.]. No differences 
were noted in the number of receptors present in individual membrane preparations 
derived from cells grown in the presence of either 10 % or 2  % (v/v) foetal bovine 
serum.
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Table 5. 3.
The binding of f2-Hl DADLE to membranes of control and dh cAMP 
differentiated ( 1 mM. 6  davs ) NG108 - 15 cells.
Prep rlH l DAL AMID Rinding
ffmQl frQiynfl / mg prQfcin) 
Control db cAMP
differentiated
1 199.5 111.8
2 148 77
3 149 89
4 196 80
av. 173.1 + 24.6 89.5 ± 13.7
Membranes (150 jig) of control or db cAMP differentiated NG108 -15 cells were 
incubated for 20 minutes at 30 °C with 20 nM [^H] DADLE in the presence or absence 
of DALAMID (10 |iM ) as described in section 2.15. The data in the table is from 
individual experiments performed on membranes from 4 separate preparations and 
represent the difference between total and non - specific binding and hence are 
indicative of specific binding. Each individual point is expressed as the mean of two 
replicates which varied by less than 10 % and the average value for the 4 preparations 
represents the mean ± S.E.M.
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Figure 5. 9.
The binding of l^Hl DADLE to membranes of control and db cAMP -
differentiated NG108 - 15 cells.
Membranes (150 jig), of control ( )  or db cAMP - differentiated (1 mM, 6  
days) ( no. NG108-15 cells were incubated with varying concentrations of [3ffJ 
DADLE in the presence or absence of DALAMID (10 uM) as detailed in section 2. 
15. The data in this representative experiment show the difference between total and 
non-specific binding and hence is indicative of specific binding. Each point is the mean 
of two replicates which varied by less than 10 %. Similar results were obtained in 3 
other experiments.
Inset. The data presented as Fig. 5. 9. was subjected to Scatchard analysis. The ! 
membranes (150 ug) from control (®) or db cAMP treated (cr) NG108 -15 cells are 
represented.
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5. 3. Discussion
The results presented in this chapter demonstrate that morphological 
differentiation of NG108 - 15 cells with db cAMP is accompanied not only by an 
increase in the levels of G0a  but also by a decrease in the levels of Gj2a. These 
changes were concommitant with alterations in the signal transducing capacity of the 8 - 
opioid receptor as measured by its ability to interact with both its corresponding G - 
protein and effector.
The responsiveness of both control and db cAMP - treated membranes to opioid 
peptides as assessed by either interaction with G - protein [ GTPase activity ] or more 
distally with the adenylyl cyclase effector system was examined. In both of these cases 
the maximal effect of the ligand at saturating concentrations was markedly lowered, if 
not completely abolished, in the treated cell membranes in comparison to those from the 
untreated cells. There was no marked difference in the concentrations of the agonist 
required to produce half - maximal effects. However, as the number of opioid receptors 
present in the differentiated membranes was lower than in the control cells by some 50 
%, it is not possible to assess with any certainty whether the alteration in receptors or 
the decrease in the amounts of G{2a was primarily responsible for functional changes 
caused by differentiation. The observed loss of receptor was somewhat suprising since 
Moses & Snell reported that differentiation of NG108 -15 cells with db cAMP resulted 
in a three fold increase in 8 - opioid receptor density [Moses & Snell, 1974]. However 
other studies have indicated that receptor expression in cultured cells can be modulated 
by agents that induce cellular differentiation [Noronha - Blob et al., 1986; Zhu & 
Chang, 1988; Monsma et al.9 1990].
Cellular responses to many hormones and neurotransmitters decline rapidly 
despite continuous exposure of cells to these stimuli. This waning of the stimulated 
response in the face of continuous agonist stimulation has been termed desensitization.
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Most investigators have focussed on the p - adrenergic receptor, through which the 
stimulatory actions of catecholamines on adenylyl cyclase are mediated A major 
mechanism for desensitization of adenylyl cyclase appears to be feedback regulation of 
the receptors via phosphorylation by protein kinase A. Studies with avian erythrocytes 
have shown a close correlation between catecholamine - induced desensitization and p - 
adrenergic receptor phosphorylation [Stadel et al., 1983; Stadel et al., 1986; Sibley et 
al., 1984]. These findings were taken further when it was demonstrated that the 
purified hamster lung p - adrenergic receptor is stoichiometrically phosphorylated by 
the cAMP - dependent protein kinase predominantly on two serine residues and that 
receptor phosphorylation directly inhibited its coupling to Gsa  [Benovic et al., 1985].
Protein kinase C is also able to phosphorylate the p - adrenergic receptor in 
vitro, albeit to a lesser stoichiometry than protein kinase A [Bouvier et al., 1987]. 
Stimulation of certain cells with 1 2 -0 -  tetradecanoyl 13 - acetate ( TPA), a phorbol 
ester that activates protein kinase C, has been demonstrated to influence hormone - 
sensitive adenylyl cyclase. In turkey erythrocytes TPA induces desensitization of p - 
adrenergic receptor - mediated stimulation of adenylyl cyclase. Such treatment had no 
effect on receptor number but was accompanied by a three - fold increase in 
phosphorylation of the P - adrenergic receptor [Kelleher et al., 1984].
On the other hand, in wild type S49 lymphoma cells, treatment with TPA 
resulted in an increase in agonist - stimulated, as well as basal, guanine - nucleotide - 
and fluoride - stimulated adenylyl cyclase activities [Bell et al., 1985]. These results 
suggested that phorbol ester facilitated the productive interaction of Gsa  with adenylyl 
cyclase presumably through protein kinase C. Recently Benovic and coworkers have 
identified a novel cAMP - independent kinase that appears to be involved in 
desensitization and phosphorylation of the p - adrenergic receptor [Benovic et al.,
1986]. This cytosolic enzyme, termed the p - adrenergic receptor kinase ( PARK)
I'M
appears to be ubiquitous in mammalian tissues so far examined and has the unusual 
property that it phosphorylates only the agonist - occupied form of the receptor.
The 5 - opioid receptor from NG108 -15 cells has been purified to apparent 
homogenity as a glycosylated protein with a Mr of around 58 kDa on SDS - PAGE 
[Simonds et al., 1985]. Preliminary results from cloning experiments of 5 - opioid 
receptors indicate that this receptor and the ji - opioid receptor may be products of the 
same gene. [Cabon et al., 1988]. However, no complete sequences derived from 
cDNA sequences have been reported for any of the classes of opioid - receptor and as 
such little can be stated about any possible covalent modification that they may 
undergo^
It has been demonstrated that treatment with TPA can produce phosphorylation 
of the catalytic subunit of adenylyl cyclase in frog erythrocytes and, moreover, purified 
protein kinase C can directly phosphorylate, in vitro, the catalytic subunit of adenylyl 
cyclase purified from bovine brain suggesting that phosphorylation of adenylyl cyclase 
by protein kinase C may be involved in the phorbol ester - induced enhancement of 
adenylyl cyclase activity [Yoshimasa et al., 1987]. A cDNA encoding an adenylyl 
cylase from bovine brain has recently been cloned [Krupinski et al, 1989]. The cDNA 
predicts an 1134 amino acid protein with an internally repeated structure and multiple 
transmembrane spanning regions. The protein also contains a single concensus motif 
for protein phosphorylation by protein kinase C and another for protein kinase A.
Katada and coworkers were first to demonstrate the phosphorylation of a G - 
protein a  - subunit when they demonstrated that a solubilized purified Gj preparation 
was a substrate for protein kinase C [Katada et al., 1985]. More recently, both the 
purified human insulin receptor kinase and protein kinase A have been shown to 
phosphorylate the a  subunit of purified solubilized G[ preparations [O'Brien et al.,
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1987; Krupinski et al., 1988; Watanabe et al., 1988]. In contrast, Pyne and 
coworkers were able to demonstrate that Gja can be phosphorylated in intact 
hepatocytes treated with either TPA or glucagon but not with insulin [Pyne et al.,
1989]. This G - protein was subsequndy identified as the a  subunit of G{2 using 
immunoprecipitation techniques with specific antisera [Bushfield et al., 1990].
Attenuation of opioid receptor activity can be achieved in NG108 - 15 cells with 
pharmacological manipulation. Chronic exposure of these cells to opioid agonists 
results in a loss of the receptor - mediated inhibition of adenylyl cyclase [Law et al., 
1983] and incubation of the cells with phorbol ester abolished up to 45 % of the opioid 
- mediated inhibition of adenylyl cyclase with a loss of up to 40 % of the receptor itself 
[Louie et al., 1990] thus it would appear that changes in receptor number are in 
themselves enough to produce functional changes.
A number of previous studies have shown that under certain conditions such as 
differentiation and in some pathological states, modulations in the levels of some G - 
proteins can occur [ see chapter four ]. However information about what effects 
these changes have on the interaction of that G - protein with its receptor and /  or 
effector has not been forthcoming. More information is known about the consequences 
of these changes upon the complete signalling processes.
Differentiation of 3T3 - LI cells from fibroblasts to adipocytes is accompanied 
by increased responsiveness of adenylyl cyclase to lipolytic agents [Rubin et al.,
1977]. Gierschik and coworkers were able to demonstrate that this differentiation is 
associated with alterations in the levels of G{ and G0  [Gierschik et al., 1986a]. Neer 
and colleagues showed that carbachol, a muscarinic agonist, was able to increasingly 
inhibit adenylyl cyclase in embryonic chick heart from 2.5 days in ovo until 3 days post 
hatching, a phenomenon which was primarily a result of the maturation of the 
muscarinic receptors. However it should be noted that differentiation of these cells was
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accompanied with a 2 - 3 fold increase in the levels of G0a  [Liang et al., 1986].
It is well established that activation of opioid receptors of the 8  - subtype in 
NG108 - 15 cells results in an inhibition of adenylyl cyclase activity [Koski & Klee, 
1981]. Since this inhibition can be correlated with opioid - stimulation of high - affinity 
GTPase and because the affinity of binding of opioid ligands to this receptor is reduced 
in the presence of non - hydrolysable GTP analogues, the effects of the ligand must be 
transduced via a G - protein. Also, since pretreatment of these cells with pertussis toxin 
results in the attenuation of both the receptor - mediated stimulation of GTPase activity 
[Bums et al., 1983] and inhibition of adenylyl cyclase [Kurose et al., 1983], then the 
G - protein(s) involved must be a substrate for the toxin.
Using a monoclonal antibody which has been epitope mapped to a region close 
to the C - terminus of rod outer segment Tda, Hamm and colleagues were able to block 
the interaction between rhodopsin and transducin [Hamm et al., 1987; Deretic &
Hamm, 1987]. This work was extended when it was shown that this same antibody 
could block Gj - mediated inhibition of adenylyl cyclase [Hamm et al., 1989] thus 
confirming the prediction from the theoretical model put forward by Bourne and 
coworkers that the C - terminus of the G - protein is the site of coupling to its receptor 
[Masters et al., 1986].
NG108 - 15 cells have recently been shown to contain three pertussis toxin - 
sensitve G - proteins, namely the a  subunits of Gi2, Gj3 and G0  [McKenzie & 
Milligan, 1990]. A recent study has shown that preincubation of NG108 -15 
membranes with antiserum AS7, which specifically recognises the C - terminal 
decapeptide of Gj2oc, attenuated the effects of the 8 - opioid receptor resulting in an 
abolition of both DADLE stimulation of GTPase activity and DADLE mediated 
inhibition of adenylyl cyclase [McKenzie & Milligan, 1990]. Incubation with the other
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available C - terminal anti - G - protein antisera had no effect on either of these 
parameters implying that Gj2a is the transducing element between this receptor and 
adenylyl cyclase. Further evidence to support this conclusion was obtained as 
pretreatment of NG108 -15 cell membranes with the IgG fraction of antiserum AS7 
reduced the affinity of the [^H] DADLE for the opioid receptor, this reduction being the 
same as that produced by either GppNHp or by pretreatment with pertussis toxin, both 
of which prevent interaction of receptors with pertussis - toxin sensitive G - proteins.
In similar studies, Simonds and coworkers were able to show that the tx2  - 
adrenergic inhibition of adenylyl cyclase in platelet membranes was blocked by 
pretreatment with C- terminal antibodies reactive to Gj2a but not with antibodies to 
Gi3a or G(x)za  [Simonds et al., 1989] and the affinity of binding of agonists to the
a2g adrenergic receptor of NG108 -15 cells is reduced by antiserum AS7 [McClue & 
Milligan, 1990].
Unfortunately it was not possible to use these techniques directly to investigate 
whether differentiation results in a switch in receptor interaction from G-2 to GQ.The 
reduction in DADLE - stimulated GTPase noted in membranes from db cAMP - 
differentiated cells made antibody uncoupling experiments, such as those described by 
McKenzie & Milligan, impossible to perform, simply because no effect would have 
been seen in differentiated membranes [McKenzie & Milligan, 1990].The other 
approach of using the antibodies to reduce the affinity of the receptor for its ligand 
could not be used since the reduction in receptor number observed upon differentiation 
made it difficult to see the small shift in the affinity which would result
Following cAMP - induced differentiation of these cells it is possible to measure 
an oc2  - adrenergic receptor - mediated depression of a voltage - dependent calcium 
current [Docherty & McFadzean, 1989]. This response is abolished by pretreatment of
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these cells with pertussis toxin, implying the involvement of a pertussis toxin - 
sensitive G - protein in transducing this signal. More recently, McFadzean and 
coworkers have microinjected prostaglandin Ej_ differentiated NG108 - 15 cells with 
the antipeptide antisera raised the C - terminal sequences of Gj[2a, Gj3a and G0 a, 
namely AS7,13B and OC1. The effects of each antiserum on adrenaline - induced 
inhibition of the current was assessed. Adrenaline, at maximally effective 
concentrations, was able to depress the Ca?+ current by some 26 %. Intracellular 
injection of antiserum OC1 essentially abolished the <x2 - adrenergic inhibition whereas 
the other antisera had no effect thus providing strong evidence for the involvement of 
G0a  in the regulation of Ca^+ channel function [McFadzean et al., 1989]. Similar 
conclusions had been reached by Hescheler et al. who were able to reconstitute the a  
subunits of Gj and G0, which had been purified from bovine brain, into differentiated 
NG108 -15 cells which had been pretreated with pertussis toxin. They were able to 
demonstrate a reconstitution of opioid - mediated depression of Ca^+ current and that 
the G0a  fraction was 10 times as effective as Gjcc [Hescheler et al., 1987]. It should 
be noted that since the G - proteins were purified from brain then the Gi was probably 
largely Gil which still has its function to be clearly defined, also, since the purification 
of G - proteins is extremely difficult the possibility of other contaminating G - protein a  
subunits cannot be discounted.
Upon differentiation of NG108 -15 cells there would appear to be a change in 8  
- opioid function from inhibition of adenylyl cyclase in the undifferentiated cell to 
modulation of Ca^+ currents in cells in the differentiated state. However this could 
simply be a reflection of receptor loss and not primarily due to modulation of the G - 
proteins. It is tempting to speculate however, that it is the respective amounts of a 
particular G - protein which would dictate the defined transducing pathway for that 
receptor. NG108 -15 cells appear to only contain one subset of opioid receptors, 
namely the 8  - receptor. The other opioid subsets can themselves be further subdivided 
into subgroups. The p. - opioid receptor consists of two such subtypes, fjq and that
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can be distinguished pharmacologically [Pasternak, 1986] and the iq - opioid receptor 
subtype differs from K2  in its ability to selectively bind benzeneacetamidine [Zukin et 
al., 1988]. Although diversity of the 5 - opioid receptor has yet to be established the
v
possibility of the existance of multiple forms cannot be discounted. Thus, two distinct 
opioid receptors with pharmacological characteristics of the 5 - subtype, each 
interacting via different G - proteins, would be able to produce distinct effects within a 
particular cell. This could certainly be the case with the altered effects of the <x2 - 
adrenergic ligands noted with differentiation in the NG108 -15 cells. Two distinct oc2 - 
adrenoreceptors, o2p^ and oc2 g, have been pharmacologically characterized on the 
basis of ligand binding [Bylund, 1985]. Purification of the isoforms from human 
platelet and neonatal rat lung revealed that they differed both in apparent molecular 
weight and in the number or type of their associated oligosaccharide moieties 
suggesting distinct gene products [Lanier et al.,1988]. Molecular characterization of 
these two receptors has recently been performed, these studies show that although the 
receptor isoforms display some heterogeneity in primary structure there is some 77 % 
agreement in what are the putative transmembrane domains [Kobilka et al., 1987; Zeng 
et al., 1990].
The effects of dopamine on pituitary D2  receptors were first assumed to be 
mediated solely by the inhibition of adenylyl cyclase, thus subsequently inhibiting the 
release of prolactin [Cote et al., 1984]. However recent evidence has questioned the 
role of cAMP in these dopamine - mediated effects since they appear to be associated 
with Ca2+ mobilization, [Delbeke & Dannies, 1985] a phenomenon that is probably 
mediated by dopaminergic inhibition of phosphatidylinositol turnover in pituitary 
tissues [Baudry et al., 1986; Enjalbert et al., 1986]. Moreover D2  receptors have been 
show to activate K+ channels in rat corpus striatum [Freedman & Weight, 1988] and 
rat pituitary [Israel etal., 1985] and dopamine has been shown to inhibit a Ca^+ 
current in snail neurons [Harris - Warrick et al., 1988]. Thus D2  receptors appear to
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be functionally coupled to the inhibition of adenylyl cyclase, to the attenuation of 
phospholipase C and to the regulation of various ion channels. Senogles et al. were 
able to show that partial purification of the D2  receptor by affinity chromatography 
resulted in the co - purification of two associated approximately 40 kDa pertussis toxin 
substrates [Senogles et al., 1987] and more recently that the a  - subunit of G[2 
appeared to couple with the D2  receptor with a 10 fold higher affinity than any of the 
other G - protein a  subunits tested [Senogles et al., 1990]. Two forms of the D2  
receptor have been cloned from a number of cDNA sources including rat brain 
[Bunzow etaL, 1988; Giros e ta l, 1989; Monsma e ta l, 1989], rat pituitary [Eidne 
et al., 1989] and human pituitary [Dal Toso et al., 1989] cDNA libraries. The longer 
form of the cDNA includes an additional 87 base pair insertion in the coding region and 
hence encodes an additional 29 amino acids in the functionally important third 
cytoplasmic loop. It is this loop which is one of the important sites for the coupling of a 
G - protein to its receptor. In the case of the p - adrenergic receptor, deletions or 
substitutions in the corresponding loop area tend to diminish or abolish G - protein 
activation [O'Dowd et al., 1988]. Mutational analyses of this kind will prove 
invaluable in the determination of G - protein specificity with the dopamine D2  receptor 
and indeed with all other G - protein - linked receptors.
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Chapter 6.
IDENTIFICATION OF 2 DISTINCT ISOFORMS OF THE GUANINE 
NUCLEOTIDE - BINDING PROTEIN G^g IN NG108 ■ 15 CELLS AND 
THEIR INDEPENDENT REGULATION DURING cA M P IN D U C E D
DIFFERENTIATION.
Chapter 6.
IDENTIFICATION OF 2 DISTINCT ISOFORMS OF THE OITANTNF. 
NUCLEOTIDE - BINDING PROTEIN G^g IN NG108 - 15 CELLS AND 
THEIR INDEPENDENT REGULATION DIJRTNG cAMP - TNDITCED 
DIFFERENTIATION.
6. 1. Introduction.
It was shown in chapter 4. that morphological differentiation of NG108 -15 
cells with any of a number of pharmacological agents,which act by a common 
mechanism of raising intracellular cAMP, is accompanied by an increase in the levels of 
G0a  as assessed by ADP - ribosylation by pertussis toxin and by immunoblotting with 
a series of specific antipeptide antisera raised against various regions of G0 oc.
Four pertussis toxin - substrates have recently been purified from bovine brain 
using high resolution Mono - Q anion - exchange chromatography [Goldsmith et al., 
1988a]. Comparison of these polypeptides with cloned cDNAs encoding putative a  
subunits using either specific anti - peptide antisera or their migrations on two - 
dimensional SDS - PAGE identified the a  subunits of G0, Gjl and Gf2. The fourth 
protein was a novel G -protein of slightly above 39 kDa which had a more basic pi (
6.0 against 5.6) and was indistinguishable from G0a  on immunoblots with a number 
of specific antisera. It was concluded that this protein, termed G0 a*, could represent a 
novel G0 a, although it is unclear at the present time if these proteins are the products of 
distinct genes, stem from differential splicing of nuclear RNA transcribed from a single 
gene or represent covalently modified forms of the same peptide.
One - dimensional SDS - PAGE analysis revealed only a single immunoreactive
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species of G0a  in NG108 -15 cells. The experiments described in chapter 6  
investigate the possibility of multiple forms of immunoreactive G0  in these cells using 
two - dimensional gel analysis.
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6. 2. Results.
6 . 2, 1. Analysis of G£ a  in membranes of NG108 ■ 15 cells bv two - 
dimensional immunoblotting reveals two isoforms which are 
differentially modulated upon morphological differentiation.
Membranes from control NG108 -15 cells and from cells differentiated by 
treatment for 6  days with each of dibutyryl cAMP (1 mM), 8 -bromo cAMP (1 mM), 
prostaglandin (10 pM) or forskolin (10 pM) were subjected to 2 - D SDS - PAGE 
analysis. The membranes were first solubilized for 1 hr at 4 °C with a buffer containing 
1 % (w/v) nonidet P - 40 in order to extract the G - proteins from the membranes. The 
solubilized fraction was then subjected to an isoelectric focussing first dimension 
followed by conventional SDS - PAGE (10% (w/v) acrylamide) and subsequent 
immunoblotting [ sections 2 . 1 1 . & 2 . 1 2 . ].
Resolution of membranes on such a system indicated that there was no gross 
alteration in the relative amounts of the most prevalent polypeptides brought about by 
differentiation. Fig. 6 .1 . shows a silver stained gel from control ( a ) and db 
cAMP - differentiated ( b ) membranes resolved using such a 2 - D strategy. All of the 
other differentiating treatments produced similar silver staining profiles ( results not 
shown ).
Fig. 6 .2 . shows membranes from control and db cAMP - differentiated 
which had been subjected to resolution with 2 - D SDS - PAGE (10 % (w/v) 
acrylamide) and subsequent immunoblot analysis with antiserum OC1. In contrast to 
the 1 - D analysis of these membranes [ see chapter 4 ], which revealed only one 
immunoreactive band, immunoblotting of 2 - D gels using antiserum OC1 identified 
distinct immunoreactive species of some 39 kDa with isoelectric points of 5.5 and 5.8.
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Figure 6. 1.
Two - Dimensional SDS - PAGE analysis of membranes from control 
and db cAMP - differentiated NG108 - 15 cells.
Membranes (150 p g ) from control (a) and db cAMP - differentiated cells (b) 
were solubilized for 1 hour at 4 °C and resolved by 2 - D SDS - PAGE (10 % (w/v) 
acrylamide ) as described in section 2.11. The resultant gels were silver stained as 
in section 2. 9. 2. and the positions of marker proteins with known molecular 
weights are indicated
Figure 6. 1.
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Figure 6. 2.
Two - Dimensional immunoblot analysis of membranes from control and 
db cAMP - differentiated NG108 - 15 cells with antiserum PCI to detect 
multiple isoforms of O^a  .
Membranes (150 Jig) from control (a) and db cAMP - differentiated cells (b) 
were solubilized for 1 hour at 4 °C, resolved by 2 - D SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted using antiserum OCl ( 1 : 2 0 0  dilution) as described 
in section 2.11. & 2.12. Similar results were obtained in 3 other experiments.
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Greater immunoreactivity was observed routinely for the more basic form of 
G0a  in membranes from control cells [ Fig. 6 . 2. ( a ) ] and, assuming that the 
antiserum identifies these two polypeptides equally, this suggested that the basic 
isoform was present in higher amounts in these cells. Immunoblots of db cAMP - 
differentiated cells also shows the presence of two specific immunoreactive 39 kDa 
polypeptides [ Fig. 6 . 2. ( b ) ]. Whilst the levels of the basic form of G0a  were 
almost unchanged from those of the control cells, the levels of the acidic isoform were 
markedly increased. Indeed it can be seen that the acidic isoform was now the 
predominant species in differentiated cells.
Treatment of NG108 -15 cells with the other differentiating agents produced 
qualitatively similar results. Membranes from control cells ( a ) and membranes from 
cells differentiated for 6  days with 1 mM 8 - bromo cAMP ( b ), 10 jiM forskolin ( c ) 
and 10 jllM  PGEi ( d ) ( see section 2. 4. 6 . )  were subjected to 2 - D SDS - PAGE 
(10 % (w/v) acrylamide ) and immunoblotted with antiserum OC1 [ Fig. 6 . 3. ]. In 
all cases there was an increase in immunoreactivity of the acidic isoform caused by each 
of the treatments suggesting that the observed increase in G0a  imunoreactivity on 1 - D 
SDS - PAGE elicited by morphological differentiation was due to an increase in the 
acidic isoform of two observed species of G0a  in the NG108 -15 cell.
To confirm that each of the two proteins identified with antiserum OC1 did 
indeed represent forms of G0 a, identical studies on the variously - treated membranes 
were performed using antiserum ONlwhich was raised against a different region of 
G0a  from antiserum OC1 [ see Table 2.1. ]. This antiserum also specifically 
identified two 39 kDa polypeptide species with isoelectric points of 5.5 and 5.8 which 
were equivalent to those observed with antiserum OC1. In control cells the basic 
isoform was the most prevalent and there was a marked increase in immunoreactivity in 
the acidic isoform upon differentiation with each of the treatments [ Figs. 6 . 4. & 6 .
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Figure 6. 3.
Two - Dimensional immunoblot analysis of membranes from control and 
cAMP - differentiated NG108 - 15 cells with antiserum P C I to detect 
multiple isoforms of •
Membranes (150 jig) from control (a) and cAMP - differentiated cells (b - d) 
were solubilized for 1 hour at 4 °C, resolved by 2 - D SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted using antiserum OC1 ( 1 : 2 0 0  dilution) as described 
in section 2. 11. & 2.12. Two immunoreactive G0a  species with pis of 5.8 and
5.5 were observed in all immunoblots. Panel ( b ) shows cells differentiated with 8 - 
bromo cAMP (1 m M ), panel ( c ) with forskolin (10 jiM ) and panel ( d ) with PGEj 
(10 JiM). Similar results were obtained in 3 other experiments. B is the basic side and 
A is the acidic side from the isoelectric focussing first dimension.
Figure 6. 3.
5. ] .
The possibilty that the two G0a  isoforms found in NG108 -15 differed in 
some way from each other by some form of covalent modification was investigated.
6 . 2. 2. The two forms of G ^a  found in NG108 - 15 cells are substrates 
for ADP - ribosvlation bv pertussis toxin.
The first possibility considered was that the two forms of G0a  might represent 
ADP - ribosylated and non - modified forms of the same protein. To assess this, 
NG108 - 15 cells were treated in culture with pertussis toxin ( 25 ng / ml, 16 hours) as 
described in section 2. 4. 7. and membranes prepared. Incubation of cells in vivo 
with pertussis toxin catalyses the transfer of a ADP - ribose group from the donor 
NAD+ onto a conserved cysteine which is four residues from the carboxy terminus of 
those G - proteins, including G0 a, which are pertussis toxin substrates [Milligan
1988].
Membranes from control and pertussis toxin - treated NG108 -15 cells were 
subjected to 2 - D SDS - PAGE (10 % (w/v) acrylamide), immunoblotted with 
antiserum OCl and the mobility of the forms of G0a  were compared. Following toxin 
treatment, two polypeptides of some 39 kDa were still identified by antiserum OCl, but 
both migrated as more acidic forms in comparison to the polypeptides identified in 
membranes from the untreated cells [ Fig. 6 . 6 . ]. The presence of a polypeptide of 
some 64 kDa and pi 5.7, which was identified by antiserum OCl but which was not a 
substrate for pertussis toxin - catalysed ADP - ribosylation and hence did not alter in 
mobility following pertussis toxin treatment, provided, in a serendipitous manner, an 
internal control for pertussis toxin - catalysed shifts in mobility of the two G0a  
isoforms. The 64 kDa polypeptide was not identified by antiserum ONI and hence is
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Figure 6. 4.
Two - Dimensional immunoblot analysis of membranes from control and 
db cAMP - differentiated NG108 - 15 cells with antiserum ONI to detect 
multiple isoforms of G^a  .
Membranes (150 fig ) from control (a) and db cAMP - differentiated cells (b) 
were solubilized for 1 hour at 4 °C, resolved by 2 - D SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted using antiserum ONI ( 1 : 2 0 0  dilution) as described 
in sections 2. 11. & 2.12. Similar results were obtained in 3 other experiments.
Figure 6. 4.
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Figure 6. 5.
Two - Dimensional immunoblot analysis of membranes from control and 
cAMP - differentiated NG108 - 15 cells with antiserum ONI to detect 
multiple isoforms of
Membranes (150 |ig ) from control (a) and cAMP - differentiated cells (b - d) 
were solubilized for 1 hour at 4 °C, resolved by 2 - D SDS - PAGE (10 % (w/v) 
acrylamide) and immunoblotted using antiserum ONI ( 1 : 2 0 0  dilution) as described 
in section 2. 11. & 2. 12, Two immunoreactive G0a  species with pis of 5.8 and
5.5 were observed in all immunoblots. Panel ( b ) shows cells differentiated with 8 - 
bromo cAMP (1 m M ), panel ( c ) with forskolin (10 pM ) and panel ( d ) with PGEj 
(10 |iM ).B is the basic side and A is the acidic side from the isoelectric focussing first 
dimension. Similar results were obtained in 3 other experiments.
Figure 6. 5.
Figure 6. 6.
Both acidic and basic forms of G£ a  are substrates for pertussis toxin - 
catalysed ADP-ribosvlation.
Membranes (150 jig) of untreated (a) and pertussis toxin-pretreated (25 ng/ml, 
24 h.) (b) NG108-15 cells were resolved in 2-dimensional SDS-PAGE and 
immunoblotted with antiserum OCl (1: 1000 dilution) as primary reagent Two 
immunoreactive G0a  species with pis of 5.8 and 5.5 were observed in all 
immunoblots. A 64 kDa polypeptide which was identified by the antiserum but which 
was not a substrate for pertussis toxin-catalysed ADP-ribosylation acted as an internal 
control to demonstrate that both isoforms of G0a  migrated as more acidic species 
following pertussis toxin treatment of the cells.B is the basic side and A is the acidic 
side from the isoelectric focussing first dimension.A second experiment produced 
similar results.
Figure 6. 6
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unlikely to be closely related to G0 a. Attempts to incorporate radioactivity, using 
[32p]NAD+ and thiol-activated pertussis toxin, into polypeptides in membranes of the 
pertussis toxin-treated NG108-15 cells were unsuccessful, demonstrating that the entire 
pool of pertussis toxin-sensitive G-proteins had been ADP-ribosylated by the 
pretreatment This being so it would appear that if the differences between the two 
isoforms of G0a  in NG108 -15 are indeed due to one of them being ADP - 
ribosylated, presumably the acidic form, then such a modification cannot be at the 
cysteine residue which is the target for pertussis toxin.
6 . 2. 3. Differences in the G^a  isoforms are not due to phosphorylation 
of one of the polypeptides.
It has been demonstrated recently that the pertussis toxin - sensitive G - protein, 
Gi2a, can act as a substrate for phosphorylation by protein kinase C in hepatocytes 
[Bushfield et al., 1990]. Further, this protein, which appears to be the true Gj of the 
adenylyl cyclase cascade in hepatocytes [Bushfield et al., 1990] and in NG108 -15 
cells [McKenzie & Milligan, 1990], is inactivated by such phosphorylation. Guanine 
nucleotide regulation of the inhibition of adenylyl cyclase can be restored by treatment 
of hepatocyte membranes with alkaline phosphatase. Phosphorylation of G0a  would 
result in the protein migrating as a more acidic entity under the conditions used in the 2  
- D immunoblot system and may account for the presence of the two G0a  isoforms.
To assess if the two isoforms of G0a  differed only in their phosphate content, 
membranes of db cAMP - differentiated NG108-15 cells were treated with alkaline 
phosphatase, under conditions which can remove phosphate from the a  subunit of G{2.
Membranes from db cAMP - treated NG108 -15 cells were incubated with 
alkaline phosphatase (800 units /  m l) for 30 minutes at 37 °C as described in section 
2.16. After this incubation the membranes were subjected to analysis by 2 - D SDS -
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PAGE (10 % (w/v) acrylamide) and immunoblotted with antiserum ONI [ Fig. 6 .
7. ]. No difference was observed between the untreated membranes ( panel a ) and 
those treated with alkaline phosphatase ( panel b ).
6 . 2. 4. Analysis of the isoforms of G£ a  using SDS - urea - PAGE 
immunoblotting.
Whilst 2 - dimensional electrophoresis allowed the resolution of the two forms 
of G0 a, it was noted that in some experiments a distinct fraction of the total G0a  
immunoreactivity appeared not to penetrate adequately into the isoelectic focussing tube 
gel and following the 2 nd dimension separation, was thus detected at the extreme basic 
edge of the immunoblot. Resolution of the forms of GqOC in a 1 - D gel system in which 
the total sample has been accepted into the gel would have distinct advantages over the 
2 - D system. Resolution of the two isoforms on a 1 - D system is possible if 4 M 
deionized urea is included in the SDS - PAGE resolving gel [ section 2. 8 . 3. ].
When analysed on a 2 - D immunoblot system the isoforms of G0oc migrate as 
39 kDa polypeptides. Fig. 6 . 8 . shows membranes from db cAMP - differentiated 
NG108 -15 cells which were subjected to an IEF first dimension followed by SDS - 
PAGE (12.5 % (w/v) acrylamide) analysis and subsequent immunoblotting with 
antiserum ONI [ panel a] and those resolved on a similar SDS - PAGE gel containing 
4 M deionized urea [ panel b ]. Whilst there appears to be no difference in mobility 
between the isoforms on the conventional immunoblot, a distinct shift was observed on 
the proteins separated in the presence of urea. The acidic isoform, termed G0 loc, was 
seen to migrate slightly more slowly on the blot when compared to the basic form, 
G0 2a.
187
Figure 6. 7.
Two - dimensional immunoblot analysis of db cAMP - differentiated ( 1 
mM. 6  davs ) NG108 ■ 15 membranes. Effect of alkaline phosphatase 
treatm ent.
Membranes (150 fig) from cAMP - differentiated cells were incubated for 30 
minutes at 37 °C in the absence ( a ) or presence ( b ) of alkaline phosphatase (800 
units /  ml ) as described in section 2.16.1. The membranes were then solubilized 
for 1 hour at 4 °C, resolved by 2 - D SDS - PAGE (10 % (w/v) acrylamide) and 
immunoblotted using antiserum ONI ( 1  : 2 0 0  dilution) as described in section 2 . 
11. & 2 .12.Two immunoreactive G0a  species with pis of 5.8 and 5.5 were 
observed in all immunoblots.B is the basic side and A is the acidic side from the 
isoelectric focussing first dimension. Similar results were obtained in 3 other 
experiments.
Figure 6 . 7.
Figure 6. 8.
Two - dimensional SDS-urea PAGE analysis of membranes of
IVG1Q8-15 ggllg, Thq aciflp fprm (G ^lLflf Qq£L migrates more 
slowly than the basic form (G^2 ) in this gel system.
Membranes (150 jig) from db cAMP - differentiated cells were solubilized 
for 1 hour at 4 °C. The membranes were then resolved by 2 - D SDS - PAGE (
12.5 % (w/v) acrylamide) gel ( panel a ) or on the same gel system containing 4 M 
deionized urea ( panel b ) as described in section 2. 8 . 3. Immunoblotting of 
protein following transfer to nitrocellulose was performed using antiserum ONI (1 : 
1000 dilution) as primary reagent. Similar results were obtained in 3 other 
experiments.
Figure 6. 8.
The possibility of separating G0l a  and Gq2(x on a 1 - D gel was investigated. 
Membranes from rat brain and control NG108 -15 cells were resolved on 1 - D SDS - 
urea - PAGE (12.5 % (w/v) acrylamide) and immunoblotted with antiserum ONI [ 
Fig. 6 . 9. ]. Antiserum ONI, under these conditions, now recognized a second 
polypeptide in both brain ( lane 1) and in NG108 -15 membranes ( lane 2). 
However, the second polypeptide identified in brain (Go*a in the terminology of 
[Goldsmith et al., 1988]) migrated considerably more slowly in the 1-dimensional 
SDS-urea-PAGE system than did either of the G0a  forms in NG108 -15 cells 
suggesting that G0*oc is a different protein from those in NG108 -15 cells and indeed 
that G0*a is not found in these cells. This is not entirely unexpected since the 
isoelectric points measured for G0a  and G0*a were 5.6 and 6.0 respectively 
[Goldsmith et al., 1988a] compared to 5.5 and 5.8 for G0l a  and G ^ a  suggesting 
more fundamental differences in polypeptide identity.
From Fig. 6 . 9. it can be seen that G0a  and G0*a from rat brain were well 
resolved on the 1 - D system ( lane 1) whereas G0l a  and G0 2a, being much closer 
together, made it impossible to determine whether G0a  from brain has a mobility 
identical to either of the NG108 -15 isoforms.
To circumvent this problem a smaller amount of rat brain (5 (ig as opposed to 
10 jig ) was resolved as before and compared this time to membranes of control and db 
cAMP - differentiated NG108 -15 cells [ Fig. 6.10. ]. These were resolved on a 1 - 
D SDS - urea - PAGE (12. 5% (w/v) acrylamide) and immunoblotted with either 
antiserum IM1( panel a ) or OC1 ( panel c ). The form of G0oc with lower mobility 
through the gel ( G0 l<x) was present in greatly increased levels in membranes of db 
cAMP - differentiated cells compared to the undifferentiated cells, whilst the form with 
greater mobility ( G0 2 a ) was unaltered in amount ( compare lanes 2 and 3 ). The 
more slowly migrating form of G0a  in NG108 -15 cells ( G0 l a ) appears to have
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Figure 6. 9.
Neither G gla  or G^2a correspond to G^*a.
Membranes from (1) rat brain (10 Jig) and (2) untreated NG108-15 cells (50 
jig) were resolved by 1 - D SDS - PAGE (12.5 % (w/v) acrylamide ) gel and 
immunoblotted with antiserum ONI (1:1000 dilution) as primary reagent Similar 
results were obtained in 3 other experiments.
Figure 6. 10.
One - dimensional SDS - urea - PAGE analysis of G gla  and Gg2tx.
Membranes of (1) rat brain (5 pg), (2) untreated NG108-15 cells (50 pg), (3) 
db cAMP - treated (1 mM, 6  days) NG108-15 cells (50 jig) and (4) mouse brain (5 
jig) were resolved by 1-dimensional SDS-urea-PAGE and immunoblotted with antisera 
(a) IM1 (1:200 dilution), (b) I3B (1:200 dilution) and OC1 (1:1000 dilution) as 
primary reagents. Equivalent results were produced in 4 further experiments in which 
the membranes were derived from separate cultures.
Figure 6, 9,
Figure 6. 10.
migrated identically with G0a  from rat brain. However no polypeptide corresponding 
to the more rapidly migrating form of G0a  in NG108-15 cells ( G ^ a ) was detected 
in rat brain ( panels ( a ) and ( c )).
It should be noted that NG108 -15 cells were generated by fusion of rat glioma 
C6  BUI cells and mouse neuroblastoma N18TG2 cells and as such the possibility 
exists that the two G0a  -like polypeptides present in these cells were rat and mouse 
variants of G0a  produced by distinct chromosomes derived from the parental cells of 
the hybrid.
This was examined and it was demonstrated that mouse brain G0a  also 
migrated identically with the more slowly migrating polypeptide of NG108-15 cells in 
the SDS-urea-PAGE system [ Fig. 6 .10. ] . Membranes prepared from mouse brain 
cortex were immunoblotted with antiserum IM1 ( lane 4, panel a ) and antiserum 
OC1 ( lane 4, panel c ). Two isoforms of G0  were detected which corresponded to 
G0a  and G0*a when their mobilities were compared to the isoforms found in rat 
brain. As with rat brain, no immunoreactive polypeptide was detected in mouse brain 
which corresponded to the more rapidly migrating form of G0oc of NG108 -15 cells.
Since there was the possibilty of a cross - reactivity of antiserum OC1 with 
Gi3a [ see chapter 3 ] the possibility that G0 2a was actually the Gj3a gene product 
was assessed.
Membranes from rat brain, mouse brain and from control and db cAMP - 
differentiated NG108 -15 cells were resolved upon 1 - dimensional SDS - urea - 
PAGE (12.5 % (w/v) acrylamide) and immunoblotted with antiserum I3B which was 
generated against the C - terminal decapeptide of Gj3a [ Fig. 6 .1 0 .; panel (b), 
lanes 1 - 4. ]. Gj3(X, which is expressed to a considerable degree in NG108 - 15 
cells [McKenzie & Milligan, 1990], was detected by antiserum I3B but this polypeptide
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migrated considerably more slowly through the gel [ Fig. 6 .1 0 .; panel (b) ] than
i
did either form of G0  a  as identified by antisera IM1 or OC1 [ Fig. 6 . 10.; panels 
(a), (c) ]. From this figure it seen that treatment of NG108 -15 cells with db cAMP 
resulted in a considerable decrease in the immunoreactive G|3a detected with antiserum 
I3B.
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6. 3, Discussion.
The results presented in this chapter demonstrate the presence of two isoforms 
of the a  subunit of the guanine nucleotide - binding protein G0  in NG108 -15 cells. 
Morphological differentiation of these cells results in an increase in the more acidic 
isoform as assessed using 2 - dimensional immunoblotting with specific G0a  antisera. 
These results are consistent • with observations in the neuroblastoma cell line NIE 115 
where differentiation with dimethylsulphoxide resulted in the appearance of a novel 
pertussis toxin - sensitive polypeptide with immunological characteristics of G0a  
which: had an isoelectric point similar to that of the acidic isoform of G0a  in NG108 - 
15 cells [Homburger et al., 1988.; Brabet et al., 1990]. As with the isoforms in 
NG108 -15 cells, the biochemical basis of the differences between these polypeptides 
is unknown at this time.
The possibility that these proteins differed by a covalent modification was 
investigated. Although these isoforms were not separable under normal 1- dimensional 
SDS - PAGE conditions inclusion of 4 M deionized urea to the gel resulted in the 
; observation of an immunoreactive doublet Comparison with the brain GoOC isoforms 
revealed that one of the proteins ( G0la  ) had identical mobility on the gel with brain 
G0a; the other ( G02 a ) differed from both brain G0a  and G0*a.
The a  subunit of G0  was first identified as a polypeptide of 39 kDa which co- 
purified through a number of chromatographic steps with the major form of Gi(X
4? -
(Gila) from bovine brain [Stemweis & Robishaw, 1984; Neer et al, 1984; Milligan 
& Klee, 1985] where it may represent as much as 1% of brain membrane protein 
[Stemweis & Robishaw, 1984; Gierschik et a l, 1986b].
However, detailed examination of fractions containing pertussis toxin-sensitive
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G-proteins during purifications from bovine brain have indicated the presence of two 
distinct populations of G0a  [Goldsmith et al., 1988a]. These two forms differed in 
isoelectric point and as such could be resolved on high performance ion exchange 
resins [Goldsmith et al., 1988a]. These proteins termed, G0a  and G0 *a, were 
identified with two - dimensional analysis consisting of an isoelectric focussing first 
dimension followed by conventional immunoblotting with a wide selection of antisera 
and although their molecular identities were not defined the authors reasoned that G0*a 
may be a post translationally modified form of G0 a .
Since different anti - Gq(X - antisera were unable to discriminate between the 
two polypeptides found in the NG108 -15 cells, it is unclear if the two forms were 
derived from distinct but highly homologous genes or if they were generated by either 
the differential splicing of pre-mRNA derived from a single gene or by alterations in 
covalent modification subsequent to synthesis. Both of the potential explanations which 
would be consistent with the two forms being derived from a single gene have parallels 
in other G-proteins. Firstly, it is well established that up to 4 forms of Gsa  can be 
generated via differential splicing mechanisms [Bray et al., 1986; Robishaw et al., 
1986a; Robishaw et al., 1986b] and that multiple forms of Gs a  so generated can be 
detected in a single cell. Furthermore, the recent demonstration of the production of 
alternatively spliced forms of G0a  in drosophila [de Sousa et al., 1989; Thambi et 
al., 1989; Yoon et al., 1989] offers a further potential explanation for the 
identification of distinct isoforms of G0a  in NG108-15 cells as demonstrated herein. 
Similar production of isoforms of G0a  produced by differential splicing of mRNA has 
recently been observed in mammalian systems in terms of isolation of corresponding 
cDNA species. Screening of a hamster insulin - secreting tumor cell cDNA library for 
G0a  revealed the presence of two inserts each coding for a distinct G0 a. One of the 
G0oc cDNAs encoded for a protein identical to that cloned previously from rat and 
bovine tissues whilst the other encoded for a protein that appeared to be derived from 
an alternatively spliced mRNA. This novel cDNA coded for a protein that is identical to
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\G0a  in its first two - thirds and differed in the remaining carboxyl third of the 
polypeptide [Hsu et a l, 1990].
Multiple transcripts have been identified in northern blots using a mammalian 
G0a  cDNA as probe [Jones & Reed, 1987]. Secondly, members of the "Gi-like" gene 
products have been demonstrated to be substrates for each of protein kinase C [Katada 
et al., 1985; Pyne et al., 1989; Bushfield et al., 1990], protein kinase A [Watanabe 
et al., 1988] and the insulin receptor tyrosyl kinase activity [O’Brien et al., 1987; 
Krupinski et al., 1988] under various conditions .
In a recent paper, Lang was able to isolate five pertussis toxin - sensitive G - 
protein a  -  subunits from bovine brain inducing two subforms of Go0C5 presumably 
G0a  and G0*a which were not discriminated against with a number of specific 
antisera. In situ peptide mapping using SDS - PAGE revealed different cleavage 
products with different proteases on each of these proteins [Lang, 1989] suggesting 
that these proteins were different gene products each with a discrete amino acid primary 
sequence. It should be noted that in the same study only one isoform of G0a  was 
detected in NG108 -15 cells, but this is probably as a consequence of using gel 
conditions under which the two isoforms would not be separated.
Heterogeneity of G0a  is not confined to only two subtypes; Katada and 
coworkers have identified and characterized the a  - subunits of four immunologically 
G0  - like proteins, termed 1 -4 , which were distinguishable from one another on 
elution profiles from high - resolution Mono Q column chromatography [Kobayashi et 
al., 1989; Inanobe et al., 1990]. When subjected to digestion with lysylendopeptidase 
or V8 protease and then analysed by immunoblot with a polyclonal antiserum raised 
against purified G0a  from rat brain, there were significant differences in the fragments 
which were immunoreactive with the antibody among the four a  - subunits. The
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peptide fragments tended to fall into two groups, one group consisting of subunits 1 and 2  
and the other consisting of 3 and 4 and no apparent differences were observed in their 
digested patterns between 1 and 2 or 3 and 4. All four proteins served as substrates for 
pertussis toxin - catalysed ADP - ribosylation and had a measurable GTPase activity 
suggesting that they were existent in the native membranes and not artificial products 
due to proteolysis or denaturation during the purification process [Inanobe et al.,
1990].
An NAD+ : arginine ADP - ribosyltranferase that catalyses a reaction similar to 
that of cholera toxin has been purified from turkey erythrocytes [Moss & Vaughan,
1978; Moss et al., 1979]. This enzyme has been shown to ADP - ribosylate a number 
of polypeptides in both crude mixtures and purified protein preparations including both 
the a  and |3 - subunits of purified transducin [Watkins et al., 1987]. This modification 
is not restricted to retinal G - proteins, Jacquemin was able to show that Gsa  was 
subject to ADP - ribosylation by an endogenous ADP - ribosyltransferase activity in 
membranes prepared from adipocytes [Jacquemin et al., 1986].
One possibility for differential post-translational modification might have been 
that the more acidic form had become ADP - ribosylated by this endogenous ADP - 
ribosyltransferase activity. Both isoforms of G0a  in NG108 -15 cells are substrates for 
pertussis toxin - catalysed ADP - ribosylation, as following pretreatment of the cells 
with pertussis toxin and subsequent 2  - dimensional electrophoresis both isoforms now 
migrated as more acidic proteins [ Fig. 6. 6. ]. However since neither an ADP - 
ribosyltranferase inhibitor nor any means of stripping ADP - ribose groups from the 
protein was available it cannot be demonstrated definitively that the more acidic isoform 
J had not been ADP - ribosylated by an endogenous ADP - ribosyltransferase activity at 
a site other than the cysteine residue which acts as the ADP-ribose acceptor during 
pertussis toxin catalysed ADP-ribosylation. If this is true however, then given that the
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addition of ADP-ribose would cause the polypeptide to migrate as a more acidic species 
and that the acidic isoform of G0oc from NG108-15 cells appears to be identical with 
the predominant form of G0a  from both rat and mouse brain, it would suggest that 
virtually all of the G0cx in brain contains endogenously added ADP - ribose. Moreover, 
ADP - ribosylation of transducin by an endogenous NAD+: arginine ADP- 
ribosyltransferase from turkey erythrocytes [ Watkins et al., 1987] produced a large 
alteration (4 kDa) in the apparent size of transducin a  subunit as judged by its ability to 
move through an SDS-PAGE gel. ADP - ribosylation of G -protein a  subunits by 
either pertussis or cholera toxin also produce marked mobility shifts in SDS - PAGE [ 
see Fig. 4.5. for example). Given that the mobility of G0a  in 1 -dimensional SDS - 
PAGE is entirely consistent with the size of the polypeptide as assessed from isolation 
of a corresponding cDNA [ Jones & Reed, 1987 ] and that the two isoforms show 
extremely similar mobility in 1-dimensional SDS-PAGE, endogenous ADP- 
ribosylation of the more acidic polypeptide is unlikely.
In an attempt to assess whether the two forms of G0a  were identical save for 
the post-translational addition of a phosphate group, membranes from db c AMP - 
differentiated NG108 - 15 cells, which contain high levels of the acidic form of G0a  
(G0 la), were incubated with alkaline phosphatase, the membrane proteins resolved by 
2-dimensional electrophoresis and then immunoblotted using antiserum ONI. No 
alterations in the relative amounts or mobilities of the two forms were noted. This is 
despite the fact that treatment of hepatocyte membranes under these conditions causes 
the dephosphorylation of phosphorylated G{2a and the restoration of guanine 
nucleotide mediated inhibtion of adenylyl cyclase which had been ablated by treatment 
of the cells with agents which produce an activation of protein kinase C ( M. Bushfield, 
G.Murphy, G. Milligan and M.D. Houslay, unpublished).
As the a  - subunits of forms of Gj and G0  are myristoylated at their N - 
terminus [Buss et al., 1987; Schultz et al., 1987], then it might be suggested that the
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two G0a  isoforms differ in that one isoform does not contain covalently linked myristic 
acid and that this could account for the differences in isoelectric mobility. Such an 
arguJment is not consistent with the fact that myristoylation is essential for membrane 
attachment of such G - proteins [ Jones et al. 1990] and that both of the G0a  isoforms 
are membrane associated polypeptides as membrane preparations were the starting 
material for these studies. Furthermore, Homburger and coworkers have provided 
evidence that both isoforms of G0a  in NIE 115 cells contain covalently linked myristic 
acid [Homburger et al., 1988; Brabet et al., 1990].
The possibility that one of the isoforms of G0cx represents a proteolytic product 
of the other must be considered unlikely by the fact that the antisera used were directed 
against both the extreme N - terminal ( antiserum O N I) and C - terminal ( antiserum 
OC1). Further evidence to suggest the integrity of the C-terminal region of each 
polypeptide is that, as noted above, both isoforms are substrates for pertussis toxin - 
catalysed ADP -ribosylation. As this modification occurs only 4 amino acids from the C 
- terminus then any modification at the C - terminus would have to be extremely minor 
to be consistent with the immunological detection of this polypeptide. Indeed, detailed 
examinations of the cross - reactivity or otherwise between antisera raised against the 
C-terminal deapeptides of the a  subunits of Gj2, Gj3 and G0  indicate a key role for the 
C - terminal tyrosine residue in recognition of G0a  by antiserum OC1 [ Fig. 3. 8. ].
Resolution of the forms of G0a  in a 1 - dimensional system was achieved by 
the inclusion of 4 M deionized urea in the resolving phase of SDS - PAGE. The results 
obtained by this approach were entirely consistent with those obtained using the 2  - 
dimensional system. Each of three distinct anti-G0a  antisera identified each of the two 
polypeptides and each antiserum demonstrated that cAMP - induced differentiation of 
NG108 -15 cells produced elevated levels of only one of these isoforms (G0 la ). 
Because the polypeptide whose expression was increased by the differentiation
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procedure was the acidic form and because this polypeptide migrated identically with rat 
brain G0a  in the SDS - urea - PAGE system then this can be identified as G0a  rather 
than G0*a [Goldsmith et al., 1988a]. The more basic G0a  - like polypeptide of 
NG108 -15 cells (G0 2a) is not, however, identical with G0 *a. This conclusion is 
based on the differences in mobility of G0*a and G0 2a from NG108 -15 cells in 1 - 
dimensional SDS - urea - PAGE [ Fig. 6.10. ]. G0*a migrates in this system 
considerably more slowly than G0lcx whilst G0 2a actually migrated slightly more 
rapidly than G0 la .
As none of the available antisera provide a selective probe to discriminate 
between the two isoforms of G0a  in NG108 -15 cells then the assessment of which of 
these polypeptides plays the key role in receptor regulation of voltage-sensitive Ca^+ 
channels in NG108 - 15 cells is unclear [Hescheler et al., 1987, McFadzean et al.,
1989]. As cAMP - induced differentiation is necessary to record neurotransmitter- 
mediated inhibition of such currents, it is tempting to speculate that the acidic isoform 
(G0 la) is of primary importance, as this is the form which is increased markedly in 
levels during the differentiation process.
2 0 0
\FUTURE PERSPECTIVES.
The work described in this thesis consists of two main parts. Firstly a series of 
antipeptide antisera were generated against a number of G - protein subunits, primarily 
the a  subunit of G0, and these tools were used to assess changes in the levels of the 
various G - protein components in NG108 -15 cells which had been morphologically 
differentiated. One of the major disadvantages in trying to quantitate the levels of G - 
protein a  subunits, and any subsequent modulations, is the current lack of available 
purified native protein for use as standards. More recently, with the advent of genetic 
engineering, it has become possible to obtain pure preparations of recombinant G -
protein a  subunits. This would enable the development of quantitative assays calibrated
, /
with recombinant protein giving mass, rather than relative, amounts of G - proteins in 
cell preparations.
The second part of this thesis investigated the function of G0a  in these cells and 
identified two immunoreactive species of G0a  in membranes prepared from NG108 - 
15 cells. This raises two questions which will have to be addressed in the near future, 
Firstly, determination as to whether these are two distinct proteins or covalently 
modified forms of the same protein and secondly, what consequences this has in 
ascribing functionality to each of these polypeptides.
Although alkaline phosphatase treatment of membranes had no effect on the 
immunoreactivity of these two polypeptides, the possibilty that one of the proteins 
differs by addition of a phosphate group cannot be discounted. A number of kinases 
including protein kinase A, protein kinase C and the tyrosyl kinase activity of the 
insulin receptor are able to catalyse the phosphorylation of certain purified G - proteins 
[see chapter 6]. Phosphorylation of a particular G - protein may inactivate it, thus 
allowing for the expression of a number of such proteins and the possibilty of their
2 0 1
interaction with a single species of receptor. Evaluation of the role of c AMP - 
dependent protein kinase and protein kinase C - mediated phosphorylation in the control 
of expression of G0a  should be investigated..
G0 a, as well as being myristoylated, has recently been reported to contain 
thioester - linked palmitate [M. Parenti, G. Milligan & A.I. Magee, personal 
communication], therefore the possibilty that the G0a  isoforms differ by additional 
fatty acid moeities arises. Metabolic labelling studies using various radiolabelled fatty 
acids could be used to answer this problem. Indeed such studies have already indicated 
that the half life of GoOC differs from tissue to tissue. Silbert and coworkers have 
demonstrated that G0a  is degraded more quickly in GH4  pituitary cells when compared 
to cardiocytes and, since the steady - state protein levels were similar, suggested that 
the rate of Goa synthesis was different between the cell types [Silbert et al., 1990].
They also noted that the levels of mRNA encoding G0a  were approximately equal in
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both cardiocytes and GH4  cells implying that protein translation controls could be 
important determinants of G - protein a  subunits concentrations in biological 
membranes. Indeed our laboratory could not detect any changes in G0a  mRNA levels 
elicited by differentiation of NG108 - 15 cells [C. Loney, personal communication], 
thus the observed increase in the levels of immunoreactive Goa upon differentiation in 
these cells could be a reflection of changes in degradation rates of the protein as well as 
changes in the rate of synthesis. Metabolic labelling studies using [^S ] methionine and 
subsequent immunoprecipitation with specific antisera could be used to address this 
problem.
One major drawback in investigating the molecular nature of the two 
immunoreactive species of G0a  has been the lack of discriminating antisera. The 
isolation, by Hsu and collaborators, of cDNAs encoding two G0a  proteins generated 
by alternate splicing of a single gene enables for the production of novel specific
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antisera generated against distinct peptide regions of the predicted amino acid sequences 
of these proteins [Hsu et al., 1990]. These antisera may prove successful in the 
defining the molecular identity of these polypeptides. Also generation of distinct 
oligonucleotide probes from these sequences could be used to screen a cDNA library 
from NG108 -15 cells. Such work is already in progress in our laboratory.
If antisera,which were able to discriminate between the two forms of G0 oc, 
were generated, these could be used to investigate possible functions of each 
polypeptide. It should be possible be to look at the effect of these antibodies on the 
noradrenaline - induced calcium current inhibition in NG108 - 15 cells in experiments 
similar to those reported in McFadzean et al., [1989]. It may be that only one the 
antisera would have the effect that the general G0oc antiserum had. It is also possible, 
however, that the two species of G0a  isolated by Hsu and coworkers do not 
correspond to those identified in NG108 -15 cells. Probing of a cDNA library from 
these cells with a specific G0a  probe would allow isolation of any cDNA copies 
specifically for this ( these) protein(s) and subsequent predicted primary amino acid 
sequences derived from this analysis could be used to develop specific antisera. 
Assessment as to whether one or both forms of G0a  co - localise with GAP 43 may 
also provide an indication to differential functions for these isoforms.
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